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I. Introduction 
Among the huge number of natural products distributed all over the world, polyketides constitute one 
of the most important families because of their broad biological activities, such as antiviral (Takasaki 
et al., 1990), antibacterial (Yamakoshi et al., 1992) and anticancer (Yin et al., 2007) properties, 
which make them good candidates for new drug discovery. They already enfold serious classes of 
medicaments, such as picromycine, the first isolated antibiotic from the bacterium Streptomyces 
venezuelae (Suhren, 1951), and aspergiolides A, B from the fungus Aspergillus glaucus, which have 
cytotoxic effects (Du et al., 2008). In plants, curcuminoids (curcumin) and flavonoids have anti-
inflammatory (Bisht et al., 2010) and anti-cancer effects (Khan et al., 2008). Another example is the 
eucalypt polyketides, which have antiviral, antibacterial and anticancer effects. The plant is used by 
the Australians in the treatment of  influenza, fever, toothache, colds and snakebites (Ghisalberti, 
1996).  
Polyketides are widely distributed among prokaryotic and eukaryotic organisms. They are named 
polyketides because they all arise from polyketo chains. They are biosynthesized through a serious of 
decarboxylative condensation reactions catalyzed by a group of enzymes called polyketide synthases 
(PKSs), which divide further into three main groups: Type I, Type II and Type III PKSs (Hopwood, 
1997). 
Type III PKSs have, compared to the other types, drawn much attention, as they are smaller and 
simpler but still maintain the catalytic function of polyketide chain elongation and cyclization. In 
1999, chalcone synthase (CHS) from Medicago sativa (alfalfa) was the first enzyme of this class that 
has been crystallized and still is the best studied until now (Ferrer et al., 1999). Recently, many new 
CHS-like enzymes have been crystallized, which showed a structural basis for the functional 
diversity of these enzymes. In this study, crystallization of two enzymes of the same family, 
benzophenone synthase (BPS) and biphenyl synthase (BIS), was carried out. 
BPS was cloned from cell cultures of different Hypericum species like H. androsaemum and H. 
sampsonii (Liu et al., 2003). BIS was cloned from cell cultures of Sorpus aucuparia and Malus 
domestica (Liu et al., 2007). Both enzymes were expressed successfully in our laboratory and 
subjected to extensive characterization. They utilize the same starter substrate, benzoyl-CoA, which 
is a rare starter substrate for type III PKSs. BPS forms 2,4,6-trihydroxybenzophenone via the Claisen 
condensation mechanism, but BIS forms 3,5-dihydroxybiphenyl using the aldol condensation 
mechanism (Liu et al., 2003, Liu et al., 2007). These variations in the cyclization mechanism leading 
to product variability despite the same starter substrate made both enzymes good candidates for 
crystallization and structure elucidation. 
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1. Polyketide synthases (PKSs)  
They catalyze the biosynthesis of polyketides using an acyl-CoA molecule followed by subsequent 
elongations to produce the final chain in a similar pattern to fatty acid synthases (FASs). 
1.1. Major differences between PKSs and FASs: 
Substrate variation: PKSs use different starter substrates and thus exhibit a wide range of substrate 
tolerance, whereas FASs use only acetyl-CoA as starter substrate for the synthesis of saturated and 
non-saturated fatty acids. Acetyl-CoA is carboxylated to yield malonyl-CoA, which is used by both 
enzymes as chain extender. 
Post-PKS modification: In contrast to fatty acids, further changes can occur in the structure of the 
released polyketide chains, for example oxidation to introduce hydroxyl or carbonyl groups and 
methylation at oxygen, nitrogen or carbon centers.  
These differences make the polyketides a promising source of natural products biosynthesis (Revill 
et al., 1996) (Staunton & Weissman, 2001). 
2. Types of PKSs 
2.1. Type I PKSs 
They are long polypeptides consisting of many catalytic components that include three essential 
domains: β-ketosynthase (KS), acyl transferase (AT), and acyl carrier protein (ACP). Other domains 
may be added, such as dehydratase (DH), enoylreductase (ER), β-ketoreductase (KR), and 
thioesterase (TE). These components are linked to each other by covalent bonds in a similar pattern 
of type I fatty acid synthases (Figure I.1). An example of this group is 6-deoxyerythromycine B 
synthase (DEBS), which synthesizes the macrolide antibiotics such as erythromycin A (Smith & 
Tsai, 2007). They are either modular (each active site is used only once) or iterative (the active site is 
re-used repeatedly). 
2.2. Type II PKSs 
They are multienzyme complexes, each with a single active site which can be used only once or 
iteratively (Figure I.1). They resemble ß-ketoacyl synthase II of type II FAS and biosynthesize most 
of the aromatic polyketides (Watanabe & Ebizuka, 2004); an example is tetracenomycine PKS that 
synthesizes the tetracenomycine c antibiotic (Shen, 2003). 
2.3. Type III PKSs 
In comparison to the other types of PKSs, this class in particular has more intrinsic characters and 
biosynthesis steps, which are the starter substrate preference for reaction initiation, the number of 
acetyl molecules added for chain elongation, and the cyclization pattern in addition to reaction 
termination (Austin & Noel, 2003). 
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Mostly, they are called plant PKSs because of their abundance in plants. They are homodimeric 
proteins, in which the active site of each monomer catalyzes iterative reactions to produce the 
polykeide chain. They are simpler in structure in comparison to the other types (Figure I.1) (Yu et 
al., 2012). 
 
 
Fig I.1 The different classes of polyketide synthase enzymes. 
2.3.1. Type III PKSs division 
Only a small modification of the active-site architecture leads to a significant functional diversity of 
type III PKS enzymes. In general, it is the size and the shape of the active-site cavity that determine 
the starter molecule selectivity, polyketide chain length and cyclization pattern of the final product 
(Li et al., 2011). 
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According to the reaction and cyclization mechanisms, type III PKSs are grouped as follows. 
 
Chalcone synthase-type (CHS), which utilizes the Claisen condensation mechanism, in which the 
intramolecular cyclization is from C6 to C1 (Figure I.2). This mechanism is also used for fatty acids 
biosynthesis. 
Stilbene synthase-type (STS), which utilizes the aldol condensation mechanism, in which the 
intramolecular cyclization is from C2 to C7 with loss of C1 as CO2 (Figure I.2). 
Coumaroyl triacetic acid synthase-type (CTAS), which utilizes lactonization, in which a lactone 
forms between oxygen of C5 to C1 (Figure I.2). 
Stilbene carboxylate synthase-type (STCS), whih utilizes a mechanism similar to aldol 
condensation but without decarboxylation of C1 (Figure I.2).  
Other types can undergo condensation but without cyclization, such as benzalacetone synthase 
(BAS) from Rheum palmatum and curcuminoid synthase (CUS) from Oryza sativa (Flores-Sanchez 
& Verpoorte, 2009). Below, various type III PKSs are presented in more detail, with a focus on their 
crystal structures. 
 
Fig I.2 The different reaction patterns of type III polyketide synthases.  
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2.3.2. Plant type III PKSs 
2.3.2.1. Chalcon synthase (CHS) 
CHS is the best studied enzyme of type III PKSs. The first isolation of a CHS gene from parsley 
(Petroselinum hortense) was in 1983 (Reimold et al. 1983). This enzyme catalyzes the 
decarboxylative condensation of p-coumaroyl-CoA with three molecules of malonyl-CoA to produce 
naringenin chalcone, which is the precursor for flavonoid biosynthesis (Fig I.3). Flavonoids are an 
important class of natural products, which have many medicinal effects such as antioxidant, 
anticancer, antiasthmatic and antimitotic properties (Austin & Noel, 2003). The importance of the 
CHS enzyme increased even more in 1999 as the first crystal structure of CHS2 from the legume 
Medicago sativa (alfalfa) (MsCHS2) was published, which is the first crystallized enzyme of type III 
PKSs (Ferrer et al., 1999).  
 
Fig I.3 The reaction catalyzed by chalcone synthase.  
According to its structural architecture, MsCHS2 was grouped together with ketoacetyl synthases 
(KAS III) to be enfolded in thiolase-fold enzymes. They share common features starting from αβαβα 
core, dimerization, active site location and the catalytic cysteine residue for covalent binding of 
substrate and intermediates. The MsCHS2 homodimer contains two active site cavities located at the 
bottom of each monomer. At the dimer interface a loop of six residues protrudes from each monomer 
starting from Thr132 and ending with Pro138. Only Met137 of this loop contributes to the opposing 
monomer’s active site cavity (Figure I.4) (Austin & Noel, 2003). 
 
 
 
 
 
 
 
 
 
 
Fig I.4 The crystal structure of Medicago sativa chalcone synthase 2. 
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The crystal structure of MsCHS2 revealed essential residues for an active enzyme, which are 
Cys164, His303 and Asn336 (catalytic triad) (Figure I.5). Among them Cys164 is in the top, its 
absence will abolish the enzyme activity (Lanz et al., 1991). The importance of Cys164 appears from 
its nucleophilic character that provides an efficient binding site for polyketide intermediates. 
Mutation of Cys164 to Ser or Ala reduces but maintains the activity of decarboxylation of malonyl-
CoA (Jez et al., 2000b).  
 
 
 
 
 
 
 
 
Fig I.5 The catalytic triad of Medicago sativa chalcone synthase 2. 
The structure also illustrated the CoA tunnel that connects the embedded active site cavity with the 
surrounding solvent. The binding of CoA within this area allows the positioning of the substrate 
toward the active site. The residues lining this tunnel are Lys 55, Arg 58, Lys 62 and Ala 308, each 
residue binding with CoA of the corresponding substrates. The two lysines and the argenine form 
hydrogen bonds with two phosphates of the CoA and the amide nitrogen of the alanine forms a 
hydrogen bond with the first carbonyl of the pantetheine moiety. The pantetheine arm is a flexible 
important part of the CoA as it expands through the tunnel and helps in the positioning of the 
terminal substrate bound to the thioester linkage near the Cys164 (Figure I.6) (Ferrer et al., 1999) 
 
 
 
 
 
 
 
 
 
 
 
 
Fig I.6 The CoA binding tunnel of Medicago sativa chalcone synthase 2. 
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The coumaroyl-binding pocket is located at the lower left side of the CoA-binding tunnel 
containing Ser 133, Glu 192, Thr 194, Thr 197 and Ser 338). These residues surround the substrate 
and make the binding mostly through van der Waals forces (Figure I.7) (Ferrer et al., 1999). The 
steric effect of these residues participates in the choice of the different substrates that will be 
accepted by type III PKSs. Only Glu192 shows a high conservation in comparison to the other 
residues. In 2004, a new substrate binding tunnel was discovered in a type III PKS from 
Mycobacterium tuberculosis, namely PKS18. This enzyme showed a unique broad specificity for 
aliphatic long chain CoAs (C2-C20) to produce tri-and tetraketide pyrones. In comparison to the 
MsCHS2 tunnel (16 Å), this tunnel is bigger in size covering about 20 Å. This size difference 
influencing the substrates specificity emphasizes the importance of this tunnel in formation of natural 
product diversity (Sankaranarayanan et al., 2004). 
 
 
 
 
 
 
 
 
 
Fig I.7 The substrate binding pocket of Medicago sativa chalcone synthase 2. 
The malonyl-binding pocket covers a large cavity adjacent to Cys 164, including Thr 132, Met 
137, Phe 215, Ile 254, Gly 256, Phe 265 and Pro 375. Van der Waals force also dominates the 
interaction in this area as these amino acids provide few hydrogen bond donors. The size of this 
pocket controls the number of the acetyl molecules added to the starter substrate and the length of the 
growing polyketide intermediate. The shape and the surface geometry also control the cyclization 
and the aromatization into a new ring system  (Figure I.7) (Ferrer et al., 1999). Further studies 
proved the participation of the G372FGPG loop in the end result of the cyclization reactions. Pro-
375 in this loop is strictly conserved in all other members of the CHS superfamily cloned so far. 
S397FGFG is another similar loop that was found in KAS II of E. coli and it acts as the ﬂexible gate 
to the active site. Such similarity and conservation of important residues between CHS and KAS in 
polyketide and fatty acid synthases, respectively, strike the light on the evolution of seconderay 
metabolism enzymes, as CHS, from enzymes that are involved in the primary metabolism to meet 
the need for production of various secondary metabolites, such as flavonoids (Figure I.8) (Suh et al., 
2000). 
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Fig I.8 The cyclization and elongation pockets of Medicago sativa chalcone synthase 2. The G372FGPG loop 
is shown on the right.  
2.3.2.2. Stilbene synthase (STS)  
As STS is less abundant but not less important than CHS, this enzyme produces resveratrol (3,5,4'-
trihydroxy-trans-stilbene), which is considered as one of the compounds that are involved in the 
health benefits associated with red wine and grape juice consumption. These benefits are linked to 
the activities that resveratrol has, such as antitumor, anticholesterol, anti-inflammatory and cell death 
reduction properties (Romero-Perez et al., 1999). Over their approx. 400 residues, CHS and STS 
share 75%–90% amino acid identity. Both enzymes catalyze iterative condensation of three 
molecules of malonyl-CoA and one molecule of p-coumaroyl-CoA, resulting in a tetraketide 
intermediate. The cyclization pattern of this intermediate differs between the enzymes. In case of 
CHS, C6→C1intramolecular cyclization and cleavage of the C1 thioester linkage will occur to 
produce naringenin chalcone. However, the intermediate undergoes C2→C7 cyclization by removing 
of C1 in STS. This step requires thioesteras-like hydrolysis of the thioester linkage to aid in the 
decarboxylative elimination of C1 carboxylate (Figure I.9).  
 
Fig I.9 The reaction catalyzed by stilbene synthase. 
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It was possible to crystallize the first STS in 2004. It was also generated by mutation from alfalfa 
CHS2 and it showed important residues responsible for the aldol cyclization specificity. Such results 
were supported when the first crystal structure of STS from Pinus sylvestris (PsSTS) was solved 
(Austin et al., 2004a). The active site cavities were similar in CHS and STS but PsSTS contained two 
major different regions, namely regions A and B. Region A is located at the dimer interface and 
divided into three areas. Area 2 presents a six residue loop starting from Thr135 until Leu140. 
Region B presents area 4, which consists of a three residue loop located on the outer surface of the 
CoA binding tunnel. To understand the different reaction mechanisms, those two different regions 
were subjected to mutation in alfalfa CHS2. By substitution of residues in these regions to the 
corresponding ones of PsSTS, a creation of a new enzyme (18xCHS) was achieved, which produced 
resveratrol rather than chalcone as the major product. Region A was more important than region B 
for driving the aldol cyclization mechanism. Deeper studying of this region proved that the area 2 
loop is the critical location for the cyclization. In MsCHS2 three residues in this area were in contact 
with the active site cavity. Thr132 and Ser133 cover their own monomer active site cavity and 
Met137 is at the active site cavity of the other monomer (Figure I.10). 
 
 
 
 
 
 
 
 
 
 
 
Fig I.10 The important regions in the crystal structure of Pinus sylvestris STS. Region A comprises area 1 
(red), area 2 (colored), and area 3 (purple). Region B is blue. 
Residue 137 was replaced before with the corresponding one of PsSTS (Met in MsCHS2, Leu in 
PsSTS) but there was no effect on the activity. Substitution of residue 133 (Ser in MsCHS2 and Thr 
in PsSTS) had a drastic effect on the conformation of the area 2 loop, but it is far from the active site 
and it is unreasonable to be involved in the aldol cyclization mechanism. Only when Thr132 was 
substituted with Ala in the 18xCHS mutant, the production of chalcone incrased over stilbene 
(Austin et al., 2004a).  
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2.3.2.3. Benzoic acid specific type III PKSs   
Two important enzymes were cloned in our group, which follow the same reaction mechanisms of 
CHS and STS, as follows.  
2.3.2.3.1. Benzophenone synthase 
This enzyme catalyzes the formation of the C13 skeleton of important secondary metabolites, for 
example the polyprenylated benzophenones such as guttiferone F with anti-HIV and antimicrobial 
effects. Benzophenones are also the precursor for 1,3,5 and 1,3,7–trihydroxyxanthones, which posses 
antitumor and antibacterial activities, respectively. BPS condenses one molecule of benzoyl CoA and 
three molecules of malonyl-CoA to produce the linear tetraketide intermediate, which undergoes the 
cyclization mechanism of CHS using Claisen condensation to end up with 2,4,6-
trihydroxybenzophenone (Figure I.11) (Liu et al., 2003). 
 
 
Fig I.11 The reaction catalyzed by benzophenone synthase.   
Several BPSs were cloned in our work group and had different characteristics, as follows. 
A. Benzophenone synthases from Hypericum species 
Hypericaceae known previously as Guttiferae or Clusiaceae (Stevens, 2007) is a large family in the 
plant taxonomy consisting of 500 species distributed all over the world (Sanmartín, 2012). They are 
specialized by the presence of different important classes of secondary metabolites consisting mainly 
of naphthadianthrones (hypericin, pseudohypericin), phloroglucinols, flavonoids, phenylpropanoids 
and xanthones (Bruni et al., 2005). Leave extract of Hypericum perforatum has been used for many 
years in Europe to treat mild to moderate depression (Crockett & Robson, 2011). Other important 
activities such as antiviral and anti-inflammatory effects (Birt et al., 2009) made the genus 
Hypericum a good candidate for research studies due to the important economical value of this plant 
in the herbal remedy industry. 
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Hypericum androsaemum BPS (HaBPS) is the first BPS that was cloned from the cell culture of 
this species, which is distributed mainly in Western and Southern Europe (Rosaria Perrone, 2013). It 
has about 59.1% amino acids sequence identity to MsCHS2 consisting of 395 amino acids and has a 
molecular mass of 42.8 kDa. It shows a maximum activity with benzoyl-CoA in comparison to 3-
hydroxybenzoyl-CoA, which is the second preferred substrate for this enzyme. Many mutational 
works were done on this enzyme in particular because of its low Km values that reach to 5.7µM for 
benzoyl-CoA and 23.1 µM for malonyl-CoA (Liu et al., 2003). Depending on the structure of 
MsCHS2 there were 7 amino acids in the initiation/elongation cavity different from HaBPS, but 
mutation of these residues to the corresponding ones of CHS failed to convert BPS into functional 
CHS. On the other hand, a triple mutation of HaCHS could produce a functional enzyme that 
accepted benzoyl-CoA over p-coumaroyl-CoA, but the efficiency of this mutant was 10-fold less 
than that of the wild type BPS. The most successful mutation was a single amino acid substitution of 
threonine at position 135 to leucine, which converted HaBPS into a functional 2-pyrone synthase 
(HaBPST135L). 
The HaBPST135L mutant accepts also benzoyl-CoA as a substrate but it utilizes only two molecules 
of malonyl-CoA to produce 6-phenyl-4-hydroxy-2-pyrone as a major product and 2, 4, 6-
trihydroxybenzophenone as a minor product, which is the reverse situation for the wild type HaBPS 
(Fig I.12). This succefull mutation came up because of the importance of threonine at position 135 in 
the reaction mechanism in which its hydroxyl group forms hydrogen bonds with other residues in the 
active site and allows the entrance of the substrates to the elongation pocket. In case of leucin 
another pocket opens for substrate entrance which, however, can accommodates only the triketide 
intermediate after condensation of only two molecules of malonyl-CoA. This mutant also reacts with 
3-hydroxybenzoyl-CoA and in this case the hydroxyl group of the substrate blocks the entrance even 
to the new pocket, which can be explained by the inactivity of HaBPST135L with 3-
hydroxybenzoyl-CoA (Klundt et al., 2009). 
  
 
Fig I.12 The reaction catalyzed by Hypericum androsemum BPST135L.   
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Beside HaBPS, two other BPSs were cloned from Hypericum species; one from Hypericum 
perforatum (HpBPS) and the other from Hypericum calycimum (HcBPS). They are quite similar to 
HaBPS but mutational experiments on those enzymes were less characteristic in comparison to 
HsBPS, which was cloned from Hypericum sampsonii (Abdelaziz, 2014). 
Hypericum sampsonii BPS (HsBPS) is a newly cloned enzyme from the herbal medicinal plant 
Hypericum sampsonii, which is used in China for the treatment of burns, snakebites, and diarrhea 
and also in Taiwan for treating blood stasis and hepatitis. These effects are associated with the 
presence of a lot of bioactive polyprenylated benzoylphloroglucinol derivatives, such as 
sampsoniones (Xiao et al., 2007, Chen et al., 2014). HsBPS prefers benzoyl-CoA as HaBPS to 
produce 2,4,6-trihydroxybenzophenone but in contrast it accepts also salicoyl-CoA (Huang et al., 
2012). At the amino acids level, HsBPS is quite similar to HaBPS characterized by only six different 
amino acids that lie on the surface and far away from the active site cavity. They are Asp54, Ala146, 
Gly230, Ala235, Leu359 and Ser360. When any of them were changed from HaBPS to the 
corresponding one of HsBPS, the enzymatic activity was still the same but the catalytic constant 
changed. Similar mutation experiments at site 135 were done for HsBPS, yielding two new 
functional enzymes named HsBPST135I and HsBPST135L, which have the activity of 2-pyrone 
synthase, and HsBPST135K, which has the activity of hydroxycoumarin synthase (Abdelaziz, 2014). 
HsBPST135I is an interesting mutant like HaBPST135L. Although leucine and isoleucine are not 
much different from each other, the isoleucine mutant converted only HsBPS, but not HaBPS, into 
functional 2-pyrone synthase. The mutant condenses only two molecules of malonyl-CoA with 
benzoyl-CoA producing a lactone, which is similar to HaBPST135L and HsBPST135L. When the 
same mutation experiment was constructed on HaBPS, the produced mutant HaBPST135I did not 
make any change in the wild type but it gave inactive protein (Abdelaziz, 2014). 
HsBPST135K is another interesting single mutant that could convert HsBPS into functional 
hydroxycoumarin synthase (HCS), which prefers 2-hydroxybenzoyl-CoA (salicoyl-CoA) as a 
substrate and produces 4-hydroxycoumarin as the main product after the condensation of only one 
molecule of malonyl-CoA (Fig I.13) (Abdelaziz, 2014). Coumarins rise in plants upon cell damage 
in which trans-ortho-coumaric acid is converted by fungi to 4-hydroxycoumarin that combine with 
formaldehyde to give dicoumarol. This class of compounds is important for the pharmacology 
because it belongs to the medicinal anticoagulant drugs (Liu et al., 2010). The mutation of threonine 
at position 135 into lysine was also succeful in case of HaBPS but the activity of the produced 
enzyme was much lower in comparison to HsBPST135K (Abdelaziz, 2014). In general, the variation 
in substrate acceptance leading to product variation is a common character of type III PKSs, as 
exemplified by 2-hydroxybenzoyl-CoA which led to the formation of coumarins when elicitor-
treated cell cultures of Sorbus aucuparia were fed with salicoyl-N-acetylcysteamine. The production 
of coumarins in this case was due to the action of another type III PKS, named biphenyl synthase 
(Liu et al., 2010). 
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Fig I.13 The reaction catalyzed by Hypericum sampsonii BPST135K.   
B. Centaurium erythraea BPS (CeBPS)  
This is another interesting enzyme among the group of BPSs because it prefers 3-hydroxybenzoyl-
CoA over benzoyl-CoA and form 2,3',4,6-tetrahydroxybenzophenone, which is converted further to 
1,3,5-trihydroxyxanthone by xanthone synthase. C. etythraea belongs to the family Gentianaceae and 
it is known to have a high content of xanthones that play an important role in health benefits  (Figure 
I.14) (Beerhues, 1996).  
 
Fig I.14 The reaction catalyzed by Centaurium erythraea benzophenone synthase. 
C. Garcinia mangostana BPS (GmBPS)  
This plant belongs to the family Hypericaceae (Guttiferae) and was used as a traditional medicine for 
topical infections and wound healing. GmBPS prefers the starter substrate benzoyl-CoA as other 
BPSs to yield the major product 2, 4, 6-trihydroxybenzophenone and it showed 77-78% amino acid 
sequence identity with other BPSs. At the active site, it has the same amino acids of HaBPS, which 
differ from the residues in MsCHS2 (V196, L214, G216, G256, L263, F265 and S338). The enzyme 
showed wide substrate acceptance. From, salicoyl-CoA it produced 4-hydroxy coumarin similar to 
biphenyl synthase (BIS) from Sorbus aucuparia. In contrast to HaBPS, GmBPS accepted the larger 
aromatic substrates like cinnamoyl-CoA and 4-coumaroyl-CoA but allowed the condensation of two 
molecules of malonyl-CoA to produce the corresponding triketide lactones (Figure I.15) (Nualkaew 
et al., 2012). 
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Fig I.15 The reactions of Garcinia mangostana benzophenone synthase with larger aromatic substrates. 
2.3.2.3.2. Biphenyl synthase  
It is the key enzyme responsible for the synthesis of the C12 skeleton of biphenyls. Biphenyls are 
phytoalexins found together with dibenzofurans in large amounts in Maloideae, a subfamily of the 
Rosaceae which includes economically important fruit trees, such as apple (Malus) and pear (Pyrus). 
The accumulation of these phytoalexin increases mostly after fungal infection and for some species 
after the treatment of heavy metal ions. Such defense mechanisms can help the plant to survive and 
resist the diseases caused by some pathogens. Aucuparin is the most well known biphenyl, which 
was first isolated from Sorbus aucuparia in 1963.  
A. Sorbus aucuparia BIS1 (SaBIS1)  
It was cloned for the first time in our research group after the observation of high amount 
accumulation of aucuparin in the cell culture upon treatment with yeast extract. This enzyme also 
prefers benzoyl-CoA as a substrate and produces 3,5 dihydroxybiphenyl after condensation of three 
molecules of malonyl-CoA using the aldol condensation mechanism for the cyclization of the linear 
tetraketide intermediate in a similar manner of STS. It shares about 60% amino acids sequence 
identity with the other enzymes of the type III PKSs superfamily and has a molecular mass of 43 kDa 
covered by 390 amino acids. It was grouped closely to BPS in a phylogenetic tree (Figure I.16) (Liu 
et al., 2004, Liu et al., 2007). 
 
Fig I.16 The reaction catalyzed by biphenyl synthase. 
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Two other isoenzymes of biphenyl synthase were cloned from the same species namely SaBIS2 and 
SaBIS3. They share more than 90% amino acid sequence identity with BIS1 but they differ in their 
preference for ortho-hydroxybenzoyl (salicoyl)-CoA over benzoyl-CoA to yield 4-hydroxycoumarin 
after a single decarboxylative condensation with malonyl-CoA (Figure I.17) (Liu et al., 2010). 
B. Malus domestica BIS3 (MdBIS3) 
It is quite similar to the previously mentioned biphenyl synthases from Sorbus aucuparia and it was 
cloned together with other isoenzymes (BIS1, BIS2 and BIS4) from ﬁre-blight-infected shoots of 
apple. Similar to SaBISs, these isoenzymes convert benzoyl-CoA, 2-hydroxybenzoyl-CoA (salicoyl-
CoA), and 3-hydroxybenzoyl-CoA to 3,5-dihydroxybiphenyl, 4-hydroxycoumarin, and 6-(3'- 
hydroxyphenyl)-4-hydroxy-2-pyrone, respectively. Only the MdBIS3 gene showed a higher 
expression level in the stems of apple after inoculation with Erwinia amylovora, the causative 
pathogen of the fire-blight disease. Immunoﬂuorescence localization results showed that MdBIS3 
localized to the transition zone of the infected stem, which lies between the healthy and the necrotic 
tissue (Chizzali et al., 2012). 
 
Fig I.17 The reaction catalyzed by biphenyl synthase upon use of o-hydroxybenzoyl-CoA as starter.  
Benzoyl-CoA in general is a rarely used substrate among type III PKSs which is an intrinsic property 
of these enzymes. The second more challenging property is the use of the same substrate by two 
remarkable enzymes (BIS and BPS) to yield totally different groups of compounds. These 
observations made the reaction and the cyclization mechanisms very interesting to be involved in our 
research studies. Understanding the structures and comparing the active site cavities of both enzymes 
can explain the difference in their function. Interestingely, the residues which are responsible for the 
function diversity in type III PKSs are substituted in BIS and BPS. The crystallization of benzoic 
acid specific type III PKSs and the comparison with the crystal structures of CHS and STS will assist 
in deeper understanding the acceptance of small hydrophobic substrates like benzoyl-CoA by BIS 
and BPS and larger as coumaroyl-CoA by CHS and STS. The crystal structures of BIS and BPS 
disclose the differences in the shape and volume of the active sites pockets, which should indicate 
the reasons behind the differently utilized mechanisms and products formed, although using the same 
starter substrate. 
EBTISAM KHALIL  INTRODUCTION 
16 
 
2.3.2.4. Crystallization of other plant type III PKSs  
A. 2-Pyrone synthase (2-PS)  
It is similar to MsCHS2 by sharing 74% sequence identity at the amino acids level, although both 
enzymes differ in the starter substrate preference and the number of condensations utilized. The first 
crystallized pyrone synthase was cloned from Gerbera hybrida (daisy) (GhPS), which uses acetyl-
CoA as starter substrate and produces a triketide intermediate by the addition of two extra acetyl 
units derived from malonyl decarboxylation. After cyclization, 6-methyl-4hydroxy-2-pyrone is 
formed, which presents the backbone for broader pyrone synthesis (Figure I.18).  
 
 
Fig I.18 The reaction catalyzed by 2-pyrone synthase. 
The crystal structure of 2-PS in comparison to MsCHS2 demonstrated four different amino acids in 
the elongation pocket and they are Leu 202, Met 259, Leu 261, and Ile 343 in 2-PS and Thr 197, Ile 
254, Gly 256, and Ser 338 in MsCHS2 respectively (Figure I.19). Such variations allowed the 
production of a triple mutant of MsCHS2, MSCHS2T197L/G256L/S338I which did not accept p-
coumaroyl-CoA and resulted instead in methylpyrone as 2-PS. The size of the active site cavity of 2-
PS was 274 Å in comparison to 923 Å of MsCHS2, which was explained by the larger size residues 
such as Leu and Ile, which allowed this enzyme to tolerate only acetyl-CoA as a substrate to form the 
corresponding tri-and not the tetraketide intermediate (Jez et al., 2000a). The small size cavity of 2-
PS allowed it also to accept small CoA-thioesters like propionyl-CoA and benzoyl-CoA in vitro to 
produce 6-phenyl-4-hydroxy-2-pyrone, which composes the skeleton of some HIV-1 protease 
inhibitors (Austin & Noel, 2003). 
 
 
 
 
 
 
 
Fig I.19 The active site cavity of 2-pyrone synthase in comparison to the active site cavity of MsCHS2.   
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B. Benzalacetone synthase (BAS)  
It was cloned from Rheum palmatum (RpBAS) and it shares 60-75% sequence identity at the amino 
acid level with other enzymes in the superfamily of CHS. It prefers 4-coumaroyl-CoA and condenses 
one molecule of malonyl-CoA to produce benzalacetone which provides the C6-C4 skeleton of 
phenylbutanoids (Figure I.20). These compounds are the active principle of medicinal plants having 
an anti-inflammatory effect such as gingerol in Zingiber officinale (Abe et al., 2001). 
 
 
 
Fig I.20 The reaction catalyzed by benzalacetone synthase.  
In comparison to the structure of MsCHS2, BAS lacks the active site residue Phe215. This 
observation promoted a mutation to replace Ile207 and Leu208 of BAS into the corresponding ones 
of MsCHS2, Leu214 and Phe215, respectively, which resulted in the conversion of BAS into CHS 
(Abe et al., 2003). Another mutant was constructed to replace Leu125, Ile207 and Leu208 of BAS to 
the corresponding ones of MsCHS2, Thr132, Leu214 and Phe215, respectively, to increase the 
chalcone formation but the result was a loss of the activity (Shimokawa et al., 2010). The 
replacement of Gly249 in BAS with Leu decreased the activity, which is the reverse of MsCHS2, 
whose G256L mutant did not accept p-coumaroyl-CoA at all. This hypothesized the presence of a 
second alternative coumaroyl-binding pocket (Abe et al., 2007b), which was proved by solving the 
crystal structure of RpBAS together with the chalcone-producing mutant Ile207Leu/Leu208Phe. This 
crystal structure also proved for the first time the nucleophilic function of the active site cysteine in 
polyketide intermediate binding, as the crystal structure of the monoketide coumarate intermediate 
bound to the wild type enzyme was solved (Figure I.21) (Morita et al., 2008, Morita et al., 2010a). 
 
 
 
 
 
 
 
 
Fig I.21 The second coumaroyl-binding pocket of RpBAS. The different residues of RpBAS (red sticks) and 
MsCHS2 (yellow sticks) are highlighted. The monoketide intermediate and naringenin are shown as cyan 
sticks in RpBAS and MsCHS2, respectively. 
CHS BAS 
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C. Curcuminoid synthase (CUS) 
It was cloned firstly from rice (Oryza sativa) (OsCUS) and shared 49% and 51% amino acid 
identities with MsCHS2 and RpBAS, respectively. It prefers 4-coumaroyl-CoA as a starter substrate 
and condenses only one molecule of malonyl-CoA to produce bisdemethoxycurcuminl. It also results 
in the formation of dicinnamoylmethane and curcumin after reactions using cinnamoyl-CoA and 
feruloyl-CoA, respectively (Figure I.22). Curcumin is a widely known curcuminoid because of its 
antiinflammatory and antitumor activities. It was found in the rhizome of Curcuma longa, which is 
used abundantly in Asia in the traditional medicine and also as food additives. The reaction 
mechanism is similar to BAS and involves the formation of β-keto acid but differs because of the use 
of another extender in addition to malonyl-CoA. The mechanism involves the decarboxylative 
condensation of the first moiety of malonyl-CoA with 4-coumaroyl-CoA to produce the diketide 
CoA intermediate, which undergoes further hydrolysis to produce the β-keto acid. This acid then 
functions as the second extender for another coumaroyl moiety. After another decarboxylative 
condensation reaction, bisdemethoxycurcumin is formed (Figure I.22) (Katsuyama et al., 2007). 
 
 
 
 
Fig I.22 The reactions catalyzed by curcuminoid synthase. 
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Interestingly, when the crystal structure of OsCUS was solved, it showed no coumaroyl-binding 
pocket as MsCHS2 and PsSTS. Instead, another expanded downward pocket was observed, which 
presumably tolerated the 4-coumaroyldiketide acid (Figure I.23) (Morita et al., 2010b).  
 
 
 
 
 
 
 
 
 
Fig I.23 The expanded downward pocket of OsCUS. This pocket accommodates the β-keto acid and has 
important residues that differ from MsCHS2.  
A new curcumin synthase was cloned from turmeric Curcuma longa (ClCURS). It showed a unique 
acceptance of substrates lacking CoA, such as 3-oxooctanoyl-NAC. This suggested the involvement 
of a hydrophobic cavity surrounding Phe265 in the CoA binding tunnel. To prove this, a mutation 
was constructed on a residue surrounding the hydrophobic cavity Gly211.Glycine was replaced with 
the bulk residues Trp and Phe and both mutants showed weak activity in curcuminoids production. In 
addition, the crystal structure of the G211F mutant clarified the occupancy of the hydrophobic cavity 
by the phenyl group of Phe211 after mutation, which proves the importance of this cavity in β-keto 
acid binding and in curcuminoid synthesis (Figure I.24) (Katsuyama et al., 2011, Katsuyama et al., 
2009). 
 
 
 
 
 
 
 
 
 
Fig I.24 The hydrophobic cavity of CURS. Gly (red) in CURS and Phe211 (blue)  in its mutant CURSG211F 
are highlighted. 
 Gly211 
 Phe211 
Phe265 Phe265 
CURS G211F 
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D. Acridone synthase (ACS)  
It is involved in the synthesis of acridone alkaloids, which are known to be abundant in the Rutaceae 
family. Acridones have many activities including antiviral, antiplasmodial and antineoplastic 
properties, which are mainly related to their interference with DNA synthesis. ACS promotes the 
condensation of N-methylanthranilic acid and malonyl-CoA to produce 1,3-dihydroxy-N-
methylacridone and this compound provides the skeleton for more complex acridone alkaloids 
(Figure.27) (Baumert et al., 1994, Junghanns et al., 1995). CHS and ACS are similar enzymes as 
they both catalyze the Claisen condensation mechanism using three molecules of malonyl-CoA to 
produce the corresponding tetraketide. ACS specifically forms a non-aromatic intermediate, which 
undergoes dehydration to lose a water molecule before aromatization (Figure I.25) (Springob et al., 
2000).  
 
 
Fig I.25 The reactions catalyzed by acridone synthase.  
The crystal structure of novel ACS from Citrus microcarpa (CmACS) has been solved recently(Mori 
et al., 2013). Structure analysis revealed the widening of the active site cavity entrance, which 
enhanced the acceptance of various substrates, explained by main residues differing from MsCHS2. 
For example, ACS has Val at position 265 instead of Phe and the loss of the aromatic ring changed 
the shape of the active site cavity. In addition, the side chain of Ser at position 132 instead of Thr 
protrudes outside the active site cavity and the side chain of Ala at position 133 instead of Ser is 
smaller and less bulky (Figure I.26). 
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Fig I.26 The differences in the size of the active site entrances between CmACS and MsCHS2. 
Importance sites in CmACS (Ser132, Thr194 and Thr197) were mutated to Met, Met, and Tyr, 
respectively, which are the corresponding ones in C. microcarpa quinolone synthase (CmQNS). All 
single mutants produced converted ACS into functional QNS, as they accepted only N-
methylanthraniloyl-CoA to produce quinolone after one condensation reaction with malonyl-CoA. 
All the mutants did not accept p-coumaroyl-CoA as the wild type enzyme did (Figure I.27) (Mori et 
al., 2013). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig I.27 The important residues that differ between Citrus microcarpa ACS and QNS.   
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E. Quinolone synthase (QNS)  
It prefers N-methylanthraniloyl-CoA as starter substrate and catalyzes one condensation with 
malonyl-CoA to produce 4-hydroxy-1-methyl-2-quinolone (Figure I.28). Quinolone alkaloid 
derivatives are distributed in plants of Rubiaceae, such as antimalarial quinine and skimmianine that 
has cytotoxic and antiplatelet aggregation effects (Resmi et al., 2013).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig I.28 The reaction catalyzed by quinolone synthase. 
RpBAS was the first enzyme to produce quinolone by its acceptance of N-methylanthraniloyl-CoA 
(Abe et al., 2006a). Recently, quinolone synthase was first cloned from the root of Aegle marmelos 
(AmQNS), which is known for its abundant quinolone alkaloids. Mutational experiments proved the 
evolution of QNS from CHS. The substitution of two conserved residues in AmQNS (Ser132, 
Ala133) into the corresponding ones of MsCHS2 (Thr132, Ser133) led to the conversion of QNS 
into CHS, as the mutant resulted in naringenine formation after reaction with p-coumaroyl-CoA 
(Resmi et al., 2013). In 2013, the structure of CmQNS was solved and it revealed the structure 
differences as the basis for functional variation of this enzyme. Especially, it has different bulk 
residues (Met132, Ala133, Leu265) instead of Ser132, Ala133, Val265, respectively, in comparison 
to the previously cloned AmQNS. This steric hindrance changed the shape and the size of the active 
site cavity and allowed the Leu267 to permit behind Leu265 to participate in the entrance of the 
active site. In comparison to MsCHS2, the absence of the phenyl ring of Phe265 allowed the other 
Phe215 to protrude towered Leu265 and to widen the active site entrance to reach 47 Å, which is 2.8 
times larger than that of MsCHS2 (17 Å) (Figure I.29). 
 
 
 
 
 
 
 
 
 
Fig I.29 The variation in the substrate entrances of MsCHS2 and CmQNS. The orientation of the different 
residues affects the shape and size of the entrances in both enzymes. 
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Two bulk Met residues in CmQNS replace Thr132 and Thr194 of MsCHS2, which leads to the 
absence of the coumaroyl binding pocket. The presence of Tyr instead of Thr197 and the presence of 
Ala instead of Gly256 decreased the size of the active site cavity to 290Å, which is 2.6 times smaller 
than that of MsCHS2. Mutational experiments proved the critical role of Tyr197 in such a change, as 
it converted QNS into BAS after replacing it with Ala to allow the mutant to also accept   4-
coumaroyl-CoA as starter substrate (Figure I.30) (Mori et al., 2013). 
 
Fig I.30 The different active site geometries of MsCHS2, CmQNS and RpBAS. The important different 
residues surrounding the active site cavity among all enzymes are shown as sticks. Monoketide intermediate 
and naringenin are shown as cyan sticks in RpBAS and MsCHS2, respectively. 
F. Pentaketide chromone synthase (PCS) 
This plant PKS condenses five molecules of malonyl-CoA to produce 5,7-dihydroxy-2-
methylchromone. This aromatic pentaketide is the main nucleus in the synthesis of the 
furochromones kehellin and visnagin, which are known of their anti-asthmatic effects (Figure I.31). 
It was cloned from Aloe arborescens (AaPCS) and the sequence of its amino acids has about 58% 
identity with MsCHS2. Sequence comparison showed the substitution of three important residues of 
MsCHS2 (Thr197, Gly256 and Ser338) with Met207, Leu266 and Val351 of AaPCS, respectively. 
 
 
 
 
 
 
 
 
 
 
 
Fig I.31 The reactions catalyzed by pentaketide chromone synthase and subsequent enzymes. 
MsCHS2 CmQNS RpBAS 
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Similar residues were found in the amino acids sequence of octaketide synthase from Aloe 
arborescens (AaOKS), except for a Gly at position 207 instead of Met. Based on this a mutation was 
done on PCS and the produced single site mutant M207G was able to condense eight molecules of 
malonyl-CoA and transformed PCS into functionally active OKS (Abe et al., 2005b). After solving 
the crystal structures of AaPCS and its mutant M207G, a new hidden pocket was found behind the 
active site cavity of M207G in comparison to PCS, which explains the longer chain production. A 
triple mutant was further constructed by substitution of extra two aromatic bulk residues (Phe80 and 
Tyr82) at the bottom of the new pocket into Ala. The produced triple mutant (F80A/Y82A/M207G) 
produced unnatural novel nonaketide naphthopyrone after condensation of nine molecules of 
malonyl-CoA. The volume of the active site cavity of the triple mutant is four times larger than the 
one of the wild type PCS (Figure I.32) (Morita et al., 2007). 
 
 
 
 
 
 
 
 
 
Fig I.32 The differences in the size of the active site pockets of PCS and its mutants. AaPCS and its single 
mutant M207G had smaller active site pockets in comparison to the expanded large pocket of its triple mutant 
(F80A/Y82A/M207G). The crystal structure of the triple mutant was not available in PDB, but was 
constructed using PyMOL. 
PCS 
Single 
mutant 
Triple 
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G. Octaketide synthase (OKS) 
It was cloned from Aloe arborescens (AaOKS) and it condenses eight molecules of malonyl-CoA 
resulting in the formation of the octaketides SEK4 and SEK4b (Figure I.33). The Aloe plant is known 
of its abundance of important longer chain medicinal aromatic polyketides, such as aloenin 
(hexaketide), aloesin (heptaketide) and barbaloin (octaketide), but it does not produce SEK4 or 
SEK4b. So it was suggested that OKS is somehow involved in vivo in the biosynthesis of anthrones.  
Fig I.33 The reaction catalyzed by octaketide synthase.  
At the amino acids level, it shares about 91% identity with AaPCS and 60% identity with MsCHS2. 
As in PCS, three conserved residues (Thr197, Gly256, and Ser338) were substituted with Gly, Leu, 
and Val, respectively, in OKS. Gly207 was subjected to mutation and the resulting mutant G207M 
formed unnatural pentaketide 2, 7-dihydroxy-5-methylchromone. So, it converted OKS into 
functional PCS (Abe et al., 2005a). Another mutant N222G could condense ten molecules of 
malonyl-CoA to produce the unnatural compound C20 decaketide benzophenone SEK15. The solved 
structure of N222G showed an increase in the cavity volume from 652 Å to 693 Å which correlated 
to the produced longer polyketide. The residue Phe66 in N222G was further mutated with smaller 
residues, only the double mutant F66L/N222G was more interesting because another unnatural 
longer polyketides was produced namely dodecaketide naphthophenone TW95a after condensation 
of twelve molecules of malonyl-CoA. The volume of the cavity of F66L/N222G increased to 748 Å 
which explained the production of the C24 dodecaketide chain (Figure I.34) 
 
Fig I.34 The different active sites pocket sizes of OKS and its mutants. The double mutant F66L/N222G has a 
larger expanded pocket in comparison to N222G and OKS. The crystal structures of the single and double 
mutants were not available in PDB, but were constructed using the PyMOL program. 
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The dodecaketide naphthophenone TW95a proves the involvement of the CHS superfamily in the 
synthesis of anthrones in the Aloe plant. This C24 dodekaketide is the longest known polyketide 
produced by plant type III PKSs (Figure I.35) (Wanibuchi et al., 2011) 
 
 
 
 
 
 
 
 
 
 
Fig I.35 The formation of the longest known plant polyketide TW95a. 
2.3.3. Bacterial and fungal type III PKSs  
Type III PKSs were thought to be plant-specific until 1999 when a new gene called rppA was cloned 
from the soilliving ﬁlamentous bacterium Streptomyces griseus. This gene encoded a protein that 
shows signiﬁcant similarity to CHS. RppA protein condenses five molecules of malonyl-CoA 
resulting in a pentaketide intermediate, which cyclizes to 1,3,6,8-tetrahydroxynaphthalene (THN) 
(Figure I.36).  
 
Fig I.36 The reaction catalyzed by RppA. The enzyme produces THN and the instability of this product results 
in the formation of flaviolin due to oxidation. 
EBTISAM KHALIL  INTRODUCTION 
27 
 
Unlike CHS, RppA did not provide alternative products after the co-incubation of malonyl-CoA with 
either p-coumaroyl-CoA or acetyl-CoA. This indicated that, RppA is a CHS-related PKS which 
utilizes only malonyl-CoA as the starter unit (Funa et al., 1999). Since 1999, many other related 
genes were found in various bacteria and revealed that type III PKSs are distributed in a variety of 
bacteria (Moore & Hopke, 2001, Gross et al., 2006). An important example is the new family of type 
III PKSs that was found in Mycobacterium tuberculosis, which enfolds mainly PKS18 and PKS11. 
Both enzymes are involved in the biosynthesis of long-chain α-pyrones as they showed higher 
specificity toward long-chain aliphatic acyl-coenzyme A (C12 to C20) substrates. This is 
unprecedented in the CHS superfamily, as octanoyl-CoA considered to be the largest starter unit 
used by CHS and THN (Saxena et al., 2003). In general, the acceptance of long-chain acyl-CoA 
starters by bacterial type III PKSs is strongly correlated to their large active sites cavities. For 
example, the crystal structures of 1,3,6,8-tetrahydroxynaphthalene synthase (THNS) demonstrated 
the prescence of a novel cavity expanded into the floor of the main pocket (PEG-binding tunnel). 
Moreover, THNS, as all known bacterial type III PKSs, features three additional active site cysteines, 
besides the catalytic Cys at the positions 106, 168, and 171 (corresponding to 132,194 and197 of 
MsCHS2, respectively). These positions are mostly occupied by threonine residues in MsCHS2 and 
other plant type III PKSs (Figure I.37). They are less bulk and ideal for the ability of THNS to utilize 
small starters while providing adequate volume for the additional elongation steps of the polyketide 
chain. Mutagenic analysis of THNS proved the unexpected vital function of Cys106. It showed an 
important role of utilizing THNS dual cyclizations reactions (adol and Claisen) for THN biosynthesis 
(Austin et al., 2004b). The crystal structure of PKS11 also showed a similar expanded hydrophobic 
tunnel close to the active sites Cys, which accommodates the large reaction substrates (Gokulan et 
al., 2013).  
 
 
 
 
 
 
 
 
 
Fig I.37 The active site cavity of THNS. On the left, the active site cysteines are presented as sticks. They are 
bulk residues and oriented to accommodate the modeled hexaketide in the PEG-binding tunnel. On the right, 
the pocket of MsCHS2 accommodating naringenin is wider in comparison to THNS. 
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Single amino acids substitutions could reverse the cyclization specificity of two bacterial type III 
PKSs (ArsB and ArsC) obtained from the nitrogen-fixing soil bacterium, Azotobacter vinelandii. The 
ArsB W281G synthesized alkylpyrone but not alkylresorcinol. In contrast, the ArsC G284W 
synthesized alkylresorcinol with a small amount of alkylpyrone. The crystal structures of ArsC and 
its mutant ArsC G284W observed the steric wall of the mutant that reduced the volume of its active 
site cavity (Figure I.38). This hypothized that the polyketomethylene intermediate can be folded to a 
suitable form for aldol condensation only in such a small cavity of ArsCG284W. This folding is not 
suitable for lactonization as in the wild-type enzyme ArsC (Satou et al., 2013). 
 
 
 
 
 
 
 
Fig I.38 The active site cavities of ArsC and its mutant ArsC G284W. The pocket size of the mutant is smaller 
because of the prescence of W284 instead of G284. This helps in the perfect folding of the polyketide 
intermediate and allows the utilization of an aldol rather than a lactonization mechanim by ArsC G284W.  
Another intersting bacterial type III PKS, germicidin synthase (Gcs) from Streptomyces coelicolor, 
demonstrated broad substrate acceptance for acyl groups linked through a thioester bond to either 
coenzyme A (CoA) or acyl carrier protein (ACP). The catalytic efficiency for acyl-ACP was even 
10-fold higher than that for acyl-CoA. In contrast, plant type III PKSs tend to utilize a larger variety 
of acyl-CoA and not acyl-ACP, which is a general feature of type I and II PKSs (Chemler et al., 
2012). 
Not only bacterial type III PKSs were characterized, but in 2007, the first fungal type III PKS from 
Neurospora crassa was determined. This novel type III PKS catalyzes the synthesis of pentaketide 
alkylresorcylic acid from a long-chain fatty acid CoA ester and four molecules of malonyl-CoA. It 
prefers C18 stearoyl-CoA as starter and is called 2'-oxoalkylresorcylic acid synthase (ORAS) (Funa et 
al., 2007). It is the first type III PKSs that catalyses the formation of pentaketide resorcylic acid as 
most of other type III PKSs produce tetraketide resorcinols. Since then other many fungal type III 
PKSs were identified. For example Aspergillus niger AnPKS that showed specific acceptance of 
acyl-CoAs with branched chains such as isobutyryl-CoA and isovaleryl-CoA. It did not accept 
crotonyl-CoA but accepted methylcrotonyl-CoA. It accepted also aromatic CoAs such as benzoyl-
CoA and phenylacetyl-CoA. 
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Generally, fungal type III PKSs produced triketide, tetraketide and even petaketide pyrones. They 
also produced tetraketide, pentaketide and hexaketide resorcinol/resorcylic acis. Bacterial types III 
PKSs produced more specific products, such as naphthalene by THNS and phloroglucinol by PhID 
(from Pseudomonas florescens). Fungal type III PKSs utilize malonyl-CoA as extender except for 
CsyB from Aspergillus oryzae, which uses in addition acetoacetyl-CoA. Bacterial Sco7671 from 
Streptomyces coelicolor accepted methylated and ethylated malonyl-CoA as extenders (Hashimoto et 
al., 2014). 
Beyond bacteria and fungi, several species of brown algae display genes that are homologs of type 
III PKSs. Recently in 2013, the crystal structure of the Esi-PKS1 protein of the brown alga 
Ectocarpus siliculosus was solved. Esi-PKS1 functions as a phloroglucinol synthase using malonyl-
CoA as a substrate. It showed acceptance also of longer chain starters like lauroyl-CoA. The 
structure demonstrated a specific tunnel for binding of long-chain acyl-CoAs. In addition, two GF 
(G164F and G190F) are located in two loops close to the surface of the enzyme. The positions of 
these residues allowed the formation of a new pocket at the dimer interface. This pocket is absent in 
plant type III PKSs as it is occupied mostly by an aromatic residue (Tyr160 of MsCHS2) instead of 
the small residue G190 of Esi-PKS1 (Meslet-Cladiere et al., 2013). 
It is important in the future to combine all the information about the structures and reaction 
mechanisms of type III PKSs from all known sources (plants, bacteria, fungi and even algae) to 
utilize the unique function of this group of enzymes for the production of desired polyketides. 
2.3.4. Reaction mechanism of type III PKS 
The reaction mechanism of MsCHS2 includes different functions, which resemble the action of 
many enzymes. It starts with a transferase for loading the starter p-coumaroyl-CoA onto the SH 
group of the catalytic Cys164, followed by a decarboxylase for activating the extender malonyl-CoA. 
Finally, cyclase and aromatase, which, after addition of C2 units and formation of C-C bonds in the 
linked CoA chain, catalyze intrinsic intramolecular Claisen-type condensation of the linear 
tetraketide and form the final product. Actually CHS and all type III PKSs only need three essential 
residues (Cys164, His303 and Asn336 ) (numbering from MsCHS2) to perform the mentioned 
functions. The basic N-2 of His removes a proton from the SH group of Cys, which in turn activates 
the thiolate anion and provides a nucleophillic attack to the carbonyl group of the starter substrae to 
release the CoA moiety. The protonated nitrogens of His and Asn stabilize the carbonyl oxygen of 
malonyl-CoA to facilitate the decarboxylation reaction and production of acetyl carbanion, which 
attacks the carbonyl group of the starter-Cys complex and a diketide forms. This growing diketide 
will be taken again by the Cys-thiolate to allow a second molecule of malonyl-CoA to go in and 
further decarboxylation will occur to allow the addition of a new acetyl moity to the diketide.  
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Repetition of this process will occur untill the production of the tetraketide intermediate. Still bound 
to the enzyme, this intermediate undergoes cyclization and aromatization to give the final product 
(Figure I.39) (Abe, 2008, Abe & Morita, 2010).  
 
 
Fig I.39 The reaction mechanism of type III polyketide synthases. 
2.3.5. Mechanism of Claisen condensation and aldol-type cyclization 
The crystal structures of MsCHS2 and PsSTS demonstrated the significance of an important residue 
in the Claisen-aldol mechanisms variation (Thr132 in MsCHS2 and Thr135 in PsSTS). It is located 
close to the active site cavity and after mutation it showed an important effect on the production of 
resveratrol. In MsCHS2, the hydroxyl group of this residue forms hydrogen bonding with glutamate 
residue Glu192 at the back of the active site cavity but in PsSTS the changed conformation of the 
residue positions this hydroxyl group to form new hydrogen bonding by stabilizing a water molecule 
with Ser 338 (Figure I.40). This bonding pattern is similar to the catalytic activity of type II 
thioesterase discovered in E. coli. To prove this activity, an extra mutation was carried out on a 
18xCHS mutant mentioned in (1.2.3.2) and each mutant of 18xCHS (+1) (Thr132 into Ala and 
Glu192 into Gln) showed an increase in the production of chalcone rather than stilbene (Austin et al., 
2004a). 
 
 
 
 
 
 
Fig I.40 The catalytic water molecule (red sphere) in PsSTS and MsCHS2. The important residues responsible 
for the catalytic water stabilization by hydrogen bond network formation (blue dotted lines) are displayed. 
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RpBAS and OsCUS utilize an aldol similar mechanism, which involves the decarboxylation of β-
keto acids. Thr135 was not found in RpBAS and OsCUS and replaced by Leu and Asn 
respectively.The formation of the β-keto acid was correlated to the presence of a water molecule in 
the crystal structures of both enzymes but in different location compared to the one of PsSTS. In 
RpBAS this water forms a hydrogen bond network with the catalytic residues Cys157, His296 and 
Asn329 (Figure I.41). This water molecule was suggested to perform the thioesterase function, by 
which it cleaves the thioester bond of the diketide intermediate that will undergo further 
decarboxylation to produce benzalacetone (Morita et al., 2008, Morita et al., 2010a). 
 
 
 
 
 
 
 
Fig I.41 The catalytic water molecule (red sphere) in RpBAS. The catalytic triad residues responsible for its 
stabilization by hydrogen bond network formation (blue dotted lines) are displayed. 
In the crystal structure of OsCUS, another  putative water molecule forms a hydrogen bond network 
with Asn142 (Thr135 in PsSTS), Ser351, Tyr207 and Glu202 in the active site cavity and its 
function was correlated to the hydrolysis and the release of the diketide intermediate as 4-
coumaroyldiketide acid (Figure I.42) (Morita et al., 2010b).  
 
 
 
 
 
 
 
Fig I.42 The catalytic water molecule (red sphere) in OsCUS. The important residues responsible for its 
stabilization by hydrogen bond network formation (blue dotted lines) are displayed. 
 
 
EBTISAM KHALIL  INTRODUCTION 
32 
 
3. Protein crystallization and the impact of His6-tag 
Protein crystallization requires the creation of a supersaturation state. Supersaturation (non 
equilibirium state) occurs when the protein exceeds its solubility limit in the solution, which forces 
the solution to reequilibrate by the formation of a solid state (nucleus of a crystal). A stable nucleus 
in the supersaturation solution will grow until equilibrium is regained. The force that enhances the 
supersaturation or the growth of the crystal is the modification of the protein or the undersaturated 
solution poperties, i.e. high protein concentration, pH change, the addition of ligands and the use of 
precipitants like salts and polymers (Figure I.43) (McPherson & Gavira, 2014). More simply, 
crystallization is the choice among many probabilities that allow the conditions to proceed from 
equilibrium zone into supersaturation zone. 
 
 
 
  
 
 
 
 
Fig I.43 The phase diagram for protein crystallization. It shows the different paths of a crystallization screen. 
Protein crystals can only grow from a supersaturated solution. 
The His6-tag facilitates the binding of the expressed target protein to a nickel-affinity column. It was 
commonly thought that these tags have no influence on the structure or the function of the protein. 
However, they may either affect the solubility of the purified protein or increase its aggregation. 
Therefore some crystallographers prefer to cleave the tags before crystallization screens because they 
may hinder protein crystallization. One study compared the crystal structures of some proteins with 
and without His6-tags and concluded that the tags had no significant effect on the structure of the 
native protein. Actually, for some kinds of proteins it was necessary to crystallize them in the 
presence of the tag. In the future, it may be possible to design specific crystallization tags that may 
enhance protein crystallization and structure determination (Carson et al., 2007). Proteins behave 
differently and it is worth trying both constructs, i.e. either with tag or without tag, because it is 
never known which one will crystallize.   
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4. Aims of this study 
 Optimization of expression and purification for high yields of His6-tagged proteins: 
 Biphenyl synthase from Sorbus aucuparia (SaBIS1) and Malus domestica 
(MdBIS3). 
 Benzophenone synthases from Hypericum androsaemum (HaBPS) and Hypericum 
sampsonii (HsBPS). 
 Single mutants HaBPST135L and HsBPST135K. 
 
 His6-tag cleavage from purified His6-tagged proteins using TEV protease. 
 Crystallization of the purified enzymes and co-crystallization with substrates (CoA, benzoyl-
CoA) and products (3,5-dihydroxybiphenyl, 2, 4, 6- trihydroxybenzophenone) in cooperation 
with Prof. Wulf Blankenfeldt and Dr. Peer Lukat, HZI, Braunschweig.  
 Elucidation of the structural basis and explanation of the two different cyclization mechanisms 
used by BIS and BPS. 
 Disclosing the structural basis of HaBPS and HsBPS. 
 Finding structural explanations for the mutants HaT135L and HsT135K. 
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II. Materials 
1. Chemicals 
Chemicals, unless otherwise mentioned were purchased from the following companies: Roth, Sigma-
Aldrich, Applichem, Fischer Scientific and Fluka. Deionized water was supplied from a Milli-Q 
water purification system (Sartorius, Germany) and used in the preparation of all aqueous solutions. 
All solutions were autoclaved by 120°C for 20 min. Solutions of thermolabile compounds as 
ampicillin and IPTG were sterile filtered and added to autoclaved solutions under sterile conditions. 
All salts required for the bacterial culture media were supplied from Roth or Applichem.  
 
 
  
Supplier 
  
Chemicals 
 
For bacterial culture media 
Applichem 
Roth 
Roth 
Applichem 
Roth 
Yeast 
Pepton(casein) 
NaCL 
Agar 
Glycerol 
Stationary phases used in protein purification 
GE Healthcare 
Qiagen 
GE Healthcare 
GE Healthcare 
GE Healthcare 
Sephadex G-25 in PD10 desalting columns 
Nickel-nitrilotriacetic acid Agarose resin 
Sephacryl S300 HR 
Superdex S200 10/300 GL 
Mono-Q HR 5/5 anion exchange column 
Substrates used for enzyme assay 
Sigma-Aldrich Benzoyl-CoA and malonyl-CoA 
Antibiotics 
Roth 
Applichem 
Ampicillin 
Chloramphenicol 
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Supplier  Chemicals 
Reagents for biochemistry and molecular biology 
Applichem 
Roth 
Roth 
Roth 
Roth 
Roth 
Roth 
Riedel-de-Haen 
Roth 
Roth 
Thermo Scientific 
IPTG  
Immidazole  
Sodium dihydrogen phosphate 
Potassium dihydrogen phosphate 
Sodium hydroxide 
Potassium hydroxide 
Acetic acid 
Hydrochloric acid 37% 
o-Phosphoric acid 
Tris-HCl  
DNTPs 
Organic solvents  
Fischer-Scientific 
Sigma Aldrich 
Fischer-Scientific 
Fischer-Scientific 
Acros Organics 
Methanol 
Ethanol absolute 
Ethylacetate 
Chloroform 
Isopropanol 
Reagents for DNA and Protein gel electrophoresis 
Peqlab 
Roth 
NIPPON Genetics EUROPE 
Bio-Rad 
Bio-Rad 
Roth 
Roth 
Roth 
Sigma-Aldrich 
Merck 
peqGold universal agarose 
Ethidium bromide 
Medori green  
Acrylamide/Bisacrylamide 30% 
TEMED  
Glycin 
SDS 
β-mercaptoethanol 
Bromophenol blue  
Commassie-blue R250 and G250 
 Ladders 
Thermo Scientific 
Thermo Scientific 
Gene Ruler DNA ladder Mix  
Page Ruler Unstained Protein Ladder  
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2. Nutrient media, solutions and buffers 
2.1. Nutrient media for bacterial culture 
Composition Name 
Peptone (Casein)                                                20 g/l 
Yeast extract                                                       5 g/l 
1 M NaCl                                                             10 ml/l 
1 M KCl                                                             10 ml/l 
Autoclave and addition of the following sterile filtered 
solutions 
2 M Mg²                                                              10 ml/l 
2 M Glucose                                                        10 ml/l 
SOC  Media 
Peptone (Casein)                                                10 g/l 
Yeast extract                                                       5 g/l 
NaCl                                                                   10 g/l 
 
 
Agar                                                                    1% (w/v) 
LB Media 
 
 
 
 
For solid media 
IPTG (Isopropyl-β-D- 
thiogalactopydranoside)                           0.12 g/ml (0.5 M)  
 Final concentration in  
bacterial culture                                            (0.1-0.5 mM) 
For induction of protein expression 
Ampicillin               (0.269 M)   100 mg /ml aqueous soln.  
Chloramphenicol    ( 0.093 M)  30 mg/ml  soln. in ethanol 
Antibiotic for selection of transformed 
bacteria 
Glycerol:LB medium (60:40)                            250 µl   
Bacterial culture                                                750 µl 
For preservation of bacterial culture 
 
2.2. Buffers and solutions 
2.2.1. Buffers for DNA- gel electrophoresis 
2 M Tris –HCl 
0.05 M EDTA 
pH 8, adjusted by glacial acetic acid 
50X TAE buffer 
 
1% agarose gel was prepared to examine DNA products. 
 
2.2.2. Buffer for enzyme assay 
 100 mM                                           1.36 g 
Water                                               ad 100 ml 
 pH 7, adjusted by KOH 
Buffer KH2PO4 
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2.2.3. Buffers for plasmid isolation (miniprep) 
Tris-HCl                50 mM           1.5 g/250 ml 
EDTA                    10 mM         0.93 g/250 ml 
RNase A                10 µl/ml  
RNase A was added freshly before use 
Buffer I (pH 8)  
NaOH                     0.2 M              2 g/250 ml  
SDS                        1% (w/v)       2.5 g/250 ml 
Buffer II 
Potassium acetate     2.55 M     62.57 g/250 ml 
Glacial acetic acid to adjust pH 
Buffer III (pH 5.5) 
 
2.2.4. Solutions and buffers for protein gel electrophoresis (SDS-PAGE) 
Water                                          2.72 ml  
1 M Tris-HCl (pH 6.8)                 504 µl  
30% (w/v) Acrylamide/Bis           664 µl  
10% (w/v) SDS                               40 µl 
10% (w/v) APS                               40 µl 
TEMED                                             4 µl 
Staking gel (for 2 small gels)  
Water                                             2.8 ml  
1.5 M Tris-HCl (pH 8.8)             1.75 ml  
30% (w/v) Acrylamide/Bis             2.3 ml  
10% (w/v) SDS                                70 µl  
10% (w/v) APS                                70 µl 
TEMED                                           2.8 µl 
Resolving gel (for 2 small gels)  
Water                                              2.7 ml  
0.5 M Tris-HCl (pH 6.8)                1.0 ml 
Glycerol                                          2.0 ml  
10% (w/v) SDS                               3.3 ml 
 β-mercaptoethanol                         0.5 ml  
0.5% (w/v) Bromophenolblue         0.5 ml 
Protein loading buffer (2X)  
Tris base                                            15 g 
Glycine                                              72 g  
SDS                                                     5 g  
Water                                         ad 500 ml 
SDS-electrode buffer (10X)  
Coomassie blue R-250                        1 g 
Mathanol                                        500 ml  
Acetic acid                                       75 ml  
Water                                       ad 1000 ml 
Staining solution 
Methanol                                        200 ml  
Acetic acid                                       76 ml  
Water                                       ad 1000 ml 
Destaining solution 
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2.2.5. Buffers for extraction and purification of His6-tagged fusion proteins from IMAC 
2.2.5.1. Buffers for BIS and BPS* 
50 mM Tris-HCl                               
300 mM NaCl                                    
10 mM Imidazole 
10% Glycerol                            
 Water                                                          ad 500 ml 
Lysis buffer 
50 mM Tris-HCl                               
300 mM NaCl                                    
30 mM Imidazole 
10% Glycerol                                                        
Water                                                           ad 500 ml 
Washing buffer Ι 
50 mM Tris-HCl                               
1 M NaCl                                    
50 mM Imidazole 
10% Glycerol                                                         
Water                                                           ad 500 ml 
Washing buffer ΙΙ 
50 mM Tris-HCl                               
300 mM NaCl                                    
80 mM Imidazole  
10% Glycerol                                                       
 Water                                                         ad 500 ml 
Washing buffer ΙΙΙ 
50 mM Tris-HCl                               
300 mM NaCl                                    
250 mM Imidazole 
10% Glycerol                                                       
 Water                                                        ad 500 ml 
Elution buffer 
 
*pH of all buffers adjusted to 8 with HCl. 
2.2.5.2. Buffers for TEV protease* 
Lysis buffer 50 mM Tris-HCl 
200 mM NaCl 
Water                                                       ad 500 ml 
After sonication add from autoclaved 1 M Imidazole to a 
final concentration of 10 Mm 
Washing buffer A 50 mM Tris-HCl 
300 mM NaCl  
30 mM Imidazole 
1 mM β-mercaptoethanol 
20% (v/v) Glycerol 
Water                                                 ad 500 ml 
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Washing buffer B 50 mM Tris-HCl 
300 mM NaCl 
50 mM Imidazole 
1 mM β-mercaptoethanol 
20% (v/v)  Glycerol 
Water                                                  ad 500 ml 
Elution buffer 50 mM Tris-HCl 
300 mM NaCl 
300 mM Imidazole 
1 mM β-mercaptoethanol 
20% (v/v)  Glycerol 
Water                                                  ad 500 ml 
 
*pH of all buffers adjusted to 8 with HCl. 
2.2.6. Buffers for desalting and SEC 
 
50 mM Tris-HCl                               
100 mM NaCl                                    
10% Glycerol                               
 Water                                                  ad 500 ml 
pH   7.4   adjusted by HCl 
For BIS 
50 mM Tris-HCl                              
100 mM NaCl                                    
10% Glycerol                               
 Water                                                  ad 500 ml 
pH   8.4   adjusted by HCl 
For BPS 
50 mM Tris-HCl  
150 mM NaCl 
1 mM DTT (Dithiothreitol) 
20% (v/v) Glycerol 
Water                                             ad 500 ml 
pH 8 adjusted by HCl 
For TEV protease 
 
2.2.7. Buffers for IEC 
 
20 mM 
10% 
pH 7.5 adjusted by HCl 
Tris –HCl 
Glycerol 
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2.2.8. Solution to determine the protein amount 
The Coomassie-Brilliant blue 
G250 powder was dissolved 
in ethanol by stirring. 
Orthophosphoric acid was 
added, and then the volume 
was completed with water. 
The solution was filtered till 
no blue color could be seen. 
It was kept protected from 
light in an amber glass bottle 
by 4°C. 
Coomassie-Brilliant               100 mg 
blue G-250                        
  
Ethanol 96%                             50 ml  
       
O-phosphoric acid                   100 ml 
85% w/v                            
 
Water                                ad 1000 ml  
 
Bradford-dye solution 
 
2.2.9. Solutions for PD-10 washing and Ni-NTA agarose regeneration and recharging 
Wash with 25 ml (5x column volume) then 
wash with water till getting a neutral eluent 
by testing the eluent with litmus paper 
PD10 washing solution NaOH (0.16 M)  
0.2 M acetic acid  
30% glycerol  
Deionized water   
  
Used Ni-NTA agarose of blue color was washed  
with 10x volume of the following solutions in the 
same order 
2CV  6 M guanidine HCl 
5CV  water 
3CV  2% SDS 
1CV of  25%, 50%, 75%, and 100% EtOH 
1CV of 75%, 50%, 25% EtOH 
1CV  water 
5CV of 100 mM  EDTA   pH 8 
2CV  water 
2CV of 100 mM  NiSO4 
2CV  water 
2CV  6 M guanidine HCl  
Equilibrate with 2CV of suitable buffer  
Finally store the resin in 20% EtOH 
Used Ni-NTA agarose of white or brown color 
was recharged with the following solutions in the 
same order 
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3. Materials used for molecular biology 
3.1. Bacteria strains 
Genotype Purpose E. coli 
F'φ80δlacZ9M15endA1hsdR17(rkmk+)supE44
thi1 λgyrA96relA19 (lacZYA-argFV169) deoR 
Deliver high yield plasmid 
preparation for downstream 
applications, chemically 
competent 
DH5  
F-, ompT hsdSB (rB- mB-) gal dcm (DE3) 
pLysS (CamR)  
For protein overexpression 
(Invitrogen), chemically 
competent 
BL21(DE3) 
pLysS 
 
3.2. Cloning vectors 
Invitrogen pRSET-B vector  ( for protein expression)  
Novagen   pET 52b (+) (for C-terminal SaBIS1 production) 
  
3.3. Enzymes 
Name 
 
Purpose Supplier 
Phusion Hot Start II High 
fidelity DNA polymerase 
High fidelity amplification of DNA Thermo Scientific 
Dpn I Digest the parental DNA template and to 
select for mutation containing synthesized 
DNA 
Thermo Scientific 
 
Kpn I 
 
Nhe I 
Endonucleolytic cleavage of DNA to give 
specific double-stranded fragments with 
terminal 5'-phosphates 
Thermo Scientific 
 
Thermo Scientific 
BamH I 
Sal I 
For C-terminal His6-tagged SaBIS1 
production 
Thermo Scientific 
Thermo Scientific  
EcoR I DNA linearization  Thermo Scientific 
RNase A Digestion of RNA for plasmid isolation Thermo Scientific 
T4 ligase Ligation of sticky ends of DNA Thermo Scientific 
FastAP Thermosensitive 
Alkaline Phosphatase 
Catalyzes the release of 5'- and 3'-phosphate 
groups from linearized vector DNA and 
preventing its recircularization 
Thermo Scientific 
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3.4. Primers  
All the primers were synthesized in HPSF (High Purity Salt Free) quality at Eurofins Genomics 
(Ebersberg, Germany). 
C-terminal His-6 tagged SaBIS1 primers 
5 Bam Sa BIS1     
3 Sa BIS1 TEV 
Tm 60.8 °C 
Tm 80.3 °C 
AGT CGG ATC CTG AGA ATC TTT ATT TTC AGG                                               
GCA TGT CGA CGC CCT GAA AAT AAA GAT TCT CGC 
ATG GAA TAG ATT CAC TAC GCA G 
 
HaBPS and HaBPST135L mutant primers 
HaBPSC167A Sen 
HaBPSC167A Ant 
HaBPSC167S Sen 
HaBPSC167S Ant 
Tm 81.7 °C 
Tm 80.3 °C 
Tm 80.5 °C 
Tm 79.1 °C 
CAG GGC GCC TTC GCT GGG GGC ACG GCC 
C GAA GGC GCC CTG GTT GTA GAG CAT GAC GCG C 
CAG GGC TCC TTC GCT GGG GGC ACG GCC 
C GAA GGA GCC CTG GTT GTA GAG CAT GAC GCG C 
 
MdBIS3 mutation primers   
MdBIS3C167A Sen 
MdBIS3C167A Ant 
Tm 74.6 °C 
Tm 69.5 °C 
T GAA GCT GGC GCC TAT GCT GGT GCG ACA GTC C 
GC ATA GGC GCC AGC TTC ATA GAT CAT GGT T C 
 
Artificial HaBPS mutation primers   
HaBPSaA133C Sen 
HaBPSaA133C Ant 
 
HaBPSaV138F Sen 
 
HaBPSaV138F Ant 
HaBPSaY168F Sen 
HaBPSaY168F Ant 
HaBPSaV199M Sen 
 
HaBPSaV199M Ant 
HaBPSaS219A Sen 
HaBPSaS219A Ant 
HaBPSaG257A Sen 
 
HaBPSaG257A Ant 
HaBPSaK272S Sen 
 
HaBPSaK272S Ant 
Tm > 75 °C 
Tm 67,1 °C 
 
Tm > 75 °C 
 
Tm 67,7 °C 
Tm 73,6 °C 
Tm 65,4 °C 
Tm 72,9 °C 
 
Tm 64,8 °C 
Tm > 75 °C 
Tm 68,0 °C 
Tm > 75 °C 
 
Tm 73,3 °C 
Tm 69,5 °C 
 
Tm 64,9 °C 
AC GTG GTG TTC TGC ACG GCC TCG GGG GTC ATG 
GT GCA GAA CAC CAC GTG TGT TAT TTT CGA AAT 
TG 
ACG GCC TCG GGG TTC ATG ATG CCC GGC GCA 
GAC TA 
CAT GAA CCC CGA GGC CGT GCA G 
AA GCA GGC TGT TTT GCT GGG GGG ACG GCA C 
GC AAA ACA GCC TGC TTC ATA TAA CAT GAC G 
A AAC ACC GCC ATG TTT TTC CAC GCC CCG AAT 
GAG TC 
AAA CAT GGC GGT GTT TTC CGC GCA TA 
AA GCC CTG TTC GCA GAT GGC GCG GCT GCT CTG 
TC TGC GAA CAG GGC TTG ACC CAC TAT C 
GT TCC GAC GGC GCC GTC ACG GCG CAT ATT TAC 
GAA ATG 
GAC GGC GCC GTC GGA ACC CGG C 
GC TAT TTT TTG AGC GAA GAT GTA ATC CCT CTG 
GTC C 
TC GCT CAA AAA ATA GCT AAA CCC CAT TTC GTA 
AAT A 
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4. Instruments 
4.1. Instruments of TUB 
Company  Model  Instrument  
Sartorius 
 Systec 
WTW GmbH 
Heraeus  
Pharmacia Biotech 
IKA-Labortechnik 
Branson (G.Heinemann) 
Techne  
Sartorius 
Julabo  
 Ilmvac 
Biometra 
IKA 
Vilber Lourmat 
 
 
 
BioRad 
BioRad 
 
 
Hettich 
Heraeus Sepatech 
Beckman Coulter 
Sigma Centrifuges 
 
 
Infors HT 
Infors HT 
 
 
Heraeus  
Heraeus  
 
LA 230S  
Vx-120 Systec GmbH 
Digital pH meter 325 
Hera Freeze 
Ultrospect 1000 
VF2 
Sonifier 250 
Dri Block BD-3 
Arium 611 VF 
TopTech MW-4 
VCZ 224 
T-Professional basic gradient 
VF2 
Infinity-3000 
 
 
 
Wide Mini-Sub Cell GT  
Mini PROTEAN Tetra Cell   
 
 
Universal 32R 
Biofuge 13 
AvantiA - J-E Centrifuge 
Sigma 1-15K 
 
 
Multitron  
 KF4 
 
 
Laminar Air HLB 2472 
Laminar Air HLB 2460 
 
 
Balance  
Autoclave 
pH Meter 
-80°C Freezer 
Spectrophotometer 
Magnetic rotator 
Ultrasonic Cell-Disrupter 
Thermo block  
Water purification system 
Heating circulator water bath 
Diaphragm vacuum pumps 
Thermocycler 
Vortex shaker 
Gel documentation  
 
 
Electrophoresis chambers: 
Agarose gels 
Polyacrylamide gels 
 
 
Centrifuges 
 
 
 
 
 
Incubator Shakers 
 
 
 
Clean benchs 
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4.2. Instruments of crystallization in HZI 
Instrument Model Company 
HPLC 
 
Auto sampler 
Pump 
Detector 
Software 
Degasser 
 
Column 
 
Column 
LaChrom Elite System 
 
L-2200 auto sampler 
L-2130 Pump 
L-2455 diode array detector 
EZChrome Elite  
Model 2005 Degasser 
 
Hyper Clone ODS column 
(C18, 250 x 4.6 mm, 3 μm) 
Symmetry® glass lined column  
C8, 150 x 4.6 mm, 3.5 µm 
 
VWR-Hitachi 
 
VWR-Hitachi 
VWR-Hitachi 
VWR-Hitachi 
Agilent 
VWR-Hitachi 
 
Phenomenex 
 
Waters  
Instrument  Model  Company  
FPLC: Machine 
          Columns 
 
ITC 
 
MST 
Thermofluor 
 
Robot 
Imager 
X-Rays: Generator  
              Optics  
              Detector  
              Goniometer   
 
Self-made radom screens                
Äkta Purifier 10 
Superdex S200 16/60      
Superdex 200 10/30 
VPITC 
 
Monolith NT.115 
Self-designed screen with SyPro 
Orange 
HoneyBee 961 
Rockimager1000 
Micromax 007 HF rotating anode 
Varimax  
Saturn 944+ CCD  
AFC-11 goniometer 
 
Design in Rockmaker 
Set up in Formulator34 
GE Healthcare 
GE Healthcare                    
GE Healthcare              
MicroCal/GE Healthcare 
/Malvern 
Nanotemper 
Sigma-Aldrich ran in              
a BioRAD CFX96 RT-Cycler 
Digilab 
Formulatrix 
Rigaku 
Rigaku 
Rigaku 
Rigaku 
 
Formulatrix 
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III. Methods 
1. General molecular biology methods 
1.1. Bacterial growth 
Culturing of the E. coli strains was carried out as a rule in LB medium (II.2.1.) containing the 
appropriate antibiotics (II.2.1.). For plasmid isolation a single colony was transferred from LB plate 
with a sterile toothpick  into 5 ml LB medium and was grown overnight at 37 ° C in a rotary shaker. 
To obtain the E. coli in sufficient quantity for protein expression, the single colony was transferred 
initially into 10 ml of LB medium and after 12-14 hours, 4 ml of the overnight culture were 
transferred into 100 ml LB medium and incubated to an OD600 0.6-0.8. Since this small scale culture 
was not sufficient for a purpose such as crystallization larger volumes of the medium were used to 
express the target protein in high amount, single colony was grown in 50 ml LB medium for 6-8 
hours, the flasks were placed at room temperature. In the next morning 25 ml of this culture were 
transferred into 400 ml of LB medium in baffle flasks and incubated 4 hours to reach OD600 1. 
Nearly the same protocol was performed for TEV protease but differs in the growing of the bacteria 
first in 5 ml LB medium for overnight and in the next morning 2 ml of this culture were transferred 
into 400 ml LB and were growing until OD600 0.6 was reached. 
1.2. Enumeration of bacteria 
A photometric estimation of bacterial growth and density was determined by measuring of its 
turbidity in the culture media (Maier, 1992) in which the light scattering is caused by the growing of 
the organisms and at a wavelength of 600 nm an absorbance of 1 ml of inoculated LB medium 
against sterile medium was measured.                                                                                         
Absorption of OD600 = 1 corresponds to an approximate E. coli cell count of 8 x 10
8
. 
1.3. Bacterial glycerol stock 
For the permanent storage of E. coli BL21 (DE3) containing the desired plasmids, an aliquot of 750 
µl bacterial cultures with OD600 0.6 was mixed with 250 µl autoclaved stock solution (40 ml LB 
medium + 60 ml glycerol). The bacterial glycerol stock was stored then at -80°C. Recovery from the 
frozen culture was done by scratching with a sterile loop and streaking on the surface of an LB agar 
plate containing the appropriate antibiotic. The plate can be stored at 4° C for short-term use (max. 4 
weeks).   
1.4. Quantification of DNA concentration 
The concentration of nucleic acids was determined by measuring the absorbance value of the DNA 
sample at wavelength of 260 nm. One unit absorbance value at wavelength 260 nm (ε260) 
corresponds 50 ng/µl double-stranded DNA (Sambrook et al., 2001).                                                 
[c] = A* ε260* dilution factor             [c]; concentration of DNA.  
Purity was determined by calculating the ratio of the absorbance at 260 nm to the absorbance at 280 
nm. Pure samples having an A260/A280 ratio of 1.7-1.9 ensure the appropriate quality.  
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1.5. Agarose gel electrophoresis 
Ethidium bromide and Midori green stains were used for visualization of DNA bands. They 
intercalate in nucleic acid molecules and its fluorescence increases 20-fold after this binding. 
According to the number of the samples the corresponding volume of TAE buffer and agarose 
weight were mixed and boiled in a microwave. After cooling down, the staining dye was added and 
the mixture was poured in the gel tray and left to solidify at room temperature. Samples were loaded 
on the gel after mixing with loading dye along with DNA ladder then the run started after putting the 
gel in a chamber filled with TAE buffer and under electric current (220 V). The run stopped when 
the visible dye in the loaded sample migrate 2/3 distance of the gel length (~30 min). Finally the 
bands in the gel were visualized under UV-equipped transilluminator. 
1.6. Preparation of competent cells of E. coli 
E.coli cells treated with calcium ions can take in the foreign DNA-plasmid and are called “competent 
cells”. They are used in the recombinant DNA experiments for transformation; their preparation was 
done according to the modified methods in the literatures (Maier, 1992, Birnboim & Doly, 1979, 
Katsuyama et al., 2011).  A single colony from an overnight agar plate or a sterile loop from a frozen 
culture was inoculated into 5 ml of LB medium and incubated with shaking at 37°C overnight. One 
ml of this fresh culture was transferred to 50 ml LB medium and incubated at 37°C with shaking 
until the OD600 reached 0.6-0.8. The culture was then chilled for 10 min on ice and the cells were 
harvested by centrifugation at 3000 rpm and 4°C for 10 min. The pellet was washed with 50 ml of 
ice-cold 0.05 M CaCl2 and the cells were harvested again by centrifugation as above and 
resuspended in 20 ml of 0.05 M CaCl2. The cell suspension was then kept in ice for 20 minutes. 
After centrifugation the pellets were resuspended in 940 µl of 0.05 M CaCl2 solution and incubated 
for 15 min on ice, afterwards 140 µl glycerol was added. The competent cells were stored at -80°C as 
50 µl aliquots until further usage. 
1.7. Transformation of plasmids into E. coli 
1.7.1. Transformation into E. coli strain DH5 
This strain of E.coli was used for plasmid maintenance because it has high transformation efficiency 
and high plasmid yields. The following procedure was used: 50 μl E.coli DH5α competent cells from 
-80°C storage (III.1.6.) were incubated 5 minutes in ice followed by addition of 1 μl of foreign 
plasmid DNA. After mixing and incubation of the mixture on ice for 25 minutes a heat shock at 42°C 
for 45 seconds was applied to force the foreign plasmid enter the cells followed directly by 5 minutes 
incubation at 4°C. In order to maximize the transformation efficiency cells were allowed to grow in 
250 μl SOC medium with continuous shaking at 37°C for 60- 90 min. Finally the whole bacterial 
suspension is plated on LB-agar medium containing ampicillin (100 μg/ml). 
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1.7.2. Transformation into E. coli strain BL21 (DE3) pLysS 
E.coli strain BL21 is mainly used for high-level of gene expression and production of recombinant 
protein in a bacterial system. The transformation procedure was the same as with DH5α (III.1.7.1.) 
except that, the heat shock time was for 20 seconds and 700-900 μl SOC medium was used for 
growing of bacterial culture. After one hour of incubation at 37°C about 100 μl of bacterial 
suspension was finally plated on LB-agar medium containing ampicillin (100 μg/ml) and 
chloramphenicol (30 μg/ml). Ampicillin resistance is acquired from the expression vector and 
chloramphenicol resistance is acquired from the host cells. For TEV protease the used host cells were 
BL21/DE3 tuner and only ampicillin was used for its growing. Fresh plates were used always for the 
desired protein before each purification and crystallization procedure. 
1.8. Plasmid isolation from E. coli miniprep 
Plasmid isolation was performed using an alkaline hydrolysis method (Birnboim & Doly, 1979) in 
which a single colony from the transformed DH5α plate was inoculated into 5 ml LB medium 
containing 100 µg/ml ampicillin and grown over night at 37°C. In the second day 2 ml cultures were 
centrifuged at 5000 rpm for 5 min. Bacterial pellets were then resuspended in buffer I (300 µl) 
containing RNase A then buffer II (300 µl) was added and the bacterial suspension was mixed by 
inverting continuously 6 times and incubated at room temperature for maximum 5 min. At this step 
lysis of the cell wall took place in addition to denaturation of large chromosomal DNA. RNA is 
destroyed by RNase A. Precipitation of proteins was done by adding ice-cooled buffer III (300 µl) 
and gentle mixing by inversion upside-down 6 times then incubation on ice for 20 min. 
Centrifugation at 13.000 rpm for 10 min was done to exclude the denatured proteins and genomic 
DNA. Then the clear supernatant containing the plasmid DNA solution (800 µl) was transferred to a 
new Eppendorf tube. Residual contaminants and hydrolysed protein were extracted by vortex with 
800 µl chloroform followed by centrifugation at 13.000 rpm for 10 min. The aqueous layer was then 
transferred to a new Eppendorf tube and isopropanol (0.7 volume of the aqueous layer volume) was 
added then the mixture was centrifuged at 13000 rpm for 10 min to precipitate plasmid DNA. The 
pellets were washed with 70% ethanol (500 µl) followed by centrifugation at 13.000 rpm for 10 min. 
The supernatant is discarded and the plasmid pellets are dried by 37°C and then dissolved in 50 µl 
distilled water. This purified plasmid can be directly used after measuring the concentration as 
described in (III.1.4.) for transformation (III.1.7.) or stored at -20°C for further usage. 
1.9. Digestion with restriction endonucleases 
It is possible to cut a specific region of DNA strand using endonucleases. These enzymes hydrolyze 
the phosphodiester bond between the 5'-phosphate group of a nucleotide and the 3'-hydroxy group of 
the neighboring nucleotide by the recognition of a palindromic sequence which is unique for each 
restriction endonuclease. This will help in the ligation of DNA insert and vector which are cut with 
the same endonuclease. In 20 µl reaction mixture about 0.5-1µg plasmid DNA was incubated at 
37°C for 3 hours with 1 µl endonuclease and 2 µl of 10x restriction endonuclease specific buffer. 
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1.10. Isolation of DNA by gel extraction 
By the use of innuPREP DOUBLE pure kit from Analytikjena. Salts and macromolecules are 
removed by washing with ethanolic wash buffer without elution of DNA fragments. With an alkaline 
buffer of low ionic strength, the DNA is eluted and stored at -20°C. 
1.11. Ligation and dephosphorylation  
The DNA insert and the vector were mixed in molar ratio of 3:1, added to 1 µl of 10x T4 DNA ligase 
buffer, mixed with 0.25 µl of T4 DNA ligase, the final volume was completed with distilled water to 
10 µl. The mixture was incubated for 3hrs at 16°C and subsequently transformed in E.coli DH5α as 
described in (III.1.7.1.).  Dephosphorylation of the vector after digestion is an important step before 
the ligation because it minimizes the ligation of the digested vector with itself. This process will help 
in the transformation of more recombinant but not recircularized vector plasmid to the bacterial cells. 
In this reaction 2 µl of 10x reaction buffer for AP (alkaline phosphatase) was mixed with 1 µl 
FastAP Thermosensitive Alkaline Phosphatase and the final volume was completed to 20 µl using 
the digested vector. The mixture was then incubated for 20 min at 37°C followed by inactivation of 
the enzyme for 15 min at 65°C. Finally the vector was purified from the reaction components as 
described in (III.1.10.). 
1.12. Polymerase chain reaction (PCR) 
This reaction utilizes DNA polymerase which synthesizes complementary strands of DNA using a 
DNA template and primers by adding nucleotides to the 3′-end of the primer. It requires three steps: 
The denaturation step: the separation of the double strands to form single stranded DNA by heating 
the DNA for 20–30 s at 95-98 °C.                                                                                                               
The annealing step: the primers anneal to their specific template by using specific annealing 
temperature (between 45-70 °C) which is 3-5 °C below the Tm of the primers.                                
The extension step: the multiplication of the initital DNA template by heating at 72 °C which is the 
optimum temperature for most thermostable DNA polymerases.  
The reaction components and conditions were as follows using the recommended protocol of Q5
®
 
High-Fidelity DNA Polymerase: 
Component  Amounts  
5X Q5 Reaction Buffer 
10 mM dNTPs 
10 µM Forward Primer 
10 µM Reverse Primer 
Template DNA 
Q5 High-Fidelity DNA Polymerase 
Nuclease-Free Water 
10 µl 
1 µl 
2.5 µl 
2.5 µl 
100 ng 
0.5 µl 
to 50 µl 
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1.13. Site-directed mutagenesis PCR (SDM-PCR) 
The QuickChange™ site-directed mutagenesis procedure from Stratagene was used, in which two 
oligonucleotide primers with the desired mutation were designed according to the modified primer 
protocol of Liu and Naismith (2008). The primers will anneal to the template DNA using PCR and 
after extension by DNA polymerase a mutated plasmid will be generated which can be used as a 
template in the subsequent cycles.The conditions were as follows: 
PCR reaction constituents PCR program 
10 pmol sense mutagenic primer 
10 pmol Anti-sense mutagenic primer 
 
Template DNA 5-50 ng/µl 
 
5x  Phusion HF buffer 
2 U/μl Phusion Hot Start II DNA 
Polymerase 
 
10 mM dNTPs mix 
 
Up to 50 µl PCR water 
2.5 µl 
2.5 µl 
 
1 µl  
 
10 µl 
0.5 µl 
 
 
1 µl 
 
Temp 
°C 
Time Step 
Lid 98 
 
98 
98 
 
98 
63 
72 
 
72 
4 
 
 
Pause 
30 sec 
 
10 sec 
30 sec          
2 min 
 
10 min 
Pause  
Preheating on 
 
 
Initial 
denaturation 
Denaturation  
Anneling 
Extension 
 
Final extension  
 
One µl of DpnI restriction enzyme was added to the SDM-PCR product and the mixture was 
incubated for 3hrs at 37°C. This enzyme is specific for methylated and hemimethylated DNA and it 
will digest only the parental DNA template. After that 6µl of DpnI treated PCR product was used for 
transformation of E. coli DH5α competent cells (III.1.7.1.). 
1.14. Expression and protein induction 
Protein expression was performed by low temperature to slow the metabolic processing of the 
bacteria and then giving the opportunity for the protein to be correctly folded. After growing of the 
bacteria in 400 ml LB medium until OD600 1, the expression was then induced by the addition of 0.1-
0.2 mM IPTG to the bacterial suspension and the flasks were incubated at 24°C in the shaker for 4 
hours. Thereafter the cells were harvested by centrifugation at 6000 rpm for 16 min. At this point the 
cell pellets were stored at -20°C for several weeks. For TEV protease, the induction was performed 
by the addition of 0.2 mM IPTG and the incubation was at 20°C for overnight. 
 
 
 25     
cycles 
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1.15. Cell lysis 
The bacterial pellet from 800ml medium (III.1.13.) was suspended in 16-18 ml lysis buffer and 
disrupted by sonication on ice for 8-10 min in the sonifier at duty cycle 40% and output control of 
1.5. This solution was centrifuged at 4°C for 20 minutes at 14,000 rpm and the clear supernatant was 
used for protein purification by affinity chromatography. For TEV protease, a pellet from 2 L 
medium was suspended using 40 ml lysis buffer and after sonication the solution was centrifuged at 
4°C for 20 minutes at 20,000 rpm. 
2. General biochemical methods 
2.1. Protein purification  
2.1.1. IMAC (immobilized metal affinity chromatography) (Ni-NTA agarose) 
Since all recombinant proteins used in this work were cloned with a polyhistidinetag (His6- tag), they 
could quickly and easily purified by the use Ni-NTA agarose (Quiagen, Hilden).  The Ni2 + ions 
have six complex binding sites, four sites are bound to nitrilotriacetic acid which is linked to 
sepharose matrix and the other two remaining binding sites are available to interact with each 
histidine of the His6 -tag. The elution of the protein can be achieved either through a reduction of pH 
(pH 4.5-5.3) as the protonated nitrogen can no longer bind to the nickel ions or by the addition of 
imidazole to the elution buffer because imidazole competes with histidin residues due to its structural 
equivalence. At concentrations between 100-250 mM it can displace the His6-tag which is bound to 
the matrix. Since the purification under native condition was carried out an increase in the 
concentration of imidazole was gentler on the protein as pH reduction. The addition of low 
concentrations of imidazole for washing and lysis buffer was to prevent the nonspecific binding of 
foreign proteins. The solution (III.1.14.) obtained after cell disruption was added to 0.8 ml Ni-NTA 
agarose and gently mixed for one hour at 4°C. After this incubation the solution was poured through 
an empty PD10 column and the gel matrix was retained. The agarose with the bound protein was 
washed using the wash buffers in (2.2.5.).  
Firstly it was washed 10 times with 1 ml wash buffer I (30 mM imidazole), then followed by 6 times 
with 1 ml wash buffer II (50mM immidazole) and finally by 4 times with 1 ml wash buffer III (80 
mM immidazole). The elution of the target protein was performed with 5 times 0.5 ml elution buffer 
(250 mM imidazole). For TEV protease, 2 ml Ni-NTA agarose was used and the purification was 
performed by washing the column 10 times with 1 ml wash buffer A then followed by 8 times with 1 
ml wash buffer B. 
For large amounts of protein, the required amount of Ni-NTA agarose was calculated according to 
the column capacity in which 1 ml Ni-NTA agarose can bind 5-10 mg protein. The washing times 
should be increased to 10 times for different washing buffers. 
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2.1.2. Size exclusion chromatography (SEC) 
2.1.2.1. PD-10 columns 
Although the imidazole in the buffers did not affect the enzyme activity, it should be removed for 
crystallization approaches and storage of the protein at -20°C. It was also necessary to reduce the 
ionic strength during the Ni-NTA purifications for the crystallization. Therefore the protein solution 
obtained in (III.2.1.1.) was desalted using size exclusion chromatography. For this purpose, PD10 
column (3.5 ml bed volume, separation region 1000-5000 Da Amersham Biosciences) was 
equilibrated with 30 ml of the desalting buffer (II.2.2.6.) and then 2.5 ml of the protein solution from 
(III.2.1.1.) was applied. When the solution is completely immersed into the separation bed, elution of 
the protein was carried out with 3.5 ml of the desalting buffer, so the low molecular weight salts will 
be retained within the pores of the gel matrix and the protein can be eluted with the void volume. 
2.1.2.2. Superdex high resolution columns 
As PD-10 columns were used for small protein amounts highly concentrated samples of protein were 
desalted and highly purified using preparative size exclusion chromatography columns such as 
superdex S200 10/30 for small amount samples (less than 5mg/lml) and superdex S200 16/60 for 
large amount samples (more than 10 mg/ml). Moreover the use of such columns was essential to 
identify the homogeneity of a protein sample before the crystallization process. As SEC separations 
are based on diffusion into and out of the pores of the column’s packing material, the larger proteins 
cannot access the pores and elute earlier such as aggregates that may formed during any stage of the 
purification process. The smaller proteins are trapped within the pores, which results in longer 
retention times and later elution, such as our target proteins. After equilibration of the column using 
the desalting buffer, 0.5-1 ml of highly concentrated protein samples (10-30 mg/ml) were injected 
and the eluted fractions corresponding to the sharp large peak were collected and concentrated to the 
desired concentration for crystallization screens.    
2.1.3. Ion exchange chromatography (IEC) 
To get protein in a good quality especially for crystallization purposes, different purification steps 
are needed. Affinity chromatography and size exclusion chromatography are the most famous 
techniquese and they work for almost all proteins such as BPS. But for other proteins such as BIS 
additional steps should be included to get a sample in a good quality, which is ion exchange 
chromatography. 
2.1.3.1. Mono Q anion exchange column 
Anion exchange chromatography was used to purify substances with a negative charge at high pH 
level, such as proteins. The column is pre-equilibrated with the buffer (II.2.2.7.) before the protein 
mixture is applied, then the elution can start using a salt gradient (0-1 M) NaCl. The negative ions in 
the salt solution (Cl-) compete with proteins in binding to the resin. Unbound proteins are collected 
in the flow-through and/or in subsequent buffer washes, but proteins that bind to the resin are 
retained and can be eluted by gradual increase in the salt concentration in the elution buffer.  
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2.2. Cleavage of His6-tag using TEV protease  
TEV protease (Tabaco-Etch-Virus) is an enzyme that was used to cut the His6-tags from the His6-
tagged proteins. Since the enzyme itself has a His6-tag, it binds easily to be removed from the final 
purified protein solution. For the use of TEV protease the proteins had to be provided with a 
recognition site for this enzyme directly in the beginning of the protein that was cloned. This 
recognition site has seven amino acids Glu-Asn-Leu-Tyr-Phe-Gln-(Gly/Ser) (ENLYFQ (G/S), where 
the cleavage occurs between the Gln and Gly/Ser residues. The available construct with this site was 
provided for Sorbus aucoparia BIS1 by Dr. Maren Lütge (Lütge, 2012). The TEV 
protease construct that was used in this work was provided by HZI (Helmholtz Centre for Infection 
Research) in Braunschweig and was purified and stored at -80°C in our lab. The concentrated 
proteins were cut with TEV at different temperatures, 4°C, 16°C, 25°C and 37°C, with gentle 
shaking for different time intervals. Different ratios of TEV and the target proteins were used ranging 
from 1:50, 1:30 and 1:10. After cutting, the TEV protease and His6 were removed via affinity 
chromatography with Ni-NTA agarose (III.2.1.1.). The target proteins were then collected in the flow 
through and the washing fractions. 
2.3. Concentration of protein for crystallization 
For the crystallization approach, the protein concentration should be high (about 20 mg/ml) at the 
end of the purification processes. For this purpose, the protein solution from III.2.1 was concentrated 
using vivaspin centrifugal concentrators (Sartorius, Göttingen). The membrane filter of these 
concentrators had a molecular weight cut-off of 10 kDa whereby proteins in size of 86 kDa are 
retained in the solution above the membrane. The centrifugation was performed at 9000 rpm and 4°C 
for 10-60 min to reach the final concentration needed for gel filtration or crystallization. 
2.4. Determination of protein content 
Colorimetric measurement of protein was carried out using the Bradford protein assay (Bradford, 
1976) in which a coomassie brilliant blue G-250 dye interacts with aromatic and basic amino acids of 
the protein. The negative charged sulfonate anions of the dye donate charges to the cationic amino 
acids, which results in the exposure of the hydrophobic part of the protein that will interact with the 
phenyl residues of the dye by van der Waals forces. Upon interaction with protein the absorption 
maximum of the dye shifts from 465 nm (red, free form) to 595 nm (blue, bound form). The assay 
was done using 900 µl Bradford solution that was completed to 1000 µl by the addition of 100 µl of 
protein and buffer mixture. After gradual mixing a blue color appears and reaches to its maximum 
after two minutes and is stable for 1 h. For concentration measurement, a standard curve was 
constructed using the absorbance of serially diluted samples of bovine serum albumin (BSA) 
solution (1 mg/ml). 
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2.5. Protein storage 
For enzyme assays, it was possible to store aliquots of the protein solution at 4°C for about a month 
or more without any effect on the activity, especially in the crystallization buffers which contain 
glycerol and no imidazole. However, at -20°C the activity decreased gradually depending on the 
freezing and thawing times. Enzyme batches that were used for the crystallization approaches were 
fresh in most cases, but it was also possible to store the protein at -80C° in liquid nitrogen for a short 
period until the time of the next crystallization screen.  
2.6. SDS gel electrophoresis (SDS-PAGE) 
SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) is the most common 
analytical technique used to separate and characterize proteins according to their molecular 
masses(Laemmli, 1970) and it was mainly used in this work to detect the size and the purity of the 
proteins. In the stacking zone proteins migrate through large pores; no separation takes place rather 
all the proteins in a sample will collect as a thin compact band at front of the resolving gel. The 
resolving gel has a narrower pore size and proteins will be separated according to their masses, the 
low molecular weight proteins will run faster than large molecular weight proteins. Bisacrylamide 
interconnect the polymer chains of acrylamide and the polymerization reaction is initiated by the 
addition of ammonium peroxydisulfate (APS), a radical initiator, and N,N,N′,N′-
tetramethylethylenediamine (TEMED), a polymerization catalyst. The degree of polymerization and 
hence the pore size of the gel is dependent on the amount of acrylamide and the pH of the 
polymerization reaction. 
2.6.1. Sample preparation 
The protein samples were denaturated in the presence of the loading buffer (II.2.2.4.) at 95C for 5 
min. During denaturation the protein is defolded and becomes uniformly coated with negative 
charges from SDS in the loading buffer, this process will cancel the differences between proteins 
regarding their charges. Glycerol in the sample buffer ensures that all samples will sink and settle 
down in the pockets of the SDS-PAGE gel, while bromophenol blue, a small size dye, migrates 
faster than any protein and helps trace the protein bands in the gel.  
2.6.2. Setting of the gel 
The resolving gel ingredients (II.2.2.4.) are mixed together then poured between the glass plates of 
the instrument and overlaid with water to avoid interaction with air. After gel formation (20 min), 
water is absorbed away with filter paper. The same procedures are carried out for the stacking gel, 
except that a comb is added to create the sample pockets. After 20 min or less the gel is formed. 
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2.6.3. Electrophoresis and protein band detection 
The gel is immersed in a chamber filled with the electrophoresie buffer (II.2.2.4), so the sample 
pockets are washed to remove any air bubbles that may hinder the electrophoresis. Protein samples 
are prepared as mentioned before (2.5.1.) and loaded in the pockets of the stacking gel. The gel was 
run at 35 mA / 200 V max supplied by a standard power pack P25 (Biometra).  The run ends when 
the dye bromophenol blue reaches the front of the gel. After electrophoresis the protein bands are 
detected by immersing the gel in coomassie blue staining solution (II.2.2.4.) with gentle shaking for 
10-30 min and then de-stained by immersing the gel in methanol-acetic acid de-staining solution 
(II.2.2.4.) for 4 hrs or overnight. 
3. General analytical methods 
3.1. HPLC and enzyme assay 
A standard assay was followed up for all enzymes in this work to ensure the activity of the protein 
after purification and before the crystallization process. This protocol was optimized to detect the 
activity for most type III PKSs in our research group (Liu et al., 2003). The reaction mixture was 
prepared using the listed amounts of enzyme and substrates in the following table. The final volume 
was completed to 250 µl using the assay buffer (II.2.2.2.). Then incubation at 35°C for 10 min was 
carried out.  
The reaction was stopped by further addition of 27 µl 50% acetic acid and the enzymatic products 
were extracted twice with 250 µl ethyl acetate by vigorous mixing and then centrifugation at 13.000 
rpm for 10 min. The two organic phases were combined and dried under vacuum for 30 min, the 
final residue was dissolved in 50 µl of methanol for HPLC analysis. 
 Volume  End concentration 
Enzyme  2-4 µg 
Benzoyl-CoA (230.5 µM) 15 µl 13.8 µM 
Malonyl-CoA (234.5 µM) 20 µl 18.8 µM 
0.1M KH2PO4 buffer  (pH 7) ad to 250 µl 
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4. Protein crystallization  
Protein concentrations can be enhanced to form crystals when the solution in which they are 
dissolved becomes supersaturated. As many methods in protein crystallization were developed to 
promote this super-saturation stage the most abundant and the one that was used in this work is the 
vapour diffusion method. 
4.1. Vapour diffusion 
A drop of the highly concentrated soluble protein solution, which was mixed equivalently with the 
reservoir contents is allowed to equilibrate against the reservoir containing the crystallization 
components (buffers and precipitants). After equilibration the concentration of the protein and the 
precipitants in the drop will increase and thus prompt the growth of the crystal (Russo Krauss et al., 
2013). 
4.1.1. Sitting drop method 
In this method a drop consisting of equal amounts of protein and buffer solution was placed on a 
platform over a well, which contains a higher volume of the same buffer solution (Figure III.1). 
Random screens were done in the first crystallization process of each protein using a robot, which 
pipettes 60 µl of many buffer solutions from different kits into a plate containing 96 wells. 
Thereafter, 0.2 µl was taken from the well to be placed on the platform and then 0.2µl of the highly 
concentrated protein (5-28 mg) was added. Finally, the plates were sealed with a permeable film and 
kept at R.T under regular checking by taking images periodically using a rockimager. The kits 
involved different buffers, precipitants and pH values to get the first hits, which developed even 
small disordered crystals. Then, further optimization of the promising conditions was done using a 
formulator device and new screens were designed to enhance the growth of good crystals.   
 
 
 
 
 
 
 
Fig III.1 Sitting drop method. 
 
 
Permeable film 
Platform with a drop  
of equal amounts of 
protein and buffer 
solution 
Well with buffer 
solution 
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4.1.2. Hanging drop method 
This technique is not quite different from the previous method, except that the drop will suspend 
from a cover slip over the well (Figure III.2). It was used to obtain larger protein crystals and to 
optimize the crystallization conditions. By the variation of salt concentrations, pH values, buffer 
concentrations and the addition of different precipitants, an improvement in protein crystallization 
should be achieved. In this method, plates of 24 crystallization wells were used, into which 700 μl 
each of the respective crystallization buffer were pipetted. Then 2.0 - 5.0 μl of this buffer solution 
were mixed with the same volume of the protein solution and applied to the inner part of the screw 
cap. The plates were finally closed with the caps and kept at R.T under regular checking. 
  
 
 
 
 
 
Fig III.2 Hanging drop method. 
4.2. Seeding 
Seeding is a tool used to improve crystal growth and formation. In this technique, previously grown 
crystals are washed with water. Either a single crystal was transferred and applied into a new protein 
drop containing fresh buffer solution (macroseeding) or too small crystals that were obtained after 
smashing an old crystal were transferred and applied into a new protein drop containing fresh buffer 
solution (microseeding) (Figure III.3). Seeding can also be used as a technique for optimization of 
the crystallization conditions (Bergfors, 2003). 
 
Fig III.3 Macroseeding (left) and microseeding (right).
Well with buffer 
solution 
Screw cap with a drop 
of equal amounts of 
protein and buffer 
solution 
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4.3. Soaking and co-crystallization 
Getting the structure of enzyme-substrate or enzyme-product complexes is one of the important aims 
of this project. It provides us with more information about the binding pattern of these molecules in 
the enzymes and determines the essential residues in the active site cavity, which are important for 
enzyme interaction and activity. 
Soaking is the method of choice because of its ease. In this method, the growing crystal of the 
enzyme was soaked for a period of time with the substrates or the products. Different time intervals 
were used ranging from 10 sec, 5 min, 2-3 days to 2 weeks. Also, different concentrations of the 
substrates and the products were used starting from 10 mM until 20 mM. 
Co-crystallization is different from soaking. The protein solution is mixed with the substrate or the 
product solution and allowed to incubate on ice for a period of time. Thereafter, the mix was 
subjected to the crystallizations screens. For co-crystallization we also used substrates or products 
from 10 mM until 20 mM and the incubation time was 1 hr.  
4.4. Thermofluor assay 
This is a thermal shift assay, which measures the unfolding pattern of a protein. It measures the 
binding affinity of the protein to different ligands and additives. This binding is evaluated from the 
difference of the unfolding temperature (ΔTm) in the presence of ligands relative to the one in the 
absence of ligands. A sensitive fluorescent dye is used to detect the thermal unfolding of the protein 
after binding (Lo et al., 2004). When the thermal shift increases, then the protein is more unfolded in 
response to the ligand which was added to the protein solution. However, when the thermal shift 
decreases then the protein is less unfolded in response to the ligand which was added to the protein 
solution. This observation led to the use of the Thermofluor assay in the improvement of protein 
stability by the addition of some substances like salts to the solution. 
Thermofluor Manual 
A stock of 5000x Sypro Orange was diluted 100 times to get 250 µl of 50x dye solution. About 250 
µl protein solution of a 2 mg/ml concentration was also prepared. 
Buffer screen 
Masterblock of different buffers (A, B, C and D) was used, in which the following amounts were 
pipeted in a 96-well PCR plate. 
40 µl of the buffer 
5 µl of the protein 
5 µl of Sypro Orange 
 
The components were mixed by pipeting up and down. Then the seal film was used to close the 
plate. After centrifugation of the plate to get rid of air bubbles, it was put into the PCR machine and 
the lid was closed. The run was started using a specific CFX program. Finally, the data were stored. 
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Additive screen 
After the buffer screen, one buffer condition was chosen to test different additives (F, G and H). We 
prepared the buffer of interest as 8x concentrated and pipetted as follows, using the same previous 
concentrations of the protein and Sypro Orange. 
35 µl of the additive solution 
5 µl of the 8x buffer 
5 µl of the protein 
5 µl of Sypro Orange 
 
After mixing by pipetting the screen was performed as previously described. 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 50mM 
Acetate 
pH 4.0 
50mM 
Acetate 
pH 4.4 
50mM 
Citrate 
pH 5.0 
50mM 
Citrate 
pH 5.4 
50mM 
MES pH 
6.0 
50mM 
MES pH 
6.4 
50mM 
HEPES 
pH 7.0 
50mM 
HEPES 
pH 7.4 
50mM 
Tris-HCl  
pH 8.0 
50mM 
Tris-HCl  
pH 8.4 
50mM 
CHES  
pH 9.0 
50mM 
CHES  
pH 9.4 
B 50mM 
Acetate 
pH 4.0 
100m
M 
NaCl 
50mM 
Acetate 
pH 4.4 
100m
M 
NaCl 
50mM 
Citrate 
pH 5.0 
100m
M 
NaCl 
50mM 
Citrate 
pH 5.4 
100m
M 
NaCl 
50mM 
MES  
pH 6.0 
100mM 
NaCl 
50mM 
MES  
pH 6.4 
100mM 
NaCl 
50mM 
HEPES 
pH 7.0 
100mM 
NaCl 
50mM 
HEPES 
pH 7.4 
100mM 
NaCl 
50mM 
Tris-HCl  
pH 8.0 
100mM 
NaCl 
50mM 
Tris-HCl  
pH 8.4 
100mM 
NaCl 
50mM 
CHES  
pH 9.0 
100mM 
NaCl 
50mM 
CHES  
pH 9.4 
100m
M 
NaCl 
C 50mM 
Acetate 
pH 4.0 
200m
M 
NaCl 
50mM 
Acetate 
pH 4.4 
200m
M 
NaCl 
50mM 
Citrate 
pH 5.0 
200m
M 
NaCl 
50mM 
Citrate 
pH 5.4 
200m
M 
NaCl 
50mM 
MES  
pH 6.0 
200mM 
NaCl 
50mM 
MES  
pH 6.4 
200mM 
NaCl 
50mM 
HEPES 
pH 7.0 
200mM 
NaCl 
50mM 
HEPES 
pH 7.4 
200mM 
NaCl 
50mM 
Tris-HCl  
pH 8.0 
200mM 
NaCl 
50mM 
Tris-HCl  
pH 8.4 
200mM 
NaCl 
50mM 
CHES  
pH 9.0 
200mM 
NaCl 
50mM 
CHES  
pH 9.4 
200m
M 
NaCl 
D 50mM 
Acetate 
pH 4.0 
500m
M 
NaCl 
50mM 
Acetate 
pH 4.4 
500m
M 
NaCl 
50mM 
Citrate 
pH 5.0 
500m
M 
NaCl 
50mM 
Citrate 
pH 5.4 
500m
M 
NaCl 
50mM 
MES  
pH 6.0 
500mM 
NaCl 
50mM 
MES  
pH 6.4 
500mM 
NaCl 
50mM 
HEPES 
pH 7.0 
500mM 
NaCl 
50mM 
HEPES 
pH 7.4 
500mM 
NaCl 
50mM 
Tris-HCl  
pH 8.0 
500mM 
NaCl 
50mM 
Tris-HCl  
pH 8.4 
500mM 
NaCl 
50mM 
CHES  
pH 9.0 
500mM 
NaCl 
50mM 
CHES  
pH 9.4 
500m
M 
NaCl 
E 
F 2mM 
ATP 
2mM 
ADP 
2mM 
AMP 
2mM 
GTP 
2mM 
GDP 
2mM 
NAD 
2mM 
FAD 
1% 
Glycerol 
5% 
Glycerol 
10% 
Glycerol 
20% 
Glycerol 
3% 
DMSO 
G 1mM 
DTT 
5mM 
DTT 
10mM 
CaCl2 
10mM 
MgCl2 
10mM 
MnCl2 
10mM 
ZnCl2 
10mM 
NiCl2 
10mM 
FeCl3 
100mM 
KCl 
100mM 
LiCl 
200mM 
KSCN 
10mM 
spermid
-in 
H 10mM 
Argini-
n 
10mM 
Alanin 
10mM 
Methion
-in 
100m
M 
Glycin 
3% 
Glucose 
3% 
Galactose 
10mM 
Urea 
5% 
PEG400 
0.5% n-
hexyl 
gluco-
pyranosid 
0.05% n-
decyl 
gluco-
pyranosid 
0.01% 
Triton 
X100 
H2O as 
referen
-ce 
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4.5. Isothermal Titration Calorimetry (ITC) 
This is another technique which estimates the binding interaction between macromolecules and 
ligands by measuring all thermodynamic parameters needed for binding such as affinity, enthalpy 
and stoichiometry. The experiment involves the titration of a specific ligand into the protein under 
isothermal conditions. The produced thermal signal after titration measures the heat absorbed or 
released after binding between the ligand and the protein. After many injections of ligand, this signal 
will reach zero as the protein is fully saturated by the ligand (Figure III.4)  (Duff et al., 2011). 
 
 
 
 
 
 
Fig III.4 Isothermal calorimetry setup. 
ITC Manual 
The preparation of 2 L degassed distilled water and 1L degassed buffer is essential before starting the 
experiment to avoid any noise signals from the bubbles in the solutions. After dilution of the ligand 
and the protein with the buffer, they were also degassed using Thermovac. 
1. After washing the reference cell, it is filled with 2 ml degassed water.  
2. After washing the sample cell several times with water, it is filled with 2 ml degassed buffer 
solution in addition to 2 ml degassed protein solution. 
3. The syringe is also washed with the degassed water and then with the degassed buffer. The 
needle is dried with tissue to remove any adhesive drops. 
4. The syringe is filled with the degassed ligand and placed in the sample cell. 
 
After setting the previous conditions, the ITC experiment starts and the essential parameters are fixed 
using a specific computer program. 
1. Mostly fewer injections with higher injection volumes are used (8-10 µl) - (30 injections). 
2. The time spacing between the injections is 240 sec. The initial delay before the first injection 
(120 sec) is important for baseline establishment. 
3. The temperature is mostly adjusted to room temperature but a range of 20-37C° can be used. 
After finishing the experiment, the data are collected and the results are analysed. 
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4.6. X ray measurement 
The protein crystals were taken from the stock solution using a Nylon-eyelet and washed in cryo-
buffer. They were taken again with the loop and stored in a dry cold nitrogen stream. The addition of 
glycerol prevents the formation of ice crystals, which may interfere later with the image. To avoid 
thawing during the measurement, the crystals were washed again with cold nitrogen. The generator 
MicroMax 007 was used as a source for X-ray radiation and the diffraction pattern of the crystals 
was recorded and stored using a Saturn 944+ CCD detector. The exposure time for measurement was 
2 min and complete datasets were recorded after rotation of the crystals in 0.5° angular steps in the 
range of 0-180° (Figure III.5). 
 
 
 
 
 
 
Fig III.5 X-ray radiation system. 
4.7. Data analysis and structure elucidation 
Many datasets and images were obtained after x-ray diffraction. At this stage, the crystallographer 
should follow many steps for data processing to get the final structure of the enzyme, as follows. 
1. Indexing of the reflections (spots in the diffraction pattern) to determine the adequate space 
group (symmetry of the crystal). 
2. Merging and scaling of the reflections by detection of the relative intensities and strengths of 
the spots in different images.  
3.Integration of the data considering the determined space group by getting only one file with 
the records of indexes and intensities of all reflections in the images. 
4.Importing of the integrated data using a data processing program (PHENIX, CCP4…etc) 
5.Phasing of the data and building of an electron density map by molecular replacement with 
known related structures to determine the orientation and the position of the molecules in the 
crystal and to find the molecular model. 
6.Refining the molecular model and depositing it to pdb. 
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Schematic diagram for data analysis and structure elucidation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig III.6 Data analysis and the steps of structure elucidation. 
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IV. Results 
In 2007, Torben Raeth was able to crystallize BIS1 from Sorbus aucuparia (SaBIS1) without His6-
tag (Raeth, 2007). Two datasets at 20.00–3.15 Å and 22.88–3.16 Å were used for structure 
refinement, based on the crystal structure of alfalfa CHS2. The crystals were small, which explains 
their low resolution, and the data were not enough to elucidate the aldol cyclization mechanism of 
SaBIS1. The structure also showed unusual electron density close to the catalytic Cys because of the 
presence of oxygen due to the oxidation of the sulphur (Raeth, 2007). In 2012, Maren Lütge 
continued the crystallization of SaBIS1 even with different constructs, but the crystals were small in 
size and not enough for x-ray measurement (Lütge, 2012). In this work, we basically started from the 
beginning by optimization of expression, purification, His6-tag cleavage, protein stability and 
homogeneity tests in addition to buffer screening for crystallization. 
1. TEV protease purification 
The TEV construct provided by HZI, Braunschweig, contained a His6-tag, allowing for purification 
on Ni-NTA-agarose. One to 2 mg of TEV protease (~ 35 kDa) were produced using 5 L LB medium 
and an induction time of 20 h. The pellets were harvested and subjected to affinity chromatography 
(III.2.1.1.). The eluate was collected and buffer exchange was carried out using PD-10 (III.2.1.2.1.). 
The protein content was determined using the Bradford method (III.2.3.). The fractions were 
supplied with 50% (v/v) glycerol and stored at -80°C. Aliquots were used to examine the purity by 
SDS-PAGE (III.2.5) (Figure IV.1). The TEV purification process had to be fast as this protease has 
the property of autolysis, i.e. cleaving itself, resulting in reduction of its efficiency in target protein 
cleavage. 
 
 
 
 
 
 
 
 
 
 
 
Fig IV.1 SDS-PAGE for checking the purity of TEV protease. Five fractions were tested. 
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2. Cutting and removal of His6-tag 
2.1. N-terminally His6-tagged SaBIS1 
The optimization of the cleavage with TEV prortease was performed using N-terminally His6-tagged 
SaBIS1 as the target protein. The best known working conditions for TEV protease were cleavage at 
30°C using a 1:50 ratio of TEV to target protein. In the beginning, cutting was carried out using the 
1:50 ratio at 4°C (Lütge, 2012). However, at 4°C the cleavage was slow and incomplete and a double 
band appeared at almost all time intervals (Figure IV.2). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig IV.2 TEV protease cleavage of SaBIS1 at 4 °C. SDS PAGE shows incomplete cutting of tagged SaBIS1 
using a 1:10 ratio of TEV protease and target protein at 4 °C. 
Different ratios and temperatures were tried to achieve a complete cutting in short time intervals 
without influence on the activity of the target protein beside the use of less amounts of TEV protease. 
At 16 °C, when the ratio of TEV protease to SaBIS1 was 1:30, it needed 20 h to reach the complete 
cutting. When the ratio of TEV protease to SaBIS1 was 1:10, only 6 h were needed for the complete 
cleavage (Figure IV.3a). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig IV.3a Cleavage of tagged SaBIS1 at 16 °C using TEV protease and varying hours. The SDS-PAGE gel 
shows efficient cutting of tagged SaBIS1 at different ratios of TEV protease to SaBIS1. The faint lower band 
(~ 35 kDa) represents TEV protease. 
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Similar results were obtained at 25 °C. Efficient cutting was observed after 20 h using a 1:30 ratio 
and nearly complete cutting was achieved after 6 h using a 1:10 ratio (Figure IV.3b). 
 
 
 
 
 
 
 
 
 
        
 
 
 
 
Fig IV.3b Cleavage of tagged SaBIS1 at 25 °C using TEV protease at various ratios and times. The SDS-
PAGE gel shows the efficient cutting of tagged SaBIS1 after 6 h using a 1:10 ratio of TEV protease to 
SaBIS1. The faint lower band (approx. 35 kDa) represents TEV protease. 
A faster and efficient cleavage was carried out by using a 1:30 ratio of TEV protease to the target 
protein and incubating the mixture under slow shaking at 37 °C (Figure IV.3c). 
 
 
 
  
 
 
 
 
 
 
 
 
Fig IV.3c Cleavage of tagged SaBIS1 at 37 °C using TEV protease. The SDS-PAGE gel shows efficient 
cutting of tagged SaBIS1 after 4 h using a 1:30 of TEV protease to SaBIS1. It also shows the slight size 
differences between the samples before and after removal of the His6-tag. 
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After 4 h cleavage, the resulting tag-free SaBIS1 is still active (Figure IV.4). 
 
 
 
 
 
 
 
 
 
 
 
Fig IV.4 Activity of SaBIS1 after 4 h cutting with TEV protease at 37 °C. The peak of the product (3,5-
dihydroxybiphenyl) and the corresponding UV spectrum (208 and 254 nm) remained unchanged after cutting. 
The cleaved proteins samples were combined and mixed for 1 h with Ni-NTA agarose. The flow 
through of the column was pooled, concentrated and subjected to gel filtration chromatography using 
the buffer Tris-HCl pH 7.75 (Lütge, 2012). Although the chromatogram showed a sharp single peak, 
SDS PAGE of the protein fractions revealed an unexpected and insufficient separation of the cutted 
and non-cutted enzymes (Figure IV.5).  
 
 
Fig IV.5 Incomplete cutting of N-terminally His6-tagged SaBIS1. A sharp peak appeared upon gel filtration 
chromatography, but SDS-PAGE showed a mixture of the cutted and non-cutted enzymes in most protein 
fractions. 
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2.2. C-terminally His6-tagged SaBIS1 
Higher concentrations of TEV protease until 1:1 TEV protease to N-terminally His6-tagged SaBIS1 
did not improve the cutting process. The separation of the cutted and non-cutted enzymes was 
difficult even when we tried to separate them by ion exchange chromatography. Therefore, the new 
idea was to construct C-terminally His6-tagged SaBIS1. The presence of the tag at the C-terminus 
may promote better and eventually complete cutting of tagged SaBIS1 with TEV protease. After 
primer design (II 3.4.) and PCR (III 1.12.), the new C-terminally His6-tagged SaBIS1 was produced 
using the new vector pET-52b (+) (5.2 kb) (Figure IV.6).  
 
 
 
 
 
 
 
Fig IV.6 Cloning of C-terminally His6-tagged SaBIS1. The agarose gel presents the double digestion of the 
constructed plasmid by BamHI and SalI to show the single bands of insert (SaBIS1) and vector (pET-52b). 
The C-terminally His6-tagged SaBIS1 was expressed, purified and cutted using the same conditions 
previously used for the N-terminally tagged protein (IV 3.1.). The construct exhibited a lower 
expression level than the one for the N-terminally tagged protein, producing less protein amount as 
indicated by SDS PAGE. A sharp single peak appeared after gel filtration chromatography, but the 
fractions again showed a mixture of cutted and non-cutted enzyme proteins (Figure IV.7). 
 
 
Fig IV.7 Incomplete cutting of C-terminally His6-tagged SaBIS1. A sharp peak appeared upon gel filtration 
chromatography, however, SDS PAGE showed a mixture of cutted and non-cutted enzymes in all protein 
fractions. 
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Another two truncated versions of SaBIS1 and HaBPS were tested (Lütge, 2012). They have the 
same amino acids sequences like SaBIS1 and HaBPS, but without the first 13 N-terminal amino 
acids of SaBIS1 (BIS-13AA) and without the first 19 N-terminal amino acids of HaBPS (BPS-
19AA). The removed amino acids represent disordered regions in the beginning of the sequences, 
analogous to the already crystallized MsCHS2. Firstly, both enzymes were tested to ensure their 
activity after the shortening process (Figure IV.8).  
 
Fig IV.8 Activities of BIS-13AA and BPS-19AA. HPLC profiles and corresponding UV spectra of the BIS 
product (3,5-dihydroxybiphenyl; 208 and 254 nm) and the BPS product (2,4,6-trihydroxybenzophenone; 208 
and 304 nm) are shown. 
Unfortunately, both purified and cutted proteins, BIS-13AA and BPS-19AA, showed sharp single 
peaks after gel filtration chromatography but again mixtures of the cutted and non-cutted enzymes in 
SDS-PAGE (Figure IV.9). 
 
 
 
 
 
 
 
 
 
Fig IV.9 Purification and cleavage of tagged BPS-19AA. The SDS-PAGE gel shows the incomplete cutting 
process and the appearance of a double band despite a sharp peak in the gel filtration chromatogram. 
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The cutting process with all the previously used constructs and conditions was always unsuccessful. 
In addition, the two-step purification, before and after cutting the enzymes, is time-consuming, not to 
mention that the cutting process itself takes time. Also, the extensive purification steps due to the 
cutting process led to a significant decrease in the final protein amount, which in turn is a problem 
for the crystallization process, as we should end up with a highly concentrated protein sample. All 
these above-mentioned difficulties led us to think about purification and crystallization of the full 
His6-tagged protein without any cutting. It was meanwhile proved that the purification tags in many 
proteins had no significant effect on the structures of the native proteins (Carson et al., 2007). 
Therefore, the work was started from the beginning, using the N-terminally His6-tagged constructs of 
both enzymes (MdBIS and HaBPS). In addition, optimization was carried out to improve the 
purification protocol and to select buffers for ensuring a good quality of highly purified proteins for 
crystallization and structure elucidation.  
3. Expression and purification of large amounts of target proteins 
The first requirements for protein crystallization are high purity (≥ 98%, as indicated by a single 
band on a SDS-PAGE gel) and high concentration (≥ 5-10 mg/ml). Therefore, a good expression 
and purification system was developed.  
3.1.Affinity chromatography and PD-10 
All the enzyme proteins used in this work were cloned and expressed with a N-terminal His6-tag in 
the expression vector pRsetB, enabling purification from E. coli using Ni-NTA-agarose. Freshly 
transformed bacteria and new plates were prepared before any crystallization process of target 
proteins. Large amounts of proteins had to be produced and therefore large culture volumes were 
used. The individual proteins expressed differently and hence different culture volumes were used to 
get the desired concentration, for example, SaBIS1 needed a larger culture volume to get highly 
concentrated protein in comparison to the other enzymes. The pellets were harvested and subjected 
to affinity chromatography (III.2.1.1). Optimization of the purification was carried out using buffers 
containing different concentrations of imidazole (30 mM, 50 mM and 80 mM) to ensure the 
elimination of all foreign proteins. For larger pellets, as with SaBIS1, the column was washed 
extensively by increasing the washing times and steps. The eluates were collected and buffer 
exchange was carried out using PD-10 (III.2.1.2.1.). The pooled fractions were concentrated using a 
Vivaspin concentrator (III.2.2.) and the protein content was determined using the Bradford method 
(III.2.3.). Finally, the purity was checked using SDS-PAGE (III.2.5.) (Figure IV.10).  
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Fig IV.10 SDS-PAGE of purified SaBIS1. The gel shows the purified fractions before concentration and the 
final concentrated sample of purified protein.
 
The differences in the purification steps and culture volumes of all target proteins are illustrated in 
the following Table 1:  
Table 1. Survey of the expression and purification conditions used for the various target proteins  
Protein  SaBIS1 
HsBPST135K 
MdBIS3, MdBIS3C159A 
 
HaBPS,HaBPSC167A  
HaBPST135L 
Culture volume 5-7 L 3-5 L 3 L 
Produced amount 20-40 mg 20-30 mg 20 mg 
IPTG concentration 0.125 Mm 0.1875 Mm 0.25 mM 
Washing steps: 
30 mM imidazolebuffer 
50 mM imidazole buffer 
80 mM imidazole buffer 
 
16 times (1 ml) 
10 times (1 ml) 
8 times (1 ml) 
 
12 times (1 ml) 
8 times (1 ml) 
6 times (1 ml) 
 
10 times (1 ml) 
6 times (1 ml) 
4 times (1 ml) 
 
The time for culturing or bacteria growing and induction was optimized to perform the purification 
process in minimum time intervals and to keep the protein as fresh as possible for crystallization. 
The first day was for preculturing. The second day was for culturing for 3-4 h until OD 1, induction 
for 4 h and pellet storage at -20 °C. The third day at TUBS was for protein purification, 
concentration, SDS-PAGE and carrying the protein sample to HZI, where, the sample was directly 
subjected to gel filtration. In the fourth day, the protein fractions were concentrated, another SDS-
PAGE was performed and finally the crystallization screens were done. 
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3.2. Thermofluor assay and buffer optimization  
The second important condition for the crystallization is the stability of the protein, which was 
targeted by screening the best buffer conditions for the enzyme using the thermofluor assay. This test 
was conducted in cooperation with Dr. Peer Lukat (HZI, Braunschweig). The following six buffers 
were used to test the stability of the protein: acetate, citrate, MES, HEPES, tris-HCl and CHES. They 
were tested at different pH values and salt (NaCl) concentrations. Thereafter, different additives like 
glycerol, DTT, PEG400 and galactose were tested for their effect on the stability of the protein in the 
respective buffer (III 4.4.). High melting temperatures between 47-51 C° were recorded for the best 
buffer conditions for protein stability. Such values were recorded for SaBIS1 after using the buffers 
50 mM Tris-HCl and 50 mM HEPES. After further screens for additives, salts and pH, the following 
buffer was selected as the buffer of choice for SaBIS1 (Figure IV.11a, b):  
50 mM Tris-HCl, 100 mM NaCl, 10% glycerol, pH 7.4 
 
 
 
 
 
 
 
 
Fig IV.11a Thermofluor assay results to detect the best buffer for SaBIS1. A level of 100 mM NaCl resulted 
in high stability of the protein in Tris-HCl buffer pH 7.4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig IV.11b Thermoflour assay results to detect the best additive for SaBIS1. Concentrations of 10% and 20% 
glycerol (red) showed high thermal signals, which indicated better stability of SaBIS1 in this buffer. 
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Similar melting temperatures were recorded for MdBIS3 using the buffer 50mM Tris-HCl. After 
further screens for additives, salts and pH, the following buffer turned out to be the choice for 
MdBIS3 (Figure IV.12a, b): 
50 mM Tris-HCl, 300 mM NaCl, 10% glycerol, 1% galactose, pH 8.4 
 
 
 
 
 
 
 
 
 
 
Fig IV.12a Thermoflour assay results to detect the best buffer for MdBIS3. Levels of 200-500 mM NaCl 
resulted in high stability of the protein in Tris-HCl buffer pH 8.4. 
 
 
 
 
 
 
 
 
 
 
 
Fig IV.12b Thermoflour assay results to detect the best additive for MdBIS3. A concentration of 3% galactose 
(red) showed a high thermal signal, which indicated better stability of MdBIS3 in this buffer. 
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In case of HaBPS, similar values were recorded as for SaBIS1, also resulting in the same buffer (50 
mM Tris-HCl). After further screens for additives, salts and pH, the following buffer was picked as 
the choice for Hypericum BPSs (Figure IV.13a, b):  
  50 mM Tris-HCl, 100 mM NaCl, 10% glycerol,  pH 8.4 
 
 
 
 
 
 
 
 
 
Fig IV.13a Thermoflour assay results to detect the best buffer for HaBPS. A level of 100 mM NaCl, as the 
other higher concentrations, resulted in high stability of HaBPS in Tris-HCl buffer pH 8.4. 
 
 
 
 
 
 
 
 
 
 
 
Fig IV.13b Thermoflour assay results to detect the best additive for HaBPS. Concentrations of 10% and 20% 
glycerol (red) showed high thermal signals, which indicated better stability of HaBPS in this buffer. 
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3.3. Gel filtration and ion exchange chromatography 
The third important condition for the crystallization is protein homogeneity, which is indicated by a 
single sharp peak of the dimer in the chromatogram of gel filtration on sephacryl and superdex 
columns (III 2.1.2.2). This chromatography was conducted in cooperation with Dr. Peer Lukat (HZI, 
Braunschweig). The purpose of the separation was to get rid of both any aggregates that had formed 
during the purification process and any other impurities that were difficult to remove by affinity 
chromatography. For SaBIS1, there were always four main peaks in the chromatogram (Figure 
IV.14). It was essential to separate them first by ion exchange chromatography using a Mono-Q 
column (III 2.1.3.1). In the end, only the single peak of the dimer should be left. 
 
 
 
 
 
 
 
 
 
 
 
Fig IV.14 Ion exchange chromatography of SaBIS1. Four major peaks were separated. 
After ion exchange chromatography, the fraction of the dimer, i.e. the first fraction, was collected 
and subjected to gel filtration chromatography to confirm single peak formation (Figure IV.15). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig IV.15 Single peak formation by SaBIS1 after ion exchange and gel filtration chromatographies. 
MonoQ 10/10 
0-1 M NaCl 
S200 16/60        
20 mM Tris HCl             
10% Glycerol 
150 mM NaCl 
pH 7.5 
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The homogeneity of MdBIS3 and Hypericum BPSs was indicated by single sharp peaks of the 
dimers in the chromatograms of superdex columns (III 2.1.2.2.), which were here sufficient for 
purification (Figure IV.16). 
 
Fig IV.16 Single peak formation by MdBIS3 (left) and HaBPS (right) in gel filtration chromatography. 
Additional ion exchange chromatography was not necessary. 
3.4. Final SDS-PAGE and purity confirmation 
A number of purification processes like affinity, ion exchange, and gel filtration chromatographies 
were performed to purify the proteins. In addition, many different buffers like washing, elution, and 
desalting buffers containing different components were used. The proteins were at each step in 
contact with different compounds and colums, therefore, it was essential to conduct another SDS-
PAGE after the last purification step and just before the crystallization process to ensure the final 
purity of the target protein and to eliminate any risk of impurities that could have been 
unintentionally formed (Figure IV.17). 
 
20 mM Tris-HCl 
10% Glycerol 
150 mM NaCl  
pH 8.4 
20 mM Tris HCl             
10% Glycerol  
300 mM NaCl  
1% d-Galactose 
pH 8.4 
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Fig IV.17 SDS-PAGE for final purity confirmation, before crystallization, of 1) HaBPS, 2) MdBIS3, 3) 
HaBPST135L and 4) HsBPS. Black numbers represent the protein fractions after gel filtration 
chromatography, which corresponded to the main sharp peak of the protein. Red numbers correspond to the 
non-specific hump at the beginning of the sharp peak. 
3.5. Estimation of Enzymes activities 
Since the enzymes were subjected to many different purification steps, it was essential to estimate 
their catalytic activities with their preferred substrates (III 3.1.) before going through the 
crystallization process. The formation of 3,5 dihydoxy biphenyl was confirmed after reaction of 
SaBIS1 and MdBIS3 with benzoyl-CoA and malonyl-CoA (Figure IV.18a). MdBIS3 was also tested 
for its activity with salicoyl-CoA and the formation of 4-hydroxycoumarin was confirmed (Figure 
IV.18b). 
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Fig IV.18a HPLC analysis of the formation of 3,5-dihydroxybiphenyl by SaBIS1. The UV spectrum of the 
product matched that of an authentic reference compound with absorption maxima at 208 and 254 nm. 
 
 
 
 
 
 
 
Fig IV.18b HPLC analysis of the formation of 4-hydroxycoumarin by MdBIS3. The UV spectrum of the 
product matched that of an authentic reference compound with absorption maxima at 260, 265 and 305 nm. 
The activities of HaBPS and HsBPS with benzoyl-CoA and malonyl-CoA were confirmed by 
formation of 2,4,6-trihydroxybenzophenone (Figure IV.19). 
 
 
 
 
 
 
 
Fig IV.19 HPLC analysis of the formation of 2,4,6-trihydroxybenzophenone by BPS. The UV spectrum of the 
product matched that of an authentic reference compound with absorption maxima at 202, 251 and 304 nm.  
 
nm
225 250 275 300 325 350 375 400
m
A
U
0
25
50
75
100
125
150
175
2
0
8
2
5
4
3
6
9
3
9
6
3
5
1
3
5
7
EBTISAM KHALIL  RESULTS 
77 
 
3.6. Purification at acidic pH 
According to the thermofluor test, a pH value of 8.4 was mainly used in the purification of the 
enzymes. This pH did not affect the activities of BPS and BIS, as shown by HPLC analysis of 
enzyme assays (IV 4.2.), although they are more active at slight acidic conditions (pH 5-7). The 
stability of the CoA substrates may be affected after soaking and co-crystallizaion processes, as the 
basic pH may lead to substrate degredation. Therefore, the possibility of using a slightly acidic pH 
was tested to see its effect on the purification process, the stability of the protein and the peak shape 
after gel filtration chromatography (Figure IV.20).  
 
 
 
 
 
 
 
 
Fig IV.20 Purification of HaBPS at slightly acidic pH. At pH 7, HaBPS showed a sharp peak after purification 
by gel filtration chromatography using Tris-HCl buffer.  
Further decreasing the pH below 7 was also tested for the purification of HsBPS. The acidic pH (pH 
6.7) resulted in distortion of the peak shape after gel filtration, which means that BPSs are not stable 
at acidic conditions and show aggregation (Figure IV.21). The enzymes prefer a more basic pH and 
therefore we maintained the purification conditions at the previously used basic conditions.  
 
 
 
 
 
 
 
Fig IV.21 Purification of HsBPS at slightly acidic pH. At pH 6.7, HsBPS showed an unorganized disturbed 
peak, which may indicates the unstability and aggregation at acidic conditions.  
20 mM Tris-HCl 
10% Glycerol 
150 mM NaCl  
pH 7 
20 mM Tris-HCl 
10% Glycerol 
150 mM NaCl  
pH 6.7 
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4. Crystallization and buffer screens 
4.1. Malus domestica BIS3 
Crystallization of PKSs was carried out in cooperation with Dr. P. Lukat and Prof. W. Blankenfeldt, 
HZI, Braunschweig. The first aim was the crystallization of SaBIS1. After purification optimization 
(IV.4), pure protein of high quality for the crystallization process was obtained. However, the use of 
various commercial buffer screens (JCSG+ 1-4, Morpheus, Index and Midas) failed to yield crystal 
formation; only precipitate was produced under these conditions. Here the idea of trying another BIS, 
namely MdBIS3, emerged. The protein solutions used had concentrations of 10 mg/ml and 20 
mg/ml. Drops (0.2 µl protein solution and 0.2 µl well content) were placed on a plate containing 60 
µl well volume using a robot. The plates were sealed and kept at 25 °C under continuous 
visualization using an imager. The following Table 2 shows the best buffer screens tested for 
MdBIS3, which developed good plate crystals yielding a satisfactory diffraction pattern after X-ray 
measurement (Figure IV.22). 
Table 2. Buffer screen for MdBIS3 
Crystallization kit Composition  Fig IV.22 panel No. 
Morpheus screen A12 No 12 
  
Morpheus buffer 3 (0.1 M)   pH 8.5    
Morpheus Divalents  (0.06 M)     
MPD_P1k_P3350 (37.5% w/v)                 
Water   
 
6 µl                 
6 µl               
30 µl             
18 µl 
1 
Morpheus screen E12 No 60 
 
Morpheus buffer 3 (0.1 M)   pH 8.5                      
Morpheus Ethylene glycols (0.12 M)       
MPD_P1k_P3350 (37.5% w/v)                 
Water   
6 µl            
6 µl               
30 µl             
18 µl 
2
Morpheus screen F12 No 72 
 
Morpheus buffer 3 (0.1 M)   pH 8.5                      
Morpheus monosaccharides (0.12 M)        
MPD_P1k_P3350 (37.5% w/v)                 
Water   
6 µl            
6 µl               
30 µl             
18 µl 
3
JCSG Core III B5 No 17 Tris  (0.1 M)   pH 8.5 
Sodium acetate (0.2 M)                                        
Polyethylene glycol 4000 (30 % w/v)        
Water 
6 µl                 
4 µl               
36 µl             
14 µl 
4
JCSG Core IV E12 No 60 HEPES  (0.1 M)   pH 6.5                                  
Polyethylene glycol 6000 (30 % w/v)       
Water 
6 µl     
36 µl   
18 µl 
5 
Index screen G9 No 81 Tris (0.1 M)   pH 8.5 
Amonium acetate  (0.2 M)                
Polyethylene glycol 3.350 (25% w/v)       
Water 
6 µl      
12 µl    
30 µl     
12 µl 
6 
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Fig IV.22 Crystallization hits for MdBIS3. The numbers indicate the different buffers screens, as listed in 
Table 2. All crystals developed after 48 h. 
4.2. Hypericum androsemum BPS and BPST135L 
The protein solution used had concentrations of 2, 4, 5, 8 and 10 mg/ml. The following Table 3 
presents the different buffers screens, under which needle-shaped crystals developed (Figure IV.23). 
Table 3. First buffer screen for HaBPS 
Crystallization kits Composition  Fig IV.23 panel 
No. 
Random II screen C9 No 33 MES  (0.1 M)   pH 6.233 
D-Sorbitol (0.133 M)                 
Polyethylene glycol 4000 (24.4% w/v) 
Water 
12 µl           
8 µl        
29.333 µl        
10.667 µl 
1 
Random II screen F3 No 63 
 
HEPES (0.1 M)   pH 7 
D-Sorbitol (0.106 M)              
Polyethylene glycol 4000 (25% w/v) 
Glycerol (13.9% w/v)                         
Water 
6 µl           
6.333 µl        
37.5 µl        
9.69 µl 
0.477 µl 
2 
Random II screen G3 No 75 
 
HEPES (0.1 M)   pH 6.9333 
Polyethylene glycol 200 (10% w/v) 
Polyethylene glycol 8000 (25% w/v) 
Water 
6 µl             
6 µl        
37.5 µl   
10.5 µl 
3 
Random II screen G10 No 82 MES (0.1 M)   pH 6.311 
Polyethylene glycol 4000 (21.1% w/v)  
Water 
12 µl 
25.333 µl 
22.667 µl 
4 
 1 
 2  3 
 5  4  6 
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Crystallizations-Kits Composition Fig IV.23 panel 
No. 
Random I screen A4 No 4 MES (0.1 M)   pH 6.467 
Glycerol (9.44% w/v)                
Polyethylene glycol 8000 (26.7% w/v) 
Water 
12 µl 
6.589 µl 
40 µl     
1.411 µl 
5 
Random I screen A11 No 11 HEPES (0.1 M)   pH 6.889 
Polyethylene glycol 200 (11.7% w/v) 
Polyethylene glycol 8000 (21.7% w/v) 
Water 
6 µl 
7 µl         
32.5 µl    
14.5 µl 
6 
Random I screen C6 No 30 HEPES (0.1 M)   pH 6.933 
Ammonium acetate (0.16 M)     
Polyethylene glycol 200 (11.7% w/v) 
Polyethylene glycol 3000 (20% w/v)   
Water 
6 µl 
4.833 µl        
7 µl            
24 µl   
18.167 µl 
7 
Random I screen D11 No 47 HEPES (0.1 M)   pH 6.882 
Glycerol (22.8% w/v)               
Polyethylene glycol 6000 (26.7% w/v) 
Water 
6 µl 
15.891 µl   
32 µl     
6.109 µl 
8 
Random I screen G3 No 75 MES (0.1 M)   pH 6.233 
Polyethylene glycol 6000 (26.7% w/v) 
Water 
12 µl 
32 µl          
16 µl 
9 
 
Fig IV.23 Crystallizations hits for HaBPS. The numbers refer to the corresponding conditions in Table 3. The 
needle-shaped crystals developed after 3 d and continued to grow until 21 d. 
 2  3  4  5 
 6  7  8  9 
 1 
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Bigger crystals with plate shape developed for HaBPS and HaBPST135L after further optimization 
and using higher protein concentrations (15 mg/ml and 28 mg/ml) (Figure IV.24). The optimization 
mainly depended on the use of the specific salt Poly (acrylic acid sodium salt) 2100 in the buffer 
screens. The conditions are shown in the next Table 4. 
Table 4. Second buffer screen for HaBPS and mutants 
Enzymes Crystallization 
kit 
Composition  Fig IV.24  
panel No. 
HaBPS Midas screen E7      
No 55 
 
HEPES  (0.1 M)   pH 7 
di-Sodium malonate 0.1 M                               
Poly (acrylic acid sodium salt) 2100 (30% w/v) 
Water 
6 µl 
2 µl 
36 µl 
16 µl 
1 
Midas screen 
E11    No 59 
 
HEPES  (0.1M)   pH 6.5 
Lithium sulfate 0.1 M                                       
Poly (acrylic acid sodium salt) 2100 (25% w/v)  
Water 
6 µl 
3 µl       
30 µl     
21 µl 
2 
T135L BPS 
Polyacrylate 
screen A7 No 7  
Tris-HCl (0.1M)   pH 7.889 
Lithium sulfate 0.217 M                                   
Poly (acrylic acid sodium salt) 2100 (26.7% 
w/v) Water 
6 µl 
6.5 µl    
32 µl  
15.5 µl 
3 
BPS 
Polyacrylate 
screen G7 No 78 
Tris-HCl (0.1M)   pH 7.444 
Ammonium sulfate 0.0778 M                    
Glycerol (7.22% w/v)                                       
Poly (acrylic acid sodium salt) 2100 (25% w/v) 
Water 
6 µl 
1.333 µl 
5.039 µl 
30 µl 
17.628 µl 
4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig IV.24 Plate-shaped crystals of HaBPS and HaBPST135L, which developed after using Poly (acrylic acid 
sodium salt) 2100. The numbers refer to the corresponding conditions in Table 4. The crysrals continued to 
grow until 7 d. 
 2  1 
 3  4 
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4.3. Hypericum sampsonii BPS 
Unexpectedly, HsBPS did not show any crystal formation upon using the same screens as for 
HaBPS. Therefore, higher protein concentrations were used (20 mg/ml and 24 mg/ml) and many 
cubic shape crystals developed (Figure IV.25), when using the screens in the following Table 5.  
Table 5. Buffer screen for HsBPS  
Crystallization kits Composition  Fig IV.25 panel No. 
HsBPS RI screen D10 
No 46 
MES (0.1 M)   pH 5.9 
Lithium acetate 0.211 M                              
Polyethylene glycol 3350 (15% w/v)                   
Water 
14 µl 
7.389 µl     
21 µl  
27.611 µl 
1 
HsBPS R3 screen 
A10 No 10  
 
MES (0.1 M)   pH 5.633 
Lithium acetate 0.3 M                              
Polyethylene glycol 3350 (16.7% w/v)          
Water 
12 µl 
9 µl             
20 µl          
19 µl 
2 
HsBPS R3 screen C2 
No 26  
 
MES (0.1 M)   pH 5.9 
Ammonium acetate 0.367 M                       
Glycerol (6.67% w/v)                             
Polyethylene glycol 4000 (12.2% w/v)          
Water 
12 µl 
11 µl     
4.651µl 
14.667 µl 
17.682 µl 
3 
HsBPS R3 screen C2 
No 26  
 
MES (0.1 M)   pH 6.033 
Lithium chloride 0.233 M                         
Polyethylene glycol 6000 (18.3% w/v)          
Water 
12 µl 
7 µl             
22 µl          
19 µl 
4 
 
 
 
 
 
 
 
 
 
 
Fig IV.25 Development of cubic shape crystals of HsBPS. The numbers refer to the corresponding conditions 
in Table 5. The crysrals continued to grow until 24 d. 
 1  2 
 3  4 
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5. Enzyme substrate interactions 
5.1. Isothermal titration calorimetry (ITC) 
Studying the binding between the enzymes and their substrates yields information about the 
conditions needed for efficient interaction. This was especially true after doing the optimization 
efforts, which led to the use of new buffers and compoments. Therfore, it was essential to carry out 
ITC (III 4.5.), the results of which indicate if the tested substrates can be used for soaking and co-
crystallization with the enzymes. We tested HaBPS and the mutants HaBPSC167A and 
HaBPSC167S, especially because of the oxidation of the catalytic Cys, which was observed in many 
type III PKS structures. This oxidation hinders the binding of substrates by HaBPS. The conditions 
tested are listed in the following Table 6, with 25 injections and 11 µl protein being used. 
Table 6. Conditions used for ITC 
Enzyme Substrate Condition 
HaBPS 20 µM     
40 µM    
50 µM   
Benzoyl-CoA 200 µM      
400 µM     
500 µM 
50 mM Tris-HCl  pH 8.5                    
100 mM NaCl                 
10% glycerol 
HaBPSC167A              
HaBPSC167S     
20 µM  
20 µM 
200 µM  
200 µM      
 
Although the curves resulting from the conditions used did not give the desired information about the 
interaction between HaBPS and its preferred substrate benzoyl-CoA (Figure IV.26), it was not 
possible to test different conditions and concentrations or other substrates. 
 
 
 
 
 
 
 
 
 
  
 
 
 
Fig IV.26 ITC of HaBPS and its active site mutants. Titration of the enzymes was performed using benzoyl-
CoA as a ligand. No sigmoidal curve was observed and therfore no clear interaction was detected. 
 20 µM 
HaBPS 
 40 µM HaBPS 
 50 µM 
HaBPS 
 20 µM 
HaBPSC167A 
 20 µM 
HaBPSC167S 
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5.2. Thermal shifts assay 
Since the ITC experiment did not work as expected, the implementation of an easier and faster 
thermal shift assay appeared rather feasible. This assay is quite similar to the thermofluor assay and, 
instead of using the additives, the substrates benzoyl-CoA and malonyl-CoA are added to the 
enzymes in their best buffer solutions (50 mM Tris-HCl pH 8.5, 100 mM NaCl and 10% glycerol). 
The thermal signals recorded indicate a stable interaction between HaBPS or its mutant 
HaBPSC167S and the substrates. This mutant was tested because its structure is closest to HaBPS; 
Ser is polar and similar to Cys and not hydrophobic as Ala. Thermal shifts were recorded for HaBPS 
and HaBPSC167S with benzoyl and malonyl-CoA and allowed for comparing their affinities to the 
substrates. The results indicated that substrate binding by the wild type enzyme (WT) was stronger 
and more stable than in its mutant. They also indicated that benzoyl-CoA is the best substrate for 
binding, as indicated by the higher thermal signals for HaBPS (50 °C) and HaBPSC167S (46 °C) 
(Figure IV.27).
 
 
 
 
 
 
 
 
 
 
Fig IV.27 Thermal shift assay with HaBPS and HaBPSC167S. The wild-type enzyme showed higher thermal 
shift records with both benzoyl and malonyl-CoA in comparison to its mutant. 
6. Soaking and co-crystallization 
The crystals obtained for HaBPS and HsBPS as well as MdBIS3 were successfully soaked with 10 
mM CoA for 5 min. Further soaking and co-crystalization were done with different substrates and 
products, using the wild-type enzymes HsBPS and HaBPS as well as the mutants HaBPST135L, 
HaBPSC167A and MdBIS3C159A. As in the mutants of HaBPS and MdBIS3, the instability of the 
Cys in the catalytic triad and its oxidation also appeared in some of the structure datasets of the wild-
type enzymes. As an exception, only HsBPS showed unoxidized active site Cys in all of the datasets 
that were obtained. Therefore, this enzyme was preferably tested for soaking and co-crystallization 
over HaBPS and MdBIS3. The following Table 7 presents a survey of the conditions, enzymes and 
mutants used. Although good crystals were obtained after co-crystallization or used for soaking 
experiments (Figure IV.28), there was unfortunately no definite structure datasets that showed the 
real binding between enzyme and substrate used. 
50 µM protein + 500 µM ligand            
(Final concentrations: 5µM + 50 µM) 
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Table 7. Conditions used for substrate soaking and co-crystallization 
Enzyme  Crystallization conditions  Substrate   Substrate concentration  Fig 
IV.28 
panel 
NO. 
Soaking  Co-
Cryst 
HsBPS 
13.7 
mg/ml 
HsBPS R3 screen D4 No 40                                                            Benzoyl-
CoA 
20 mM-16 h  1 
MES (0.1 M)   pH 5.767 
Lithium acetate 0.333 M                                          
2-Methyl-2,4-pentanediol (4.67%w/v)        
PEG monomethyl ether 2000 (15% w/v)                                                                   
Water 
12 µl 
10 µl       
2.8 µl           
18 µl    
17.2 µl 
HaBPS, 
HaBPS-
T135L  
28 mg/ml 
 BPS Polyacrylate screen B2 No 14 (T135L)                                                     Benzoyl-
CoA 
5 mM-5 min       
10 mM-3 d 
 2 
Tris-HCl (0.1 M)   pH 7.222 
Poly(acrylic acid sodium salt) 2100- (30% 
w/v)                                                     
Water 
6 µl        
36 µl 
               
18 µl 
HaBPS-
C167A 
28 mg/ml 
  BPS Polyacrylate screen D10 No 46 (T135L)               Benzoyl-
CoA 
10 mM-5min           
10 mM-3 d   
10 mM-2 w   
20 mM-2 d 
10 mM 3 
di-Sodium malonate (0.161 M)  
Poly(acrylic acid sodium salt) 2100- 
(26.7% w/v)                                         
Water                                                                                      
 
4.833 µl 
32 µl 
23.167 µl 
Malonyl- 
CoA 
10 mM-3 d   
10 mM-2 w 
10 mM 
2,4,6 tri- 
hydroxy- 
benzo-
phenone 
10 mM-3 d   
10 mM-2 w 
10 mM         
20 mM 
MdBIS3-
C159A 
11.8 
mg/ml 
MdBIS3-RI screen G6 No 78 C159A  Benzoyl- 
CoA 
20 mM-16 h 
20 mM-48 h 
 4 
TRIS-BASE (0.1 M)   pH 7.889 
Polyethylene glycol 4000 (21.1% w/v) 
2-Methyl-2, 4-pentanediol (8.33%) 
Lithium acetate (0.106  M)                  
Water 
7 µl 
29.556 µl 
5.833 µl 
3.694 µl 
23.917 µl 
 
Fig IV.28 Enzyme crystals either used for substrate soaking or produced by co-crystallization. The numbers 
refer to the conditions used in Table 7. 
 1  2  3  4 
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7. Structure resolution 
7.1. The structure of Hypericum androsemum BPS 
Big plate-shape crystals developed for HaBPS and produced an interpretable X-ray diffraction 
pattern, which resulted in solving the structure of HaBPS (Figure IV.29).  
 
 
 
 
 
 
 
Fig IV.29 HaBPS crystal used for synchrotron measurement. The yellow-marked region represents the area 
that was subjected to X-ray radiation. 
The crystal structure of HaBPS has the dimer shape as all type III PKSs and covers 379/409 residues, 
the first 30 residues of which were missing. That residues are missing from protein structures is not 
uncommon and happens when regions of protein molecules are disordered in the protein crystal and 
therefore can not generate a good diffraction pattern (Figure IV.30).   
 
Fig IV. 30 Secondary structure of HaBPS. It lacks the 30 N-terminal residues, the first 14 residues of which 
do not belong to the protein but to the His6-tag region. 
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The crystal structure of HaBPS consists of two main domains, the upper domain and the lower 
domain. The lower domain is more important, as most of the active site pocket is located in this area. 
The active site entrance is also located at the bottom, which presents the main door for the entry of 
the substrates toward the active sites cavity (Figure IV.31).   
Fig IV.31 The crystal structure of HaBPS with the αβαβα domain typical of type III PKSs. 
The structure of HaBPS was solved at 2.1 Å by molecular replacement (MR) using chalcone 
synthase from Freesia hybrid (FhCHS), which has recently been solved and shares 62% sequence 
identity with HaBPS at the amino acids level (Figure IV.32). With MsCHS, HaBPS shares 57.1% 
identity. 
 
Fig IV.32 Superimposed structures of HaBPS (yellow) and FhCHS (blue), which share 62% identity.  
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The structure of HaBPS in complex with CoA was solved at 1.5 Å. It shows the orientation of the 
CoA molecule in interaction with the residues of the CoA-binding tunnel (Figure IV.33).  
 
 
Fig IV.33 Crystal structure of HaBPS in complex with CoA. The CoA binding tunnel (right) contains the 
essential residues at the active site entrance (Arg 61, Arg 311 and Lys58), which interact with CoA by 
hydrogen bonds (yellow dotted lines). The essential catalytic residue Cys167 is shown as spheres. 
7.2. The structure of Hypericum androsaemum BPST135L 
The structure of the T135L mutant was solved at 1.4 Å, covering 378/409 residues, the first 31 
residues of which were missing (Figure IV.34). 
 
 
 
 
 
 
 
 
 
 
 
Fig IV.34 The crystal structure of HaBPST135L with the αβαβα domain typical of type III PKSs. 
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 The structure of HaBPST135L shows the proper geometry of the residues surrounding the mutation 
site. The orientation of Leu135 proves the formation of a new pocket, as explained previously by 
homology modelling of the mutant. It explains also why this mutant is inactive with 3-
hydroxybenzoyl CoA, as this substrate mimiks the function of the absent Thr135 and forms 
hydrogen bonds with Gly166, resulting in trapping the substrate inside the new pocket (Figure IV.35) 
(Klundt et al., 2009). 
 
Fig IV.35 Different orientations of T135 in HaBPS (blue) and L135 in HaBPST135L (purple). On the right, 
trapping of the 3-hydroxybenzoyl primed intermediate in the newly formed pocket blocks the further 
elongation reaction (Klundt et al., 2009). 
The size of the active site pocket has a large impact on the number of condensations with malonyl-
CoA and the length of the polyketide chain. This holds true for the active site pockets of wild-type 
BPS, which condenses three molecules of malonyl-CoA, and its mutant T135L, which condenses 
only two molecules of malonyl-CoA in the new pocket (Figure IV.36). 
 
Fig IV.36 The size of the pockets surrounding Leu135 in HaBPST135L and Thr135 in HaBPS. The active site 
pocket in HaBPST135L is smaller than in HaBPS, explaining the production of a triketide chain by the 
mutant rather than a tetraketide chain by the wild-type enzyme. 
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7.3. The structutre of Hypericum androsaemum C167A 
Good crystals of HaC167A were used for soaking benzoyl- and malonyl-CoAs and the product 2,4,6- 
trihydroxybenzophenone. Good diffraction patterns were obtained and the structure of HaC167A was 
solved at 2.6 Å. However, when the active site pocket was analyzed there was no complex formation 
in spite of the presence of Ala167, which widened the CoA-binding channel (Figure IV.37). 
 
 
 
 
 
 
 
Fig IV.37 Comparison of the CoA-binding tunnels in HaBPS and HaBPSC167A. On the right, the view 
through the CoA-binding tunnel in C167A presents Ala instead of oxidized Cys at position 167. The 
prescence of Ala made the channel wider in comparison to HaBPS on the left. 
7.4. The structure of Hypericum sampsonii BPS 
The crystals of HsBPS had a nice cubic shape, although smaller than those of HaBPS. After 
synchrotron measurement, the structure of HsBPS was solved at 1.7 Å by molecular replacement 
using HaBPS, in which the first 30 residues were missing (Figure IV.38). 
 
 
 
 
 
 
 
 
Fig IV.38 The crystal structure of HsBPS with the αβαβα domain typical of type III PKSs. 
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There are only six amino acids in the structure of HsBPS, which differ from HaBPS. They are lying 
on the surface of the enzyme (Figure IV.39). 
 
 
 
 
 
 
 
 
 
Fig IV.39 The crystal structure of HsBPS. The catalytic triad (green) and the six amino acids that differ 
from HaBPS (blue) are highlighted. 
The six different amino acids did not only change the biochemical properties (Abdelaziz, 2014) but 
also the active site pocket, which differed slightly in shape between HsBPS and HaBPS (Figure 
IV.40)  
 
 
 
 
 
 
 
 
 
Fig IV.40 Difference in the active site pockets of HaBPS (red) and HsBPS (purple). The six different amino 
acids, which are located on the surface, are highlighted as sticks (blue). 
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7.5. The structure of Malus domestica BIS3 
The structure of MdBIS3 was solved at 1.9 Å. Of the 380/402 residues, the first 22 residues were 
missing (Figure IV.41). 
 
 
 
 
 
 
 
 
 
 
Fig IV.41 Crystal structure of MdBIS3 with the αβαβα domain typical of type III PKSs. 
Crystals were soaked for 48 h in 20 mM fresh benzoyl-CoA solution and data were collected at a 
resolution of 2.5 Å. Co A is clearly present in two of the four monomers with occupancy  of 70-80% 
(Figure IV.42). 
 
  Fig IV.42 Presence of CoA molecules in two monomers of MdBIS3. 
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For the first time, we could see an electron density that fit perfectly to the benzene ring close to the 
catalytic Cys and we were able to see the whole benzoyl-CoA molecule (Figure IV.43).                       
 
Fig IV.43 Positive electron density of benzoyl-CoA (blue mesh) showing high Rf values. 
The positions of the neighboring residues showed perfect orientation with the location of benzoyl-
CoA in the active site pocket (Figure IV.44). 
 
 
 
 
 
 
 
 
 
 
Fig IV.44 Location of benzoyl-CoA in MdBIS3. The orientation of the neighboring residues in the active site 
cavity (Phe210 and Tyr64) is consistent with the position of the benzene ring in the benzoyl-CoA molecule. 
Phe210 
Cys159 
Phe192 
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The active site pocket of MdBIS3 strongly differs from that of HaBPS. The shape and the size of 
each pocket indicate why the enzymes catalyse different reaction mechanisms (Figure IV.45a, b). 
 
Fig IV.45a Comparison between the active site pockets of HaBPS (gray) and MdBIS3 (blue). The Cys of the 
catalytic triad is shown as sticks. The CoA molecule is displayed as sticks in MdBIS3 only. 
 
 
 
 
 
 
 
 
 
 
 
Fig IV.45b Superimposed structures of HaBPS (gray) and MdBIS3 (blue) active site cavities. The catalytic 
Cys and the CoA molecule are shown as sticks. 
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7.6. The structure of Malus domestica C159A 
For the first time, the substrate benzoyl-CoA was seen inside the active site cavity of BIS3. 
Therefore, soaking trials were carried out with the active site mutant C159A, as the cysteine was still 
not stable and underwent again oxidation in one of the chains of the MdBIS3 structure. 
The crystals of C159A were soaked with 20 mM 3,5 dihydroxybiphenyl for 48 h and the structure 
was solved at 1.86 Å. However, after structure data analysis the product was not found inside the 
active site cavity, even with the widened channel (Figure IV.46) 
 
 
 
 
 
 
 
 
 
 
Fig IV.46 Comparison of the CoA-binding tunnels in MdBIS3 and MdBIS3C159A. On the right, the view 
through the CoA-binding tunnel in C159A presents Ala instead of oxidized Cys at position 159. The 
prescence of Ala made the channel wider in comparison to MdBIS3 on the left. 
8. Transformation of BPS into BIS by mutation 
Mutation of BPS toward BIS was an idea to identify which residues are responsible for the change in 
the cyclization mechanisms, i.e. from Claisen to aldol condensation. Preliminary understanding of 
the differences in the reaction mechanisms was expected from the enzyme structures in complex with 
substrates and products after soaking or co-crystallization. Because this was not feasible, the idea of 
mutation emerged. 
8.1. Depending on Sorbus aucuperia BIS1 
In the beginning, there was only the structure of HaBPS but not yet of MdBIS3. Thus, we used only 
the structure data of SaBIS1, which was solved previously by Raeth (2007). These were the only 
available data about the structure of this enzyme. We started with a 14-fold mutant depending on the 
differences in the side chains of the residues lining the active site cavities of HaBPS and SaBIS. 
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A synthetic gene for HaBPS containing the 14 mutations was ordered (Figure IV.47a, b). 
 
Fig IV.47a Structure of HaBPS with the 14 residues selected for mutation. The mutation sites are shown as 
red sticks (left). The shape of the active site pocket (red) includes the sites for mutation (right).  
 
 
 
 
 
 
 
 
 
 
 
Fig IV.47b Comparison between the active site pockets in the modeled HaBPS 14-fold mutant (blue) and 
SaBIS1 (pink). The mutation sites are shown as sticks. 
Unfortunately this 14-fold mutant showed neither BPS nor BIS activity. 
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8.2. Depending on Malus domestica BIS3 
After comparison between the residues of the active site cavities of HaBPS and MdBIS3, a new 13-
fold mutant was produced starting from the previous 14-fold mutant. Four residues were mutated 
back to their original amino acids and three new mutations were added. So, in total seven mutation 
sites were changed (Figure IV.48a, b).  
 
Fig IV.48a Structure of HaBPS with the 13 residues selected for mutation. The mutation sites are shown as 
red sticks (left). The shape of the active site pocket (red) includes the sites for mutation (right).  
 
 
 
 
 
 
 
 
 
Fig IV.48b Comparison between the active site pockets in the modeled HaBPS 13-fold mutant (blue) and 
MdBIS3 (pink). The mutation sites are shown as sticks 
Unfortunately, this 13-fold mutant also lacked catalytic activity. Further mutations were not tackled. 
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V. Discussions 
1. Crystallization of type III PKSs  
1.1. With and without purification tag 
All crystallized type III PKSs were purified with the help of a purification tag, which is either a His-
tag as in MsCHS, PsSTS, GhPS, CmACS, CmQNS, OsCUS and AaOKS or a GST-tag as in RpBAS 
and AaPCS. The GST-tag in RpBAS and AaPCS was removed by protease digestion. The His-tag 
sizes and locations were different among the enzymes, for example, it is His8-tag in MsCHS, His6-
tag in CmACS and His4-tag in ClCURS. Its location was mostly at the N-terminus, except for 
AaOKS and ClCURS (Ferrer et al., 1999, Morita et al., 2007, Abe et al., 2007b, Morita et al., 2010b, 
Mori et al., 2013). Very recently, the structures of MdBIS3 and HaBPS (derived from a synthestic 
gene) have been solved and both enzymes have been digested with thrombin protease to remove a 
His8-tag before the crystallization process (Stewart et al., 2017). A similar digestion of His6-tag using 
thrombin was carried out earlier in our group and the crystallization process of SaBIS1 was 
successful. However, the collected datasets were not of good resolution to get a clear structure of the 
enzyme (Raeth, 2007). Our target enzymes (HaBPS, HaBPST135L, HsBPS and MdBIS3) were 
crystallized as His6-tagged proteins without cleavage because digesting them using TEV protease 
was unsuccessful. Digestion with TEV protease appears not to be the right choice for our enzymes, 
which may explain why the previous crystallization work, which mainly depended on the cutting of 
the His6-tag using TEV protease, did not advance to the desired results. This is clearly seen by SDS 
PAGE gel comparison. The digestion with thrombin is complete and resulted only in one band but 
TEV protease digestion was incomplete and resulted in a second band (Figure V.1) (Raeth, 2007, 
Lütge, 2012).  
 
Fig V.1 The best conditions for His-tag cleavage from SaBIS1 when regarding previous crystallizations 
works. In 2007, Raeth optimized the cutting using thrombin at 37 °C for only 4 h. In 2012, Lütge optimized 
the cutting using TEV protease at 4 °C and for 48 h. The cutting using TEV protease is incomplete and shows 
a faint second band in the finally digested protein sample. 
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We followed the same cutting protocol of Raeth (2007) but used TEV protease instead of thrombin. 
Although the cutting was complete by SDS-PAGE analysis, the gel filtration chromatography 
showed the appearance of another band (Figure V.2).  
 
 
 
 
 
 
 
 
 
Fig V.2 The inefficient cutting of SaBIS1. The upper SDS PAGE shows the complete cutting of His6-tagged 
SaBIS1 using TEV protease. The lower picture shows a sharp peak after gel filtration chromatography of the 
digested sample, but SDS PAGE of the final corresponding fractions (indicated by numbers) shows a mixture 
of two bands. 
The second faint band of the non-cutted enzyme indicates that its amount is less in the final protein 
sample but its presence was like an impurity. Therefore, the final sample containd non-homogenous 
protein species. As the two bands were so close in size to each other, the final protein sample always 
showed one sharp peak in gel filtration chromatography. Even when the location of the N-terminal 
His6-tag in SaBIS1was changed to a C-terminal His6-tag or when a short construct of HaBPS was 
used (BPS-19AA), the digestion was always incomplete.  
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Because of the previously mentioned complications about the non-convenient cutting with TEV 
protease, we suggested that the N-terminal and C-terminal parts of the enzymes studied here are 
folded in a pattern that makes them inaccessible to TEV protease. Therefore, we proceeded using the 
purified but still His6-tagged enzymes for the crystallizations processes. 
1.2. The catalytic triad and oxidized cysteine 
The essential three amino acids for the activity of all type III PKSs are included in the catalytic triad 
(Cys164, His303 and Asn336) (numbering from MsCHS2). Among these residues Cys is in the top, 
because the absence or the mutation of this site abolishes the enzyme activity (Lanz et al., 1991). The 
importance of this residue appears from its nucleophilic character, which provides an efficient 
binding site for the starter and the polyketide intermediates. Particular mutation of Cys164 to serine 
or alanaine reduces but maintains the decarboxylation of malonyl-CoA (Jez et al., 2000b). To 
understand the different reaction mechanisms of BPS and BIS, a clear picture about the interaction 
between this Cys in the enzymes and their substrates was needed. Therefore, many ligands were used 
for soaking into the produced crystals or for co-crystallization with the enzymes, such as benzoyl-
CoA, malonyl-CoA, 3,5 dihydroxybiphenyl and 2,4,6, trihydroxybenzophenone at different 
concentrations and time intervals, as mentioned in IV.7. None of these trials were successful, which  
was correlated to the oxidized state of the catalytic cysteine, as clearly detected in the structures of 
HaBPS and HaBPST135L (Figure V.3).  
 
Fig V.3 The oxidized Cys167 residue of the catalytic triad. Its oxidation in the active site cavities of both 
HaBPS and its mutant T135L is illustrated as dioxide. 
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This behavior was also observed in the structures of other plant type III PKSs, which were published 
as MsCHS, GhPS, PCS and OKS corresponding to the PDB numbers 1BI5, 1QLV, 2D3M and 2D52, 
respectively (Figure V.4). This oxidation of the catalytic cysteine was likewise shown before when 
the crystal structure of SaBIS1 was solved (Figure V.4) (Raeth, 2007). 
 
Fig V.4 The oxidized Cys of the catalytic triad was found in many plant type III PKSs (left). The catalytic 
triad of SaBIS1(right) also shows an oxidation of the Cys164 residue, which is  illustrated as monoxide 
(Raeth, 2007) 
1.2.1. The pH change and the use of a reducing agent 
The oxidized Cys was thought to be the reason for the unsuccessful soaking or co-crystallization. 
Firstly, we focused on the pH. Since the purification of the target enzymes was done at basic pH 
(8.4), protein isolation was then tried under acidic conditions where the pH of the buffers used was 
adjusted to 6.7 and 7 to protect the active site cysteine from oxidation under basic conditions. 
Secondly, 4 mM of the reducing agent DTT or 1 mM of the stronger reducing agent TCEP was 
added to the purification buffers to protect the active site cysteine from oxidation. Not to mention 
that most of the buffers used in the purification of the already crystallized plant type III PKSs 
contained 1-2 mM DTT. However, these modifications did not work and the cysteine was always 
oxidized after new crystallizations screens and structure data analysis. 
1.2.2. The use of active sites mutants 
The use of the active sites mutants MdBIS3C159A, HaBPSC167A and HsBPSC167S was a trial to 
open the channel for substrate entrance, in contrast to the oxygen of the oxidized cysteine which may 
block this entrance (Figure V.5). This trial was done before, the structures of MsCHSC164S with 
hexanoyl-CoA and MsCHSC164A with malonyl-CoA were solved (Figure V.5). The presence of 
these two structure complexes in PDB (1CHW and 1CML) may indicate the difficulty of using the 
wild type enzymes to get the enzyme-substrate/product complexes, for which the reason may be the 
presence of the unstable cysteine (Ferrer et al., 1999). 
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Fig V.5 The oxidized Cys167 in the active site cavity of HaBPS. The oxygen of Cys167, here highlighted as 
red spheres, may hinders the substrate from entering the active site cavity of HaBPS (left). The absence of 
active site Cys164 allowed the entrance of malonyl-CoA and hexanoyl-CoA to the active site cavities of 
MsCHSC164A (middle) and MsCHSC164S (right), respectively. 
1.2.3.The presence of an unknown ligand close to Cys167  
There was a positive difference density (green mesh) in the active site cavities of both HaBPS and its 
mutant HaBPST135L, which indicated the presence of an unknown ligand (Figure V.6).  
 
 
 
 
 
 
Fig V.6 The presence of the unknown substance (green mesh) in both HaBPS and HaBPST135L, which is in 
close contact to the catalytic Cys167. 
This electron density close to Cys167 could not be modeled to any other compounds that we have 
used either in the purification process or in the crystallization screens. This manner is also typical for 
type III PKSs and an example of this is the unintentional presence of malonic acid in the crystal 
structure of ClCURS (PDB: 3OV2) (Katsuyama et al., 2011). Malonic acid was a component of the 
crystallization buffer and formed hydrogen bonds with two conserved residues of the active site 
cavity (His303 and Asn336) (Figure V.7). 
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Fig V.7 The unintentional presence of malonic acid in ClCURS. This structure-complex aided in the 
understanding of the reaction mechanism and the need for a hydrolysis step in curcuminoid production 
(Katsuyama et al., 2011).   
Malonic acid is a mimic to β-keto acid and a mutation was carried out on His303 to study the 
importance of such an interaction. The mutant H303Q decreased the yield of curcuminoids and, in 
addition, the kcat of H303Q increased in the use of 3-oxo-5phenyl-4-pentenoic acid more than in the 
use of cinnamoyldiketide-NAC with feruloyl-CoA, which determined the importance of the 
hydrolysis step in curcuminoid formation (Katsuyama et al., 2011). In a similar trial, we used 
benzoic acid for soaking and co-crystallization but were unable to get the complex.  
Only HsBPS contained the unoxidized normal sulfhydyl group in the catalytic Cys167 (Figure V.8). 
Many reasons may explain such a result. One of them may be the development of HsBPS crystals at 
more acidic pH compared to HaBPS. In addition, the involvement of 1 mM TCEP in the purification 
buffers has to be mentioned. Therefore, we did not use an active site mutant of this enzyme as in 
HaBPS and MdBIS3 for soaking or co-crystallization purposes. However, even HsBPS that showed 
the unoxidized catalytic cysteine for soaking and co-crystallization processes did not form any 
substrate/product complexes after X-ray measurements and data analysis.  
 
  
 
 
 
  
 
 
Fig V.8 The crystal structure of HsBPS contained the unoxidized catalytic cysteine. The electron densities 
around the catalytic cysteine in two monomers of the crystal structure of HsBPS modeled only sulfhydryl 
groups but not any oxygen atoms. 
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The recently published structure of MdBIS3 also presented the oxidation of the active site cysteine to 
sulﬁnic acid derivatives (–SO2H), which prevented the transfer of substrates onto this active site 
cysteine (Stewart et al., 2017). Similarly, we always correlated the unsuccesful soaking or co-
crystallization to the oxidized cysteine, which was just an assumption because it was not really 
known if the problem is the cysteine or if something else entered the cavity and blocked the entrance 
for the substrates. The type III PKS entrance is a solvent-exposed area and many components from 
the purification or crystallization processes or any other sources can occupy this cavity. This is true 
as all type III PKSs in PDB contained somehow many components in their active sites cavities. 
These components, mainly if they are big, can block the way for the substrates to enter, as did the 
unknown ligand that we saw in the HaBPS and HaBPST135L structures. Actually, if the problem is 
only the oxidized cystein, there may really be a chance to get an enzyme complex, for example, 
GhPS contained acetoacetyl-CoA in one of the enzyme complexes after soaking the crystals with 5 
mM acetoacetyl-CoA, although the catalytic cysteine was oxidized and 5 mM DTT was used. The 
oxidation prevented the formation of a covalent acetoacetyl-enzyme complex but allowed the 
trapping of the acetoacetyl-CoA intermediate inside the enzyme cavity (Figure V.9) (Jez et al., 
2000a). 
 
 
 
 
 
 
 
 
Fig V.9 The GhPS-acetoacetyl-CoA complex (PDB: 1EE0 ; (Jez et al., 2000b, Jez et al., 2000a). Although the 
catalytic cysteine was oxidized, the enzyme product acetoacetyl-CoA could be trapped inside the active site 
cavity. 
We also used HaBPS and its mutant HaBPST135L in soaking and co-crystallizations processes 
inspite of the presence of the oxidized catalytic cysteine, but we failed to get any enzyme complexes 
after X-ray measurement and data analysis. It is not known if the unknown ligand in the active site is 
the main problem but in one trial we carried out denaturation of HaBPSC167A before going to 
crystallization using the denaturation agent 8 M urea, which should stimulate components inside the 
cavity to come out. However, after renaturation by dialysis this protein was not easily refolded back 
to its correct structure. After gel filtration all the protein aggregated and appeared in the column void 
volume. In general, refolding of proteins under gradual dialysis is 50% successful and does not work 
for all proteins.   
 Acetoacetyl CoA 
His308 
Cys169 
Asn341 
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1.3. Crystal structures of benzoic acid specific type III PKSs 
1.3.1. The CoA binding tunnel 
The structures of HaBPS and MdBIS3 with CoA were solved at 1.5 Å and 2.5 Å, respectively. Both 
showed nice orientation of the CoA molecule in the binding tunnel and how this pantetheine arm 
expands inside the tunnel to push the substrate toward the catalytic Cys. The CoA binding tunnel 
includes the residues Lys58, Arg61, Lys65 and Gly312 in HaBPS. The only difference from MdBIS3 
is the presence of Gly312 instead of Ala305. MsCHS2 contains Ala at this site but both residues 
involve the same binding pattern with the CoA molecule. Comparing the tunnel of both enzymes 
with that of MsCHS shows that Arg is the only residue that interacts directly with the CoA molecule 
and the two Lys residues are just stabilizing the Arg by hydrogen bonding and their other side chains 
are directing away from the CoA molecule (Figure V.10). 
  
Fig V.10 The CoA-binding tunnel of HaBPS and MdBIS3. In comparison with the CoA-binding tunnel of 
MsCHS (yellow ; (Ferrer et al., 1999), the different orientation of the two lysine side chains is visible. 
A three-residue solvent-exposed loop was observed in the recently published structure of MdBIS3 
(Stewart et al., 2017), which is significantly displaced toward the CoA tunnel. It resembles region B 
in PsSTS mentioned in (I.1.2.3.2.), which did not play any role in the cyclization mechanisms of STS 
and CHS. This displacement in MdBIS3 resulted in an additional hydrogen bond between the 
adenine unit of benzoyl-CoA and the backbone carbonyl of Leu262 (Figure V.11a).This additional 
hydrogen bond was found before in the CoA complex structure of GhPS (Stewart et al., 2017). Our 
results also demonstrate the clear displacement of this region in both HaBPS and MdBIS3 in 
comparison to MsCHS2 and PsSTS, but the modeled benzene ring in our MdBIS3-benzoyl-CoA 
complex did not show the additional hydrogen bond. In contrast, we found this bond in the HaBPS-
CoA complex structure (Figure V.11b). This hydrogen bond was found in our HaBPS structure 
because of the higher resolution of the dataset compared to the published one. We can see in our 
structures (MdBIS3 and HaBPS) in comparison to the structures of PsSTS and MsCHS2 that the 
displacement in region B of MdBIS3 is more similar to that in PsSTS than in HaBPS. Interestingly, 
both enzymes utilize the aldol cyclization mechanism, thus, this region may play a role in the 
different reaction mechanisms although it is not known yet (Figure V.11c). 
HaBPS MsCHS2 MdBIS3 
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V.11 The hydrogen bond between benzoyl-CoA and Leu262 in the published MdBIS3 (Stewart et al., 2017) 
(a). The structure of our HaBPS-CoA complex (violet) shows hydrogen bond (yellow dotted line) with 
Leu271, similar to the published structure of MdBIS3 (red) (b). The displacement in the region B loop of our 
MdBIS3 structure (blue) is more similar to that in PsSTS (green) than in HaBPS (violet). This displacement is 
significantly different in the loop of MsCHS2 (yellow) in comparison to the other enzymes (c). 
1.3.2. The gate keepers Phe 215 and Phe 265 (numbering from MsCHS2)  
Phe215 and Phe265 were named as ‘gate keeper’ because they are located at the active site cavity 
entrance. Their action by up and down movement of the phenyl rings resembles a gate for allowing 
and blocking the entrance for compounds between the CoA binding tunnel and the active site cavity 
(Abe & Morita, 2010). Phe215 participates in the orientation of the terminal carboxylate of malonyl-
CoA via van der Waals interactions and perform a non-polar surrounding for carbon dioxide release 
during the decarboxylation reaction (Jez et al., 2000b). Phe265 is less important than Phe215 but the 
results of converting Ruta graveolens ACS (RgACS) into CHS upon the mutation of its Ala265 into 
Phe striked the light on this site, too (Lukacin et al., 2001). It proved to participate in the shaping of 
the active site pocket in addition to its effect on the size and the widening of the entrance of the total 
cavity (Mori et al., 2013). Phe265 of MsCHS2 is replaced with Tyr in both MdBIS3 (Tyr260) and 
HaBPS (Tyr269). In HaBPS and MdBIS3, the presence of Tyr with the other gatekeeper residue Phe 
may also perform the function of the door that allows the entrance of the substrates from the tunnel 
to the cavity. Interestingly, the orientation of Tyr is similar in both enzymes; however, it is reverse to 
both residues of gatekeepers in MsCHS2 and PsSTS (Figure V.12). 
  
 
 
 
 
 
Fig V.12 The gate keepers of benzoic acid-specific type III PKSs. Note the different orientation of the gate 
keeper residues in HaBPS (purple) and MdBIS3 (blue) in comparison to MsCHS2 (yellow) and PsSTS 
(cyan) . 
a c b 
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The rotameric difference of Phe265 in the published structure of MdBIS3 was correlated to the 
displacement of the three-residue solvent-exposed loop, which may affect the kinetics of acyl-CoA 
binding in type III PKS catalysis. The conformation of Tyr260 in MdBIS3 was found to be stabilized 
by a water-mediated hydrogen bond to the carbonyl of Phe192. It was presumed that this bond is also 
present in HaBPS, but because of the low resolution diffraction data of the published HaBPS 
structure it was not possible to see this bond (Stewart et al., 2017). In our structures, we see clearly 
this water-mediated hydrogen bond in both MdBIS3 and HaBPS (Figure V.13a). 
 
 
 
 
 
 
 
Fig V.13a The water-mediated hydrogen bond in the published MdBIS3 structure (Stewart et al., 2017) ; left). 
Water-mediated hydrogen bonds between Tyr260 and Phe192 in our MdBIS3 structure (blue) and between 
Tyr269 and Thr200 in our HaBPS structure (violet).   
The rotameric state of Phe265 (MsCHS2) differs consistently between CHS and non-CHS like 
enzymes (Stewart et al., 2017). Persumely, the conformation of Tyr in our enzymes would meet the 
need for its hydroxyl group binding which is characteristic for benzoic acid-specific type III PKSs, as 
we saw this binding also in our resolved structures of HaBPST135L and HsBPS (Figure V.13b). In 
comparison to other plant type III PKSs, this site was always non polar and the size of the residue 
payed more attension than its polarity, for example it was replaced by Gly and Leu in OsCUS and 
CmQNS, respectively, but by Val in CmACS and Aegl marmelos (AmQNS).   
 
 
 
 
 
 
Fig V.13b The water-mediated hydrogen bond between Tyr269 and Thr200 of HsBPS (red) and 
HaBPST135L (pink).  
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1.3.3. The substrate binding pocket 
The substrates binding pocket of HaBPS enfolds Ser136, Glu195, Thr197, Thr200 and Gly342. 
These are quite similar to the substrate binding pocket residues of MsCHS2, except for Gly342 
which corresponds to Ser338 in MsCHS2 (Figure V.14a). The substrate binding pocket of MdBIS3 
enfolds Ser128, Glu187, Thr189, Phe192 and Gly334. These are quite similar to the substrate 
binding pocket residues of HaBPS, except for Phe192 which corresponds to Thr200 in HaBPS and 
Thr197 in MsCHS2 (Figure V.14b). 
 
Fig V.14a, b The differences in the substrate binding pockets of MsCHS2 (yellow), HaBPS (violet) and 
MdBIS3 (blue). Naringinin is shown as yellow sticks representing the coumaroyl-binding pocket of MsCHS2. 
The green stars represent the new expanded pockets behind Gly342 of HaBPS and Gly334 of MdBIS3. 
Ser338 in MsCHS2 forms hydrogen bonds with the neighboring residues Glu192 and Thr132, which 
participate in water molecule stabilization, thereby triggering the aldol switch mechanism of 
MsCHS2 (Austin et al., 2004a). This binding is absent in HaBPS because of Gly342 instead of 
Ser338 and no such hydrogen bond network was found in its crystal structure. This hydrogen bonds 
network is also impossible in MdBIS3, as Thr132 and Ser338 are replaced with Ala127 and Gly334, 
respectively, and it was actually not found in the crystal structure of MdBIS3. Mutational 
experiments proved the importance of Ser338 in polyketide chain length and cyclization because it is 
close to the catalytic Cys164 and guides the expanding or the proper folding of the linear polyketide 
intermediate into the active site pocket. For example, the S338I single mutant of MsCHS2 increased 
the production of methylpyrone in the reaction with acetyl CoA and produced CTAL after the 
reaction with p-coumaroyl-CoA (Jez et al., 2000a). Ser338 of MsCHS2 is not only absent in HaBPS 
and MdBIS3 but also absent in other plant type III PKSs. It is replaced by Gly in CmQNS, which is 
similar to HaBPS and MdBIS3. It is replaced by Ile in GhPS and by Val in AaPCS and AaOKS. It is 
replaced by Thr in Rheum palmatum aleosone synthase (RpALS), which is another plant type III 
PKS that produces heptaketide intermediate (Abe et al., 2006b). The size of the residue in this site is 
correlated to the size of the preferred substrate (the side chain of CoA). It is bulk as Ile in GhPS to 
lock its small preferred substrate acetyl-CoA. It is small as Gly in CmQNS to lock its large preferred 
substrate N-methylanthraniloyl-CoA. Similarly, the small size of Gly342 in HaBPS and MdBIS3 
locks perfectly the benzene ring of its preferred substrate benzoyl-CoA. 
a b 
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When Gly342 was substituted with larger size residues in HaBPS, the single mutants G342F, G342L, 
G342N and G342Y did not show any enzyme activity and G342A showed less enzyme activity 
(Klundt, 2008). Only G342S had the same activity like the wild type-enzyme. In addition, any 
multiple mutations involving this site did not show any enzyme activity, such as A260G/G342S and 
M267L/Y269F/G342S (Liu et al., 2003). This Gly expands behind the active site cysteines of HaBPS 
and MdBIS3 to generate novel pockets (Figure 14a, b). Those pockets are specific for MdBIS3 and 
HaBPS and were not found in the structure of MsCHS2.   
Ser133 did not prove to be important for enzymes activity in MsCHS2 because of its distance from 
the active sites cavity (Austin et al., 2004a). It was replaced with Thr in PsSTS and RpALS and with 
Ala in GhPS and RpBAS but it was not mentioned to have any effect on substrate specifity changes. 
Its abscence had an important effect on other type III PKSs. For example, it was replaced with Ala in 
RgACS and CmACS, which showed to be one of the reasons of owing the ACS larger pocket (Mori 
et al., 2013). It was also replaced with Ala in AmQNS and CmQNS, which emphasized its effect on 
the substrate specificity, as the double mutant S132T/A133S accepted p-coumaroyl-CoA and 
transformed QNS into functional CHS (Resmi et al., 2013). Interestingly, in one of the trials in our 
group to transform HaBPS into ACS, the produced single mutant S136A did not show any enzyme 
activity (Klundt, 2008). This site may play an important role in substrates acceptance for benzoic 
acid-specific typeIII PKSs. Further mutations on this site are not reported for HaBPS or MdBIS3. 
The site shows different displacement in both enzymes, especially at their hydroxyl group side 
chains (Figure 14a, b). From the structures, it is not clear if it is important to have a hydrophilic 
instead of a hydrophobic residue at this site, as we could not see any polar interaction involving this 
site. Ser136 is also at a distance from the active sites pocket, but its effect on the activity may be due 
to its close contact to other essential residues in the active site cavity, as with Thr135 and Thr197. 
Thr194 of MsCHS2 shows high conservation among plants type III PKSs. It was only replaced with 
Met in CmQNS. The side chain of Met194 in CmQNS protrudes toward Gly338, which resulted in 
the absence of the coumaroyl binding pocket of this enzyme. It showed also an influence on the 
polykeide chain elongation. For example, the single mutant T194M of CmACS resulted in the loss of 
the tetraketide acridone forming activity and instead in production of the diketide quinolone, so it 
converted ACS into functional QNS (Mori et al., 2013). Interestingly, the single mutant T197I of 
HaBPS did not show any enzyme activity. This site covers the lower part of the substrate binding 
pocket and the prescence of Ile may block this part and hinder the further entrance of the substrate 
towerd the cavity or the further elongation of the growing polyketides chain. This is also true for the 
side chain of Thr197 in HaBPS, which takes a part of the active site pocket, in contrast to Thr189 of 
MdBIS3 which shows high displacement and moves away from the active sites pocket (Figure 
14a,b). 
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Thr197 of MsCHS2 shows high diversity in plant type III PKSs. It is replaced by Leu, Cys, Met, Ala 
and Gly in GhPS, RpBAS, AaPCS, RpALS and AaOKS respectively. It is replaced by Tyr in OsCUS 
and CmQNS. Mutational experiments proved the control of this site in polyketide chain length. For 
example, the single mutant A197T in RpALS completely abolished the heptaketide producing 
activity and yielded the pentaketide 2, 7-dihydroxy-5-methylchromone (Abe et al., 2006b). In 
addition, the single mutant T197L of MsCHS produced more methylpyrone than the wild type-
enzyme (Jez et al., 2000a). In RpBAS, it did not perform a specific function as the mutant C190T 
showed the same activity as the wild type-enzyme (Abe et al., 2007b). In HaBPS, the function of 
Thr200 did not show a clear effect about polyketides chain elongation but it had a direct effect on the 
activity. Replacing it with bulk residues as Cys and Phe resulted in the production of inactive single 
mutants (T200C and T200F). Small but hydrophobic residues maintained but decreased the activity 
as the single mutant T200A was less active than the wild type-enzyme. Double mutants involving 
this site showed also the same results as T200A / A260G was less active than the wild type-enzyme 
(Klundt, 2008). This Thr is replaced by Phe192 in MdBIS3, similar to Tyr that is found at this site in 
OsCUS and CmQNS. This similarity may correlate to similar reaction mechanisms of the three 
enzymes. MdBIS3 utilizes the condensation of one molecule of malonyl-CoA with 2-
hydroxybenzoyl-CoA to form hydoxycoumarin. This single condensation is also performed in 
CmQNS and OsCUS. The hydroxyl group in Tyr207 in OsCUS was bound to a water molecule 
which is essential for the hydrolysis step to form β-ketoacid. In addition, the constructed mutant 
Y207F of OsCUS was not able to produce the main product bisdemethoxycurcumin; otherwise the 
side product triketide pyrone bisnoryangonin (BNY) was formed (Morita et al., 2010b). In CmQNS, 
such a water network was not observed and, likewise, we did not see it in our MdBIS3. The 
orientation of Phe192 in MdBIS3 is more similar to Tyr197 in CmQNS than Tyr207 in OsCUS 
(Figure 15). This similarity may be important to allow the accommodation of their similar products 
(4-hydroxycoumarin of MdBIS3 and 4-hydroxy-1-methyl-2-quinolone of CmQNS). Not to mention 
that both enzymes utilize similar substrates (salicoyl-CoA of MdBIS3 and N-methylanthraniloyl-
CoA of CmQNS), which contain similar substitutions of the phenyl ring at the ortho position. In 
addition, similar to MdBIS3, CmQNS also accepts benzoyl-CoA as starter substrate to produce the 
phenylpyrone. 
 
 
 
 
 
  
Fig V.15 The substrate-binding pockets of MdBIS3 (blue) and CmQNS (gray). Tyr197 in CmQNS and 
Phe192 in MdBIS3 have the same orientation. The bulky residues of CmQNS such as Met132 (Ala127 of 
MdBIS3) decreasesd the size of the pocket in comparison to MdBIS3. 
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1.3.4. The cyclizations pocket 
The cyclizations pocket of HaBPS consists of the residues Thr135, Met140, Phe218, Ile258, Ala260, 
Tyr269 and Pro379, the numbers and relative positions are the same as in MsCHS2, but Gly256 and 
Phe265 in MsCHS2 were replaced by Ala260 and Tyr269 in HaBPS, respectively. The cyclization 
pocket of MdBIS3 consists of the residues Ala127, Met132, Phe210, Val250, Ala252, Tyr261 and 
Pro371. It differs from HaBPS in two main residues, Ala127 and Val250 corresponding to Thr135 
and Ile258, respectively (Figure V.16).  
 
Fig V.16 The differences in the cyclizations pockets of MsCHS2 (yellow), HaBPS (violet) and MdBIS3 
(blue). Naringinin is shown as green sticks representing the cyclized aromatic ring after polyketide chain 
elongation. 
Gly256 in MsCHS2 has an impact on the size of the cyclizations pocket and the length of the 
polyketide chain. It is replaced by Leu in 2-PS, PCS and OKS and, by Met and Ala in OsCUS and 
CmQNS, respectively. The presence of Ala was proved in the crystal structure of CmQNS to be one 
of the reasons that resulted in the reduction of the active site cavity (Morita et al., 2010b, Mori et al., 
2013). The structure of MsCHS2 and several mutations on Gly256 proved its importance on the 
length and the cyclization pattern of the polyketide chain. Also, the side chain of this residue is so 
close to Phe265 and any alteration on Gly256 affects the position of the benzene ring of this residue 
and thus affects the size and the shape of the active site cavity (Jez et al., 2001). The substitution of 
Gly256 in MsCHS2 into Ala and Val produced more tetraketide lactone but substitution into Leu and 
Phe produced more triketide pyrone. Crystal structures of these mutants proved the reduction of the 
total cavity upon mutation. The side chain of Gly256 extends toward the 
initiation/elongation/cyclization pocket which has a size of 605 Å, but when it was converted into 
Ala and Val the size of this pocket decreased to reach 601 Å and 590 Å, respectively. In case of Leu 
and Phe, the size of the pocket decreased to reach 572 Å and 352 Å, respectively (Jez et al., 2001).  
Depending on these observations, similar mutations were constructed on HaCHS. The single mutants 
of HaCHS (G256A and F265Y) did not show any BPS activity. Only when extra mutations were 
combined with Gly256 and F265, a serious of enzymes were produced and some was found to have 
more activity toward benzoyl CoA.  
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For example, F265Y/S338G double mutant and L263M/F265Y/S338G triple mutant preferred 
benzoyl-CoA over coumaroyl-CoA. In contrast, G256A/L263M/F265Y triple mutant and 
G256A/L263M/F265Y/S338G quadrant mutant decreased the enzyme activity. Remarkably, similar 
reverse mutation was carried out on HaBPS, but the mutant M267L/Y269L/G342S did not show any 
CHS or even BPS activity (Liu et al., 2003). The crystal structure of HaBPS showed a relatively 
similar big cyclization pocket as in MsCHS2 and CmACS, even when it has Ala260 which is more 
bulky than Gly256 of MsCHS2 and CmACS (Figure 17a). 
 
Fig V.17a The similarly big cyclization pockets of CmACS (gray), MsCHS2 (yellow) and HaBPS (violet). 
The important different residues among the three enzymes are represented as sticks. 
CmACS is another plant type III PKSs that utilizes the Claisen cyclization reaction like HaBPS and 
MsCHS2. It demonstrates a larger cyclization pocket as it has Gly256 as MsCHS2, but in addition 
the presence of Val instead of Phe265 of MsCHS2 made the pocket even bigger. In case of HaBPS 
the presence of Tyr269 instead of Phe265 and the specific orientation of its benzene ring made the 
active site entrance wide as in CmACS (Figure 17b). This may explain the acceptance of N-
methylanthraniloyl-CoA by HaBPS but not MsCHS2. 
 
Fig V.17b The wide entrances of CmACS and HaBPS in comparison to the small entrance of MsCHS2. The 
residues responsible of such variations among the three enzymes are represented as sticks. 
ACS CHS BPS 
BPS CHS ACS 
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Ile254 of MsCHS2, which corresponds to Ile158 of HaBPS, is present in almost all plant type III 
PKSs. It shows specific replacement into Val250 in MdBIS3. The replacement of Ile254 is not 
common in plant type III PKSs and it was found only in GhPS where it was replaced by Met259 (Jez 
et al., 2000a). When Ile258 was replaced by Val in HaBPS, the produced mutant I258V showed 
similar activity to the wild-type enzyme (Klundt, 2008). 
Thr132 of MsCH2 , which corresponds to Thr135 of HaBPS, is the most important known residue of 
plant type III PKSs, as it was the key that triggered the aldol-switch mechanism of PsSTS (Austin et 
al., 2004a). It is absent in MdBIS3 and replaced with Ala127. It is also absent in CmACS and 
AmQNS, which replaces it with Ser, and in CmQNS, which replaces it with Met. It showed an 
important role in the substrate specificity in addition to its effect on the shape and size of the enzyme 
pockets (Mori et al., 2013). In one of the trials in our group to transform BPS into BIS, the mutant 
T135A of HaBPS was constructed which, however, did not show any enzyme activity (Klundt, 
2008).  
G372FGPG loop of MsCHS2, which corresponds to G375FGPG loop of PsSTS, is known as 
conserved loop in plant type III PKSs. It was found in HaBPS and MdBIS3 but with one substitution. 
The loop comprises G376LGPG in HaBPS but G368IGPG in MdBIS3. The flexibility of this loop 
proved to be important in the diversity of the compounds produced by STS and CHS (Suh et al., 
2000). As the GPG part showed conservation in all plant type III PKSs, the first two residues showed 
variation among them. For example, in CmQNS and OsCUS two other loops were found, which are 
A372IGPG and A383FGPG, respectively. In the structures of HaBPS and MdBIS3, there was a clear 
displacement in the loop residues, especially at the substitution sites of Leu377 in HaBPS and Ile369 
in MdBIS3. This is contrary to the G372FGPG loop of MsCHS2 and the G375FGPG loop of PsSTS,  
in which their loops are similar and did not show an obvious displacement (Figure V.18). Leu377 
was subjected to serious of mutations in HaBPS, the mutants L377G and L377S decreased 
significantly the activity, but the mutants  L377T and L377F produced inactive enzymes. The 
hydrophobic side chain of Phe and the bigger size of Thr in comparison to the smaller residues Gly 
and Ser may hinder the elongation of the growing polyketide chain because of the reduction in the 
size of the lined pocket (Klundt, 2008).  
 
 
 
 
 
 
Fig V.18 The displacement of the residues in the G368IGPG loop (blue) of MdBIS3 and the G376LGPG loop 
of HaBPS (purple). In comparison to Phe373 of the MsCHS2 loop (yellow) and Phe376 of the PsSTS loop 
(cyan), the prescence of Leu377 of the HaBPS loop and Ile369 of the MdBIS3 loop allows their pockets to 
expand.  
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The active sites pocket of HaBPS shows a totally different shape and geometry from MsCHS2, 
especially at the areas involved in the previously mentioned mutations sites. Those mutations 
depended mainly on amino acids sequence differences, but the crystal structures showed that even 
similar residues may have different orientations and may affect the geometry of the active site cavity. 
An example of this is the different orientation of Leu in the cyclizations pocket (Leu271 in HaBPS, 
Leu267 in MsCHS2) (Figure V.19). Signicant changes in the active sites pockets of MsCHS2, 
HaBPS and MdBIS3 do not arise from the known conserved residues of plant type III PKSs, but 
actually from their neighboring residues that show high diversity especially at specific regions in the 
HaBPS and MdBIS3 structures. For example, the conserved residues Thr197 of MsCHS2 and 
Thr200 of HaBPS, which corresponds to Phe192 of MdBIS3, protude in the same direction toward 
their active site pockets. In contrast, Phe192 has the same orientation like the neighboring residues 
Leu263 of MsCH2 and Met267 of HaBPS. Phe258 of MdBIS3, which corresponds to Leu263 of 
MsCH2 and Met267 of HaBPS, moves away from the active site pocket (Figure.19). The presence of 
the bulk residues Phe192 of MdBIS3 and Met267 of HaBPS explains why both enzymes prefer the 
hydrophobic substrate benzoyl-CoA, which contains the small size hydrophobic benzene ring. In 
addition, both residues clash sterically with the carbonyl unit of naringenin when a CHS–naringenin 
complex is superimposed with MdBIS3 and HaBPS structures. This explains why both enzymes can 
not utilize the bigger substrate 4-coumaroyl-CoA like MsCHS2. 
 
Fig V.19 The important different residues in the active site cavities of HaBPS (violet), MdBIS3 (blue) and 
MsCHS2 (yellow). These residues were mainly used for mutational experiments. Phe192 of MdBIS3 and 
Met267 of HaBPS clash sterically with the carbonyl unit of naringenin (green). 
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Collection of all different residues surrounding the initiation/elongation pockets of both enzymes 
strikes the light on three main different residues of MdBIS3, i.e. Val191, Phe192, and Phe259 which 
are replaced with Met199, Thr200, and Met267 in HaBPS respectively (Figure V.20). The single site 
mutants of HaBPS, M199V and M267F, were reported to have the same activity like the wild-type 
enzyme but the single mutant T200F and the double mutant M199V / T200F did not show any 
activity (Klundt, 2008). A triple mutant involving these three sites is not reported. 
  
Fig V.20 The different orientation of the initiation pocket residues (violet) and the elongation pocket residues 
(green) between HaBPS and MdBIS3. The catalytic triad residues (red) and the main different residues 
(orange) are highlighted. On the right, the polar interaction (red dotted line) between the initiation/elongation 
pocket residues of MdBIS3 (blue) and HaBPS (purple) is depicted. 
The active sites cavities of both HaBPS and MdBIS3 are totally different from each other and varied 
completely from the ones of MsCHS2 and PsSTS in their geometry. They show displacement at 
many loops surrounding their main active site pockets. There are common similarities between them 
and CmQNS as they show G256A/S338G substitutions in comparison to MsCHS2. 
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Specifically, MdBIS3 and CmQNS demonstrated substitution of Thr197 into Tyr (Figure V.21). 
These similar features grouped both enzymes so close to CmQNS in the phylogenetic tree (Mori et 
al., 2013).  
 
 
Fig V.21 The similar active site pockets of HaBPS (violet), MdBIS3 (blue) and CmQNS (gray). On the left, 
the marked red circle demonstrates the site of the active site cavities, which shows displacement in many 
loops of HaBPS and MdBIS3. On the right, the entrance of HaBPS (violet) is big and similar to CmQNS 
(gray), which explains why both enzymes accept the big substrate N-methylanthraniloyl-CoA in contrast to 
MdBIS3 (blue). The cyclization pocket of CmQNS is not as big as that of MdBIS3 and HaBPS, which 
explains why both enzymes form a tetraketide rather than monoketide like CmQNS.  
1.3.5.The new hidden pocket of benzoic acid-specific type III PKSs 
The structure of HaBPST135L was solved at 1.4 Å, showing the proper geometry of the residues 
surrounding the mutation site by formation of a new expanded pocket (Figure V.22a). The 
orientation of Leu135 was supposed to be the reason for the low activity of the mutant with 3-
hydroxybenzoyl-CoA. The growing 3-hydroxybenzoyl triketide functions like the absent Thr135 and 
forms hydrogen bond with the neighboring Gly166, which results in the trapping the produced 
polyketide chain inside the new pocket  (Figure V.22b) (Klundt et al., 2009). 
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Fig V.22 The different orientations of Thr135 in HaBPS (purple) and Leu135 in HaBPST135L (pink). Thr135 
forms a hydrogen bond (red dotted line) with the neighboring residue Gly166 (a). The trapping of 3-
hydroxybenzoyl-CoA in the newly formed pocket blocks the elongation reaction on this substrate (b) (Klundt 
et al., 2009). 
 The size and shape of the active sites pocket is strongly correlated to the number of condensations 
with malonyl-CoA and the length of the polyketide chain. After comparison of the active site pockets 
of wild-type HaBPS, which condenses three molecules of malonyl-CoA, and the mutant 
HaBPST135L, which condenses only two molecules of malonyl CoA, we can see a clear decrease in 
the active site pocket size of HaBPST135L. There is a new geometry surrounding L135 which is 
shown clearly by the slight displacement in Gln165 (Figure V.23). The entrance of the pocket is 
small and a phenyl moity cannot be locked inside it. The decreased size of this pocket obviously 
limits the chain extension to only two molecules of malonyl-CoA addition. 
 
 
 
 a 
 b 
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Fig V.23 The different pocket sizes of HaBPS and HaBPST135L. The size of the pocket surrounding Leu135 
in HaT135L is smaller than the pocket surrounding Thr135 in HaBPS (indicated with arrows). This explains 
the production of a triketide chain by the mutant instead of a tetraketide chain by the wild-type enzyme. 
Interestingly, Ala127 in MdBIS3 does not participate in any polar interaction, as Thr135 of HaBPS. 
Therefore, it acts exactly as Leu135 in HaBPST135L to create a bigger new pocket. In the recently 
published work about MdBIS3, a hidden pocket was discovered in the active site cavityies of both 
MdBIS3 and HaBPS. The side chains of Ala127 in MdBIS3 and Thr135 in HaBPS line the sides of 
this novel pocket. Actually, this pocket was found in the structures of our HaBPS and MdBIS3.This 
pocket is located exactly as the one that we found in the HaBPST135L structure, which was also 
discovered previously in our research group by homology modeling of HaBPS and the mutant 
HaBPST135L. This novel pocket was hypothesized to favor the production of phenylpyrone over 
phlorobenzophenone (Klundt et al., 2009). This new pocket is smaller in the solved crystal structures 
of the two BPSs (HaBPS and HsBPS) because of the hydrogen bond bridge of Thr135, but larger in 
MdBIS3 and the T135L mutant because of the abscenc of Thr135 (Figure V.24a). 
 
Fig V.24a The new pocket (marked with an arrow) of benzoic acid-specific type III PKSs. There are similarly 
big pockets in MdBIS3 (blue) and HaBPST135L (pink). The size of the new pockets of HaBPS (violet) and 
HsBPS (red) is small. The presence of Thr135 hydrogen bonds (blue dotted line) is the reason for the smaller 
pockets. 
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Comparing our structures of HaBPS and MdBIS3 demonstrates the bigger new pocket in MdBIS3 
than in HaBPS. This is bcause of the presence of more polar residues around this pocket in HaBPS 
than MdBIS3. These are mainly Thr135 and Ser343 of HaBPS, which correspond to Ala127 and 
Ala336 in MdBIS3. Thr135 and Ser343 of HaBPS are involved in many hydrogen bond networks, 
which minimize its new pocket size. These residues are localized in two main areas in both enzymes, 
which show high variation between them. They are V130VFATTSGF (a1) and G342SACVMF (a2) 
in HaBPS, corresponding to L122IFCTASCV and G335APTVHF of MdBIS3, respectively (Figure 
V.24b). The recent publication about the structure of MdBIS3 also mentioned, that sequence 
differences between the residues lining the walls of the novel pockets in BPS (T135,G342SAC) and 
BIS (A127, G335APT/S) are good targets for mutagenesis and a useful starting point for further 
exploration of the cyclization speciﬁcity. E195 of HaBPS (E192 of MsCHS2) locates between the 
previously mentioned regions a1 and a2. In addition, the suggested water-hydrogen bonds network 
involves another area (N164QGF of HaBPS and E156AGY of MdBIS3) (a3), which includes the 
important residue G166 of HaBPS. This area did not show high variation or notable displacement in 
comparison to MdBIS3. In contrast, downwards and close to E195 of HaBPS there is another 
important area (E195NTAMT of HaBPS and E187ITTVF of MdBIS3) (a4). Two main different 
residues in a4 (Thr197 and Thr200 of HaBPS corresponding to Thr189 and Phe192 of MdBIS3) 
show displacement among HaBPS and MdBIS3. From the structure, we see clearly that those two 
residues sterically decreased the size of the MdBIS3 cavity compared to that of HaBPS.  
 
 
 
 
 
 
 
 
 
 
 
Fig V.24b The four different areas surrounding the new pockets of HaBPS (violet) and MfBIS3 (blue). a1 
(red), a2 (orange), a3 (yellow) and a4 (green). 
 
 
a1 
a2 
a3 
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1.3.6. Aldol/Claisen cyclizations mechanisms and the electronic/steric effect 
The new publication (Stewart et al., 2017) also assumes, that the novel pocket of MdBIS3 contains 
ordered waters, which could function similar to the nucleophilic water that is essential for the aldol 
switch of stilbene synthases, but the low resolution structure of HaBPS prohibited further analysis. 
Interestingly, we see clearly in our structures of HaBPS and MdBIS3 different hydrogen bond 
network with one interesting water molecule. This water is located exactly as the water molecule 
found in MsCHS2, PsSTS, AhSTS and even the 18xCHS (Figure V.25). The only difference from 
our HaBPS and MdBIS3 is the location and orientation of Thr135 of HaBPS and Ala127 of MdBIS3 
(corresponding to Thr132 of MsCHS2). In HaBPS, Thr135 directs toward Gly166, which assists 
their hydrogen binding. Similar hydrogen binding of Thr132 and Gly163 was found only in MsCH2. 
In contrast, Thr132 of AhSTS and Thr135 of PsSTS direct away and do not involve any binding with 
their corresponding Gly163 and Gly166, respectively. In MdBIS3, there is no contact with its 
Gly158, as the enzyme has Ala127 instead of Thr. This is similar to HaBPST135L, which has 
Leu135 instead of Thr; the only difference is the reduction of the active site cavity of HaBPST135L 
because of the bulky Leu. This reduction resulted in triketide chain elongation and the formation of 
phenylpyrone. These variations are still related to the presence or the orientation of Thr132 and 
Ser338 of MsCHS2, which are the responsible residues for the aldol-switch mechanism in STS. 
These residues are still the critical residues in our enzymes also in addition to their interaction with 
Gly163 of MsCHS2, which resulted in the expanding of a small hidden pocket and might strongly 
relate to the aldol/Claisen cyclization mechanisms (Figure V.25). 
The orientation of Thr132 and Gly163 of MsCHS2 is the same as Thr135 and Gly166 of HaBPS. 
Both enzymes utilize the Claisen cyclizations reaction. Both residues are directed toward each other 
using one specific hydrogen bond. This bond will in turn affect the close hydrogen bonds network 
that involves the important water molecule. The only difference is the absence of Ser338 of MsCHS2 
(Gly342 of HaBPS), which resulted in the formation of the expanded new pocket. In MdBIS3, there 
is Ala127 instead of Thr135 in HaBPS, which resulted in a bigger new pocket. Ala127 of MdBIS3 
does not involve any binding with Gly158, this is similar to AhSTS, PsSTS and 18xCHS, which all 
utilize aldol cyclization reaction. Another two plants type III PKSs were analysed in their structures 
at the positions of the previously mentioned two residues. CmACS (Ser321 and Gly163) showed the 
same orientations of MsCHS2 and HaBPS and this enzyme also utilizes the Claisen condensation. 
CmQNS (Met132 and Gly163) showed the same orientation of PsSTS and MdBIS3 and this enzyme 
also utilizes aldol condensation (Figure V.25).  
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Fig V.25 The different orientations of Thr132 and Gly166 in MsCH2 and their corresponding residues in 
other plant type III PKSs. MdBIS3 utilizes the aldol cyclization reaction and shows no hydrogen bond 
between these residues similar to other enzymes utilizing the same mechanism (AhSTS, PsSTS and CmQNS). 
HaBPS utilizes the Claisen cyclization reaction and shows hydrogen bonding between the previously 
mentioned residues, similar to other enzymes utilizing the same mechanism (MsCHS2 and CmACS). The 
water molecule responsible for the aldol switch in PsSTS was found in the same location in other type III 
PKSs but in different hydrogen bond networks (yellow dotted lines). This water is close to the pocket where 
the cyclization takes place. Resveratrol in AhSTS and18xCHS and naringenin in MsCHS2 are shown as green 
sticks. 
 
 
 
HaBPST13L MdBIS3 
MsCHS2 HaBPS 
CmQNS 
CmACS 
AhSTS  18XCHS PsSTS 
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For the hidden pocket of benzoic acid-specific type III PKS, the bulk size of the surrounding residues 
affects its formation, Also, the orientation or the absence of Thr132 in relation to the presence of 
Ser338 of MsCHS2 and their hydrogen bonds network with the surrounding residues that stabilize a 
localized water molecule in a constant place in most of plant type III PKSs which is close to the 
catalytic Cys164 and the cyclizations pocket indicate that the steric factor together with the 
electronic factor are the trigger for utilizing either aldol or Claisen cyclization mechanisms. Benzoic 
acid-specific type III PKSs demonstrate totally different active sites pockets compared to those of 
MsCHS2 and PsSTS. Further mutagenesis works are needed to study the steric/electronic effects 
especially at residues surrounding Thr132 and Gly163 of MsCHS2. Actually in the literature, there is 
one study on AhSTS that ensures that the steric factor is more important as the electronic factor, 
which is known as aldol-switch of PsSTS. This study demonstrated two hydrophobic residues 
Gly255 and Met98 that play an important effect in CHS-STS functions variation. The structure of 
AhSTS (peanut) demonstrated also three main different areas, a1 (133–136), a2 (248–256) and a3 
(265–269) after comparison with the structure of MsCHS2. As a part of a1, Thr132 has the same 
position that was found in PsSTS and it also stabilizes a water molecule by contribution into 
hydrogen bond network with Glue192 and Ser338 (Figure V.32). In contrast to the previous 
mentioned study about the crystal structure of PsSTS, this one focused more on the steric effect as an 
important factor that influences the cyclizations mechanism of the enzyme. By structures comparison 
of AhSTS with MsCHS2, the side chain of its Met98 hinders the structure displacement in a1 by the 
bulkiness of its side chain and it is still not clear if the substitution of this residue alone or with other 
additional substitutions will have effect on the functional conversion between CHS and STS. More 
interesting is the substitution of Gly255 with bulkier residues, which resulted in the conversion of 
STS into functional CHS. It seems that there are more than one factor effecting the cyclization 
pattern of type III PKSs (Figure V.26) (Shomura et al., 2005). Interstingly, those two residues Met98 
and Gly255 of AhSTS are close to Thr132 and Gly153. The substitutions of Met98 and Gly255 with 
other residues surly disrupted the orientations of Thr132 and Gly153 and disrupted also their close 
water hydrogen bonds network. 
 
Fig V.26 The hydrogen bond network in peanut STS is similar to that in PsSTS (left). On the right, the 
orientation of Met98 and Gly255 (black) in AhSTS is depicted. 
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Met98 is replaced with Cys93 in MdBIS3 but it is the same residue of MsCHS2 (Leu98) and HaBPS 
(Leu101). The closeness of this residue to Thr132 of MsCHS2 should effect its orientation. Gly255 
is so close to the cyclizations pocket and the part of the product that utilizes aldol or Claisen reaction. 
It is replaced with Asp255 in MsCHS2, which changes the size of the pocket that locks the two 
hydroxyl groups of the second cyclized ring of naringenin. It is replaced with Thr259 and Val251 of 
HaBPS and MdBIS3, respectively (Figure V.27). This replacement shows a clear change in the size 
of the pocket that should lock, similarly to naringenin of MsCH2, the two hydroxyl groups of the 
second cyclized ring of biphenyl and phlorobenzophenone. The structure of enzyme-product 
complexes are needed in the future for further structure analysis and the interpretation of the 
different cyclization mechanisms. 
 
Fig V.27 The orientation of Met98 and Gly255 (black) in AhSTS (orange). In comparison to MsCHS2 
(yellow), HaBPS (violet) and MdBIS3 (blue), Met98 is so close to Thr132 and Gly255 that it results in 
different shapes and sizes of the pocket close to it in all the enzymes. 
The importance of the steric effect on the cyclization mechanisms was also reported for other type III 
PKSs because of the absence of the water molecule that is responsible for the aldol mechanism in 
PsSTS. An example is the aldol-Claisen cyclisations mechanisms alteration after mutagenesis in 
AaPCS and AaOKS. In AaPCS, an intrinsic character was found when M207 (Phe192 of MdBIS3 
and Thr200 of HaBPS) was substituted by Gly. The produced mutant utilized aldol rather than 
Claisen cyclization mechanism like the wild-type enzyme. The structure analysis supposed that the 
alteration of the reaction mechanism of AaPCS C1/C6 Claisen type cyclization into C10/C15 and 
C12/C7 aldol-type cyclization of the M207G mutant is because of the steric effect rather than the 
electronic effect (Figure V.28) (Morita et al., 2007).  
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Fig V.28 The aldol cyclization mechanism of the M207G mutant of PCS. 
The electronic effect was explained previously as aldol switch of PsSTS because of the presence of a 
hydrogen bonds network close to Ser341 (Ser338 in MsCHS2). Such network was not found in the 
structures of AaPCS or its mutant M207G. Similar to MdBIS3, this Ser was absent (Gly334) and 
replaced with the hydrophobic residue Val350 in AaPCS and its mutant. It was suggested that the 
location of residue 338 is the most important factor as it is so close to the catalytic Cys that is 
attaches to the growing polyketide chain. Thus, it performs a steric guidance for the linear 
intermediate to be extended toward other hidden pockets of the active site cavity (Figure V.24) 
(Morita et al., 2007). Moreover, the impact of the steric effect on the reaction mechanism was shown 
when the Claisen cyclization of AaPCS changed in the triple mutant (F80A/Y82A/M207G) into the 
aldol condensation pattern to release CO2 and to form the aromatic naphthalene ring (Figure V.29) 
(Abe et al., 2007a).   
Fig V.29 The aldol cyclization mechanism of the F80A/Y82A/M207G mutant of PCS. 
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Even more interesting, the mutant G207M of AaOKS (that has PCS activity) shows intrinsic 
mechanism than the natural AaPCS. Normaly, AaPCS resulted in 5,7-dihydroxy-2-methylchromone 
formation using C1/C6 Claisen-type cyclization, but this mutant produced the other isomer 2,7-
dihydroxy-5-methylchromone using C4/C9 aldol-type cyclization (Figure V.30) (Abe et al., 2005a). 
   
Fig V.30 The different aldol cyclization reactions of PCS and the G207M mutant of OKS. 
1.3.7. The crystal structure of Malus domestica BIS3 complexed with benzoyl CoA 
One of the collected datasets after X-ray measurement of the soaked crystals of MdBIS3 with 
benzoyl-CoA showed the presence of an electron density close to the catalytic Cys, which resembled 
the benzene ring. The total electron density in the active site cavity was modeled perfectly to benzoyl 
CoA. The residues of the substrate binding pocket aligned well with the substrate (Figure V.31).  
  
 
  
 
 
 
 
 
 
 
Fig V.31 The structure of MdBIS3 in complex with benzoyl-CoA (green). The residues of the catalytic triad 
(cyan), substrate binding pocket (orange), gatekeeper (red) and the CoA-binding tunnel (violet) are 
highlighted. 
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In comparison to the structure of the 18xCHS mutant complexed with resveratrol (PDB: 1U0W) 
(Austin et al., 2004a), we saw different orientation of the residues around the cavity. In addition, the 
hydoxyl group of the coumaroyl ring does not have enough place to be locked in the smaller cavity 
of MdBIS3 (Figure V.32). 
 
 
 
 
 
 
 
 
Fig V.32 The active site pockets of 18xCHS (yellow) complexed with resveratrol (blue) and MdBIS3 (red) 
complexed with benzoyl-CoA (green). The residues involved in polar interaction (blue dotted lines) with 
resveratrol are shown as sticks, like other major different residues of the substrate binding pockets. 
Based on modeling benzoyl-CoA into the HaBPS pocket and comparison to the structure of 
MsCHS2 complexed with naringenin (PDB: 1CGK), we also see that the cavity of HaBPS is smaller 
and cannot accommodate the cyclized product of MsCHS2, especially at the region of its hydroxyl 
groups (Figure V.33). 
 
 
 
 
 
 
 
 
 
Fig V.33 The active site pockets of MsCHS2 (yellow) complexed with naringenine (blue) and HaBPS (red) 
modeled with benzoyl-CoA (green). The residues involved in polar interaction (blue dotted lines) with 
naringenine are shown as sticks, like the other major different residues of the substrate binding pockets. 
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Ultimately, structural differences among PKSs that alter the volume and the shape of the 
initiation/elongation cavity allow for discrimination between starter molecules and the number of 
elongation steps to direct the nature and length of the polyketide products (Jez et al., 2000a). 
The cavities of HaBPS and the MdBIS3 are really like a reflection picture of their final products. 
Their shapes fit perfectly to the produced compounds, 3,5-dihdroxybiphenyl by MdBIS3 and 2,4,6-
trihydroxybenzophenon by HaBPS (Figure V.34a, b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig V.34a The active site pocket of 
HaBPS modeled with 2,4,6-
trihydroxybenzophenone (pink). The 
main different residue in the substrate 
binding pocket (Thr200) is marked as 
red sticks. 
 
Fig V.34b The active site pocket of 
MdBIS3 modeled with 3,5-
dihydroxybiphenyl (yellow). The main 
different residue in the substrate binding 
pocket (Phe192) is marked as red sticks. 
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1.3.8.Mutation and conversion of BPS into BIS 
Another approach was performed to understand the reaction mechanisms of both enzymes. By 
transformation of BPS into BIS, we can exactly determine the important residues responsible for 
aldol or Claisen type cyclization. By comparing the crystal structures of HaBPS and MdBIS3 and 
analyzing the residues surrounding the active site pockets, we could determine many amino acids 
which showed different side chains and orientations between the two enzymes (Table 8). The 14 or 
the 13 mutations that we made were massive and they resulted in complete loss of the activity. 
Although the 14x or the 13x mutants enfolded the residues of the initiation/elongation cavities of 
both enzymes, there was neither BPS nor BIS activity. In each mutant there is one missing site from 
the elongation pocket as shown in the following table and it may be worth in the future to include 
these extra single sites into the constructed mutants (S219A in 14x mutant) and (M199V in 13x 
mutant), which may retain either BPS or BIS activity. 
Table 8. Survey of mutations made to convert BPS into BIS 
Enzyme HaBPS MdBIS3 14x mutant 13x mutant 
Initiation pocket 
 
 
 
 
Met217 
Ile258 
Ala260 
Tyr269 
 
Leu209 
Val250 
Ala252 
Tyr261 
 
M217L 
I258V 
F262I 
A257G 
F279V 
M217L 
I258V 
F262I 
K272S 
F279V 
Elongation pocket Thr135  
Ser136 
Thr197 
Met 199 
Thr 200 
Ser219 
Met267 
Gly342 
Ala127 
Ser128 
Thr189 
Val91 
Phe192 
Ala211 
Phe259 
Gly334  
T135A 
F138V 
N164E 
M199V 
T200F 
Q165A 
M267F 
F168Y 
L377I 
T135A 
A133C 
N164E 
Q165A 
T200F 
S219A 
M267F 
 
L377I 
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The previous conversion of CHS into STS also included 18 mutation sites (18x CHS) but the 
mutation process was gradual and stepwise (Austin et al., 2004a). Each time, there was an extra 
addition of another mutation site to the previously added one. Each single mutant was tested for its 
activity to perform exactly what was the function of the residue that was replaced. This strategy 
helped for the accurate understanding of the variation in the reaction mechanisms of CHS and STS 
and provided extra information to understand more about the variety in substrates acceptance and the 
different products formed by plant type III PKSs. The authors constructed about 81 four digit number 
mutants, in which each number indicates the partial (1) or the no (0) or the complete (2) mutation of 
one of the four important different areas between the two enzymes. For example the 2222 mutant is 
for the 18xCHS, 0002 for the mutant which included full mutation in area 4 but showed only CHS 
activity, which in turn indicated the unimportance of this area in contrast to area 2 in which 1210 
mutant (8x CHS) showed STS like activity (Figure V.35) (Austin et al., 2004a). Looking in the 
structures of HaBPS and MdBIS3, this area 2 did not show notable displacement although it 
demonstrates different residues among the two enzymes.  
 
Fig V.35 The differences in area 2 loop among the four enzymes MsCHS (red), PsSTS (blue), HaBPS (pink) 
and MdBIS3 (green).  
The previous difficult mutation strategy of MsCHS2 and PsSTS was performed in two enzymes, 
which produce trace amounts of the product of the other. This was reported in Pueraria lobata CHS 
that formed 2.7-4.2% resveratrol and AhSTS that formed 1.4-2.3% naringenine (Yamaguchi et al., 
1999). In contrast, our enzymes BPS and BIS produce totally different products. For this reason, 
such a mutation strategy is worth being applied in the future. The conversion of STS into CHS is not 
reported either, therefore the mutation in the direction of BIS into BPS may be be feasible. However, 
the two enzymes share only 54% amino acids sequence similarity (Liu et al., 2007), which is very 
low in comparison to CHS and STS which have 75%-90% similarity (Austin et al., 2004a). 
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1.3.9. The crystal structures of HaBPS, HsBPS and the different surface residues 
The structure of HsBPS was solved at 1.7 Å, displaying some changes in the geometry of the active 
sites pocket compared to that of HaBPS. The amino acids sequence alignment shows only six 
different amino acids (Asp54, Ala146, Gly230, Ala235, Leu359 and Ser360). Interestingly, they are 
far from the active site, but somehow they resulted in different biochemical and functional properties 
between the two enzymes (Figure V.36).  
 
 
 
 
 
 
 
 
 
 
 
Fig V.36 The six different surface amino acids of HsBPS compared to HaBPS. The residues are shown as blue 
sticks together with Thr135 (green) in the center. Their polar interactions with other residues are shown as 
blue dotted lines. 
The crystal structures of both enzymes demonstrate different shapes of the loops. These loop do not 
only surround the cyclization pockets but are also on the surface especially at the areas where there 
are different amino acids. The residues forming these loops take different orientations especially in 
their side chains. The residues of these loops in HaBPS are E83NQ (L1), G253SDGAITA (L2), 
Y269FLKEDVI (L3), P308GGRGI (L4), V359NG (L5), the famous G376LGPGL (L6) and I393LQ 
(L7) (Figure V.37). Most of the loops include or are close to an important residue (colored with red) 
of the active sites pocket. A260 corresponds to G256 of MsCHS2 and Y269 corresponds to F265 
ofMsCHS2. Both residues, as mentioned previously, are known for their effects on substrate 
specificity and chain elongation. In addition, the loop L4 is close to His307 of the catalytic triad. The 
loop L5 contains two surface residues different from HsBPS, V359 and N360. 
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Fig V.37 The differently diplaced loops of HaBPS (green) and HsBPS (red). The main different areas are 
highlighted in blue. The numbers indicate the previously mentioned loop numbers. 
These loops surround mainly the entrance of the active sites pocket, which should correlate to the 
differences in the substrate specificities, as HsBPS accepts salicoyl-CoA and HaBPS accepts N-
methylanthraniloyl-CoA. Analyzing these loops in detail, we see a specific area of some similar 
residues in loop L4 which have different orientations between the two enzymes. These are Gly309, 
G310 and Ile313. The amine and carbonyl groups of both Gly residues are oriented in the same 
directions but highly displaced from each other. The side chain of Ile313 is directed toward the 
active sites pocket of HaBPS and in HsBPS it moves away from the cavity (Figure V.38).  
 
 
 
 
 
 
 
 
 
Fig V.38 The specifically displaced loop of HaBPS (green) and HsBPS (red). The loop surrounds the CoA 
tunnel. The side chain of Ile313 in HaBPS directs toward the active site pocket, in contrast to Ile313 of 
HsBPS. The slightly expanded pocket (marked with arrow) is located in the middle between Ile313 and 
Leu377. 
 CoA entrance 
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The previous three residues also interact with Gly312, which shows also slight displacement. This 
residue is one of the important residues of the CoA binding tunnel. There is a slightly expanded 
pocket in the surface between the three residues (Gly309, Gly310 and Ile313) and Leu377. This 
slightly expanded pocket resulted from the displacement of these residues between the two enzymes 
and it is bigger in HaBPS than that in HsBPS. These variations are at the area of the CoA binding 
tunnel and close to the substrate binding pocket and thus should correlate to the differences in the 
substrate specificities of HaBPS and HsBPS. The absence of structures of enzyme-substrate or 
enzyme-product complexes hinders the interpretation of this area at the CoA tunnel. Until now, there 
are no other type III PKS structures that are complexed with salicoyl-CoA, but in the PDB databank 
we found one PKS-like enzyme (PqsD) from Pseudomonas aeruginosa, the structure of which is 
complexed with anthranilic acid. Anthraniloyl-CoA is the first of two substrates used by PqsD. CoA 
delivers anthranilate to the PqsD active sites Cys112. PqsD uses malonyl-CoA and malonyl-ACP as 
its second substrate in a reaction that forms 2,4-dihydroxyquinoline (DHQ). It shows the dimer 
structure as type III PKSs. The structure demonstrates a similar slightly expanded pocket that locks 
the aminophenyl ring as the one that we found in HaBPS and HsBPS (Figure V.39). 
 
 
 
 
 
 
 
 
 
 
Fig V.39 The crystal structure of PqsD from Pseudomonas aeruginosa in complex with anthranilic acid (pink) 
and anthraniloyl-CoA (green). The residues of the loop above the CoA tunnel are shown as sticks. 
Comparison of the PqsD-anthranilate complex structure with our structures of HaBPS and HsBPS, 
let us, assume that, the elongations direction of the growing polyketide chain using anthraniloyl or 
N-methylanthraniloyl-CoA is downward. The bottom of the active sites pocket is not large enough 
for several elongations using this bulk substrate, therefore only one molecule of malonyl-CoA is 
added to result in the corresponding quinolone. On the other hand, the elongation with benzoyl-CoA 
will move toward the normal big benzoyl-binding pocket in the back of the cavity, which will allow 
for the addition of three molecules of malonyl-CoA.  
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These directions of elongations are likely the same in case of MdBIS3 and salicoyl-CoA, as this 
substrate is also substituted at ortho-position and undergoes only one condensation with malonyl-
CoA. As this elongation area is smaller in MdBIS3 than in HaBPS, it accepts salicoyl-CoA but not 
anthraniloyl- or N-methylanthraniloyl-CoA. Regarding HaBPS and HsBPS, this area is nearly the 
same but it is still not clear why salicoly-CoA is utilized by HsBPS and not by HaBPS. Those are 
still predictions depending on the bacterial PqsD-anthranilate complex structure because of the 
absence of complex structures for the plant type III PKSs, which use anthraniloyl- or N-
methylanthranuloyl-CoA as their natural substrates, like CmACS and CmQNS. Since there are high 
similarities between HaBPS and CmACS as well as MdBIS3 and CmQNS, as mentioned previously, 
there are great chances to transform benzoic acid-specific type III PKSs into ACS or QNS using 
mutagenesis (Figure V.40). 
  
Fig V.40 The structures of HaBPS (green), HsBPS (red) and MdBIS3 (blue) modeled with anthranilic acid. 
Anthraniloyl-CoA and anthranilic acid are shown as black sticks. The CoA molecule of the HaBPS-CoA 
structure is shown as lines. The arrows indicate the suggested pocket, which locks the resulting quinolone. 
This pocket is surrounded by Met267, which shows clear displacement in HaBPS and HsBPS and is replaced 
with Phe259 in MdBIS3. The different residues of the specific loop above the CoA tunnel are shown as sticks. 
The specific orientation of Arg311, which corresponds to Pro303 in MdBIS3, is shown in both BPSs. 
Met267 shows different orientation in HaBPS and HsBPS; the location of this residue is close to the 
pocket that probably locks the produced quinolone. Comparing the top of the CoA binding tunnel of 
HaBPS and HsBPS to that of MdBIS3, there is one interesting residue, Arg311 of BPSs, which 
corresponds to Pro303 of MdBIS3. The pyrrolidine ring of Pro303 is directed toward the cavity and 
its existence may sterically hinder the amine or N-methylamine groups of anthraniloyl- or N-
methylanthranuloyl-CoA, respectively. In contrast, Arg311 of both BPSs moves away from the 
cavity to allow the big side chains of the previously mentioned substrates to enter easily. 
Mutagenesis of this residue will indicate if it has effect on substrate acceptance, especially when 
mentioning that CmQNS has Arg307 at this site but CmACS has Pro307 instead. 
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Mutational experiments were conducted to convert HaBPS to HsBPS by substitution of the six 
surface amino acids (Glu54, Val146, Cys230, Ser235, Val359 and Asn360) to the corresponding 
ones of HsBPS (Asp54, Ala146, Gly230, Ala235, Leu359 and Ser360). HsBPS demonstrated high 
Km values for both the starter and extender substrates in comparison to other Hypericum BPSs. The 
previously produced single mutants of HaBPS showed also 3 to 4.9 and 2 to 4-fold increases in the 
malonyl-CoA and benzoyl-CoA Km values, respectively, compared to the wild-type enzyme. All the 
previous single mutants were active but only HaS235A did not show any over-expression 
(Abdelaziz, 2014). The result of no protein expression after surface amino acids mutation is actually 
expected. For example, the surface residues Arg199 and Arg350 in CHS from Pueraria lobata have 
found to maintain the structure integrity, as the side chain of Arg199 forms hydrogen bonds with the 
carbonyl oxygens of both Val261 and Leu263. In addition, the two nitrogen atoms of Arg350 are 
close to the oxygen atoms of highly conserved Glu116. Moreover the produced mutants of these two 
residues resulted in decreased yields of protein amount, which means that these Args also affect the 
protein folding (Fukuma et al., 2007).  
In HaBPS, the loop Thr135 to Tyr146 is located at the dimer interface but does not show differences 
between HaBPS, HsBPS and even HaT135L. The loop Gly230 to Ala235 is located on the surface 
and shows slight displacement among HaBPS, HsBPS and HaT135L. This region also differs in the 
sequences of H. calycinum and H. perforatum BPSs. Close to this area is the N-terminal helix 1 – 20, 
which differs in H. perforatum ssp angustifolium, and it also shows displacement HaBPS, HsBPS 
and HaT135L. The helix Val346 to Asn360 is running into the active site but does not show any 
differences between HaBPS, HsBPS and even HaT135L. Glu54 is the closest residue to the CoA 
tunnel and its orientation is similar in HaBPS, HsBPS and HaT135L. Those loops which included the 
six different amino acids between HaBPS and HsBPS did not demonstrate big changes as the 
displaced loops that we identified earlier by the crystal structures of both enzymes (Figure V.41). 
   
 
 
 
 
 
 
 
Fig V.41 The loops that include the six surface amino acids, which differ between HaBPS (green) and HsBPS 
(red). a) loop T135-Y146, b) loop G230-A235 with N-terminal helix 1-20, c) helix V346-N360, d) E54. 
 a  b 
 c  d 
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In contrast to HaBPS, two specific mutants, HsBPST135I and HsBPST135K, resulted in the 
transformation of HsBPS into phenylpyrone synthase and hydroxycoumarin synthase, respectively. 
Interestingly, the double mutant HaBPSS235A/T135I was active and resulted in phenylpyrone 
formation, although the single site mutant HaBPST135I was inactive in comparison to the active 
HsBPST135I (Abdelaziz, 2014). Even by analyzing the mutation area of both enzymes, there was no 
clear difference in the orientation of the residues surrounding Thr135. These results strongly suggest 
the high impact of the six surface amino acids on other important residues surrounding the active site 
cavity such as Thr135. The crystal structure of HsBPS demonstrates a large network between these 
six surface amino acids and the Thr135 beside the involvement of other residues which maintain the 
integrity and the geometry of the active site pocket, such as the G376LGPG loop corresponding to 
the G372FGPG loop of MsCHS2 (Figure V.42).  
 
 
 
 
 
 
 
 
  
 
 
 
Fig V.42 The six surface residues of HsBPS (blue) involved in hydrogen bonding with other residues 
(yellow). These residues together maintain the shape and the integrity of the active site pocket (red) by taking  
part in important loops (cyan), such as the G376LGPG loop (purple). This network also involves interaction 
with Thr135 (white). 
Mutational experiments proved the importance of the flexibility of the G372FGPG loop in 
polyketide formation, as it takes  part in the cyclization pocket of type III PKSs (Suh et al., 2000). 
There is also a relationship between this loop and some surface amino acids. For example, when a 
mutation was conducted on CHS from Pueraria lobata to study the effect of some surface arginines 
on the enzyme acivity, Arg68, Arg172 and Arg328 turned out to help in the correct positioning of the 
catalytic Cys-His-Asn triad and the G372FGPG loop. 
Thr137 
Asn54 
Ala146 
Ala235 
Gly230 Leu359 
Ser360 
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The Arg172 mutant showed dramatic increase in the CTAL production, as this residue is located 
close to the catalytic nucleophile Cys164 and the G372FGPG loop. It helps in the correct orientation 
of the loop toward the catalytic Cys164, which affects the cyclization reaction of the enzyme 
(Fukuma et al., 2007). 
Another important residue was found to have different orientation in HaBPS and HsBPS, which is 
Leu271 corresponding to Leu267 of MsCHS2. This residue shows different orientations in HaBPS, 
HsBPS and HaT135L. In addition, the loop close to it and just above the CoA binding tunnel shows 
clear displacement in HaBPS, HsBPS and also HaBPST135L. In CmACS, the conformational 
change of Leu267 together with Phe215 was the reason of widening its active site entrance. The 
broad active site entrance affects the starter substrate preference and the product specificity of 
CmACS (Figure V.43) (Mori et al., 2013).  
 
 
 
 
 
 
 
 
 
 
Fig V.43 The different orientations of Leu271 in HaBPS (green), HsBPS (red) and HaBPST135L. The close 
loop to Leu271 and just above the CoA tunnel shows displacement in all three enzymes. 
All these previously mentioned changes were due to the six different surface residues in HaBPS and 
HsBPS. In the future, surface residues should be the target for mutational experiments, as they 
showed in many cases an important effect on the activity of plant type III PKSs.  
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VI. Summary 
  Type III PKSs share a common αβαβα-fold and a conserved catalytic triad, Cys-His-Asn, in 
their three-dimensional structures. The identity and position of each amino acid residue of the 
active site cavity account for the differences observed between type III PKS activities. 
  Benzoic acid-specific type III PKSs constitute a very interesting group because of their close 
similarities to type II PKSs, which synthesize a serious of interesting medicinal aromatic 
products, such as antibiotics. However, in contrast to type II PKSs, they are smaller and 
simpler in their structures. They utilize benzoyl-CoA as the preferred starter substrate. 
  Benzophenone synthase (BPS) is responsible for the formation of the C13 skeleton of many 
phenolic natural products with interesting pharmacological activities. Biphenyl synthase 
(BIS) synthesizes biphenyls and, derived thereof, dibenzofurans which have antimicrobial 
activities. BPS and BIS catalyze iterative condensation of benzoyl-CoA with three molecules 
of malonyl-CoA to form a linear tetraketide. This intermediate undergoes C6       C1 Claisen 
condensation and aromatization by BPS to form trihydroxybenzophenones. In case of BIS, it 
undergoes C2       C7 aldol condensation and aromatization to form dihydroxybiphenyls. 
  Crystal structures of many plant and some microbial type III PKSs have recently been solved. 
Although, many different scenarios were hypothesized as an explanation for the two different 
reaction mechanisms of these enzymes, it remains open if either electronic or steric factors 
are the major reasons behind the difference. Despite that, it is clear that minor structural 
changes can direct the natural mechanism of one enzyme toward that of the other one, which 
leads to formation of novel unnatural products.  
  Cleavage of the His6-tag was improved at different temperatures and time intervals. The best 
cutting conditions using TEV protease were at 37 °C for 4 h. However, gel filtration 
chromatography could not separate the cutted and the non-cutted enzyme completely. 
Therefore, the crystallization process was carried out using the full His6-tagged protein. 
  Protein expression and purification optimizations were established using high culture volumes 
for H. androsaemum BPS (HaBPS), its mutant HaBPST135L, H. sampsonii BPS (HsBPS), 
and M. domestica BIS3 (MdBIS3). Crystallization of all these enzymes was carried out using 
the vapor diffusion method in close cooperation with the Department of Structure and 
Function of Proteins, Helmholtz Centre for Infection Research, Braunschweig, which 
provided the buffer screens as well as the expertise and equipment needed for protein 
crystallization. 
  The crystal structures of HaBPS and its mutant HaBPST135L were solved at 2.1 Å and 1.4 Å, 
respectively. The orientation of Leu135 proved the formation of a new pocket, which was 
explained previously by structure modelling of the mutant. The active site pocket in 
HaBPST135L is smaller than in HaBPS, which explains the production of a triketide chain 
rather than a tetraketide chain by the wild-type enzyme. 
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  The crystal structure of MdBIS3 was solved at 1.9 Å. It identified a new active site pocket, 
which resembled that of HaBPST135L and seems to be a characteristic pocket of benzoic 
acid-specific type III PKSs. The side chains of Ala127 in MdBIS3 and Thr135 in HaBPS line 
this novel pocket. 
  Claisen versus aldol cyclization differences of type III PKSs are mostly correlated to the 
presence of a water molecule in their crystal structures. Actually, a specific water molecule 
was found in the new pocket of HaBPS and MdBIS3. It is exactly present at the position of 
the water molecule that was responsible for the aldol-switch mechanism of P. sylvestris STS. 
The orientations of Thr135 and Gly166 of HaBPS influence the geometry of the 
neighbouring residues and eventually the hydrogen bond network around the new water 
molecule.  
  Oxidized catalytic Cys was observed in HaBPS and MdBIS3, which is a well-known 
phenomenon of type III PKSs. Therefore, soaking and co-crystallization were commonly 
carried out using the active site mutants HaBPSC167A and MdBIS3C159A. Benzoyl-CoA 
was modeled in one of the datasets of soaked MdBIS3 crystals.  
  The crystal structure of HsBPS was solved at 1.7 Å. In comparison to HaBPS, it has many 
displaced loops, which not only surround the active site pocket but also enclose surface areas 
with amino acids differing between the two enzymes. The side chains of the residues forming 
these loops have different orientations. Structures of enzyme-substrate and/or enzyme-
product complexes are needed for detailed interpretation of both structures. Crystallization of 
active site mutants of HsBPS, HsBPST135K and HsT135I, is important to study structural 
differences in comparison to non-active mutants of HaBPS. 
  Transformation of BPS into BIS is able to identify the main residues that are responsiple for 
the different condensation and cyclization mechanisms. However, a 14-fold mutant of BPS 
exhibited neither BIS nor BPS activity. To achieve a transformation toward BPS in the future, 
a mutagenesis strategy should be carried out, which starts with mutations of BIS or even the 
BPST135L mutant that has a similar new pocket like BIS. In addition, interesting newly 
cloned BPSs and BISs may be available in the future for crystallization, using the conditions 
optimized for HaBPS and MdBIS3, thereby increasing the chance of solving the mystery of 
the aldol/Claisen cyclization mechanism variation.  
 The active site pockets of HaBPS and MdBIS3 demonstrate high similarities in their geometry 
to two important alkaloid-synthesizing plant type III PKSs, namely C. microcarpa ACS and 
C. microcarpa QNS. In a phylogenetic tree, they are also close to CmQNS. This will provide 
the great chance of transforming benzoic acid-specific type III PKSs into ACS and QNS 
using mutagenesis. 
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VIII. Appendix  
1. Sequences of used enzymes 
Hypericum sampsonii Benzophenone synthase (HsBPS) 
ATGGCCCCTGCAATGGAGTACTCAACCCAGAACGGCCAGGGGGAGGGAAAGAAGAGGGCCAGTGTCCTCG
CCATTGGAACGACCAACCCGGAGCACTTCATCTTGCAGGAGGACTACCCGGACTTCTACTTCAGGAACACC
AACAGCGAGCACATGACCGATCTCAAGGAGAAATTCAAGCGCATCTGTGTGAAGTCTCATATTAGGAAGA
GGCACTTCTACCTGACCGAGGAGATCCTCAAGGAGAACCAGGGCATCGCCACCTACGGCGCGGGCTCCCT
GGACGCCCGCCAGAGGATCCTTGAGACTGAGGTCCCCAAGCTAGGCCAAGAGGCGGCCCTCAAGGCCATC
GCGGAGTGGGGCCAGCCCATCTCCAAGATCACCCACGTGGTGTTTGCGACCACCTCCGGGTTCATGATGCC
CGGCGCAGACTACGCCATCACCCGCCTCcTCGGCCTCAACCGCACTGTTAGGCGCGTGATGCTCTACAACC
AGGGCTGCTTTGCCGGGGGCACGGCCCTCCGAGTCGCCAAGGACCTCGCAGAGAACAACGAAGGCGCGCG
GGTCCTCGTCGTGTGCGCGGAGAACACCGCCATGACTTTCCACGCTCCCAACGAGTCCCACCTCGACGTGA
TCGTGGGGCAGGCCATGTTCTCAGATGGTGCTGCCGCTCTGATCATCGGGGCAGGCCCTGACGTTGCCGCG
GGGGAGCGCGCAGTGTTCAATATCCTATCGGCGAGCCAGACGATCGTGCCGGGCTCCGACGGGGCGATAA
CGGCGCACTTCTACGAGATGGGGATGAGCTACTTCCTTAAGGAGGACGTCATCCCTCTCTTCAGGGACAAC
ATCGCCGCCGTCATGGAGGAGGCCTTCTCCCCGCTTGGGGTCTCCGACTGGAACTCCCTCTTCTACTCCATC
CACCCCGGCGGCCGCGGTATCATCGACGGAGTCGCCGGGAACCTCGGGATCAAGGACGAGAACCTCGTGG
CCACCAGGCACGTCCTCGGCGAGTACGGGAACATGGGGTCAGCGTGCGTCATGTTCATCCTGGACGAGCTC
AGGAAGAGCTCCAAGCTCAGCGGGAAGCCCACCACCGGCGACGGCAAAGAGTTCGGCTGCCTCATCGGCC
TCGGCCCCGGCCTCACCGTGGAGGCCGTTGTCCTCCAGAGTGTCCCCATCCTCCAGTGA 
 
MAPAMEYSTQNGQGEGKKRASVLAIGTTNPEHFILQEDYPDFYFRNTNSEHMTDLKEKFKRICVKSHIRKRHFY
LTEEILKENQGIATYGAGSLDARQRILETEVPKLGQEAALKAIAEWGQPISKITHVVFATTSGFMMPGADYAITR
LLGLNRTVRRVMLYNQGCFAGGTALRVAKDLAENNEGARVLVVCAENTAMTFHAPNESHLDVIVGQAMFSD
GAAALIIGAGPDVAAGERAVFNILSASQTIVPGSDGAITAHFYEMGMSYFLKEDVIPLFRDNIAAVMEEAFSPLG
VSDWNSLFYSIHPGGRGIIDGVAGNLGIKDENLVATRHVLGEYGNMGSACVMFILDELRKSSKLSGKPTTGDGK
EFGCLIGLGPGLTVEAVVLQSVPILQ 
Hypericum androsaemum Benzophenone synthase (HaBPS) 
ATGGCCCCGGCGATGGAGTACTCAACCCAGAACGGCCAGGGGGAGGGAAAGAAGAGAGCTAGTGTCCTCG
CTATTGGAACAACCAACCCGGAACATTTCATCTTGCAGGAGGACTACCCCGACTTCTACTTCAGGAACACC
AACAGCGAGCACATGACCGAGCTCAAGGAGAAATTTAAACGTATCTGTGTTAAGTCTCATATTAGGAAGA
GGCACTTCTACCTAACCGAGGAGATTCTCAAGGAGAACCAGGGGATCGCCACCTATGGCGCGGGCTCCCTT
GACGCCCGCCAGAGGATCCTCGAGACCGAGGTCCCGAAGCTGGGTCAGGAGGCGGCCCTCAAAGCCATCG
CGGAGTGGGGCCAGCCCATCTCCAAGATAACACACGTGGTGTTCGCGACGACCTCCGGGTTCATGATGCCC
GGGGCAGACTACGTCATCACCCGCCTCCTCGGCCTCAACCGCACCGTCAGGCGCGTCATGCTCTACAACCA
GGGCTGCTTCGCTGGGGGCACGGCCCTCCGTGTCGCCAAGGACCTCGCGGAGAACAACGAGGGCGCGCGC
GTGCTCGTCGTGTGCGCGGAGAACACCGCCATGACTTTCCACGCCCCCAACGAGTCCCACCTAGACGTGAT
CGTGGGGCAAGCCATGTTCTCAGATGGCGCGGCTGCTCTGATCATCGGGGCATGCCCTGACGTTGCTTCTG
GGGAGCGCGCAGTGTTCAATATCCTGTCGGCGAGCCAGACGATCGTGCCGGGCTCCGACGGGGCGATAAC
GGCGCACTTCTACGAGATGGGGATGAGCTACTTCCTTAAGGAGGACGTCATCCCTCTCTTCCGTGATAACA
TCGCCGCCGTCATGGAGGAGGCCTTCTCTCCGCTTGGGGTCTCCGACTGGAACTCCCTCTTCTACTCCATCC
ACCCCGGTGGCCGAGGGATCATCGACGGCGTCGCCGGGAACCTTGGGATCAAGGACGAGAACCTTGTGGC
GACCAGGCACGTCCTCGGCGAGTACGGGAACATGGGGTCAGCCTGCGTGATGTTCATCCTTGACGAGCTTA
GGAAGAGCTCCAAGGTCAACGGGAAGCCCACCACCGGCGACGGCAAGGAGTTCGGCTGCCTCATCGGCCT
CGGCCCTGGCCTCACCGTGGAAGCCGTCGTCCTCCAGAGTGTCCCAATTCTCCAGTGA 
MAPAMEYSTQNGQGEGKKRASVLAIGTTNPEHFILQEDYPDFYFRNTNSEHMTELKEKFKRICVKSHIRKRHFYLTEEILK
ENQGIATYGAGSLDARQRILETEVPKLGQEAALKAIAEWGQPISKITHVVFATTSGFMMPGADYVITRLLGLNRTVRRVML
YNQGCFAGGTALRVAKDLAENNEGARVLVVCAENTAMTFHAPNESHLDVIVGQAMFSDGAAALIIGACPDVASGERAVFNI
LSASQTIVPGSDGAITAHFYEMGMSYFLKEDVIPLFRDNIAAVMEEAFSPLGVSDWNSLFYSIHPGGRGIIDGVAGNLGIK
DENLVATRHVLGEYGNMGSACVMFILDELRKSSKVNGKPTTGDGKEFGCLIGLGPGLTVEAVVLQSVPILQ 
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Malus domestica biphenyl synthase 3 (MdBIS3) 
ATGGCGCCTTTGGTTAAGAATGAGCCTCAACATGCCAAAATCCTAGCCATTGGCACTGCAAATCCACCCAA
CGTCTACCACCAAAAGGATTATCCTGATTTCTTGTTTCGAGTTACCAAAAATGAGCACAGAACAGATTTAA
GAGAGAAGTTCGATCGCATTTGTGAGAAATCAAGAACAAAGAAGCGCTACTTGCATCTAACAGAAGAGAT
GTTGAAAGCTAACCCAAACATATACACCTATGGAGCCCCATCACTCGATGTGCGCCAAGACATTTGTAACA
TTGAGGTCCCAAAGCTAGGGCAAGAAGCAGCATTGAAAGCCATCAAAGAGTGGGGCCAGCCCATTTCAAA
AATCACCCACCTCATCTTTTGCACAGCTTCTTGCGTTGACATGCCAGGTTGTGACTTCCAATTAATCAAGCT
CCTCGGCCTTGATCCATCCGTCACCAGAACCATGATCTATGAAGCTGGCTGCTATGCTGGTGCGACAGTCCT
CCGCATGGCCAAAGACTTCGCAGAGAACAATAAGGGCGCACGAGTCCTTGTGGTGTGCGCCGAGATCACG
ACCGTGTTTTTCCACGGACTCACTGACACCCACCTTGACATATTGGTGGGTCAAGCTCTTTTTGCTGACGGA
GCATCTGCTGTGATAGTTGGGGCCAATCCAGAGCCTGAAATTGAGAGGCCACTGTTTGAAATCGTGGCTTG
TAGGCAAACGATCCTACCAAACTCAGAGCATGGTGTGGTGGCCAACATTCGTGAAATGGGGTTTAATTATT
ATTTATCAGGAGATGTCCCCAAATTCGTTGGTGGAAATGTTGTGGATTTTATGACTAAAACTTTTGAAAAG
GTAGATGGGAAGAAAAAGGACTGGAACTCCTTGTTTTTCAGTGTGCACCCTGGTGGACCTGCCATTGTAGA
CCAGGTGGAGGAGAAATTGGGTTTGAAGGAAGGGAAGCTTAGGGCAACAAGGCATGTGTTGAGTGAGTAT
GGCAACATGGGAGCTCCAACTGTGCACTTTATTTTGGATGAGATGAGAAATAAGTCGATTGAGGAAGGCA
AAACCACTACTGGTGAAGGTTTGGAATGGGGTGTCGTGATTGGAATCGGACCGGGACTCACTGTCGAGAC
AGCCGTGCTGCGTAGTGAATCTATTCCATGCTAA 
MAPLVKNEPQHAKILAIGTANPPNVYHQKDYPDFLFRVTKNEHRTDLREKFDRICEKSRTKKRYLHLTEEMLKANPNIYTY
GAPSLDVRQDICNIEVPKLGQEAALKAIKEWGQPISKITHLIFCTASCVDMPGCDFQLIKLLGLDPSVTRTMIYEAGCYAG
ATVLRMAKDFAENNKGARVLVVCAEITTVFFHGLTDTHLDILVGQALFADGASAVIVGANPEPEIERPLFEIVACRQTILP
NSEHGVVANIREMGFNYYLSGDVPKFVGGNVVDFMTKTFEKVDGKKKDWNSLFFSVHPGGPAIVDQVEEKLGLKEGKLRAT
RHVLSEYGNMGAPTVHFILDEMRNKSIEEGKTTTGEGLEWGVVIGIGPGLTVETAVLRSESIPC 
Sorbus aucuparia biphenyl synthase 1 (SaBIS1) 
ATGGCGCCTTTGGTTAAGAATCATGGAGAGCCTCAACATGCCAAAATCCTAGCCATTGGCACTGCAAATCC
ACCAAACGTCTACTACCAAAAAGACTATCCTGATTTCTTGTTTCGAGTCACCAAAAATGAGCACAGGACAG
ATTTAAGAGAGAAGTTTGATCGCATTTGTGAGAAATCAAGAACAAGGAAGCGTTACTTGCATCTAACAGA
GGAGATTCTAAAGGCTAACCCAAGCATATATACCTATGGTGCCCCATCACTCGATGTGCGCCAAGACATGT
TGAATTCTGAGGTCCCAAAGCTAGGGCAACAAGCAGCACTGAAAGCCATCAAAGAGTGGGGCCAACCCAT
CTCAAAGATCACCCACCTCATCTTTTGCACAGCTTCATGTGTTGACATGCCAGGTGCCGACTTCCAATTGGT
CAAGCTCCTCGGCCTTAACCCATCTGTCACTAGAACCATGATCTACGAAGCTGGTTGCTATGCTGGTGCAA
CTGTCCTCCGCCTAGCCAAGGACTTCGCAGAGAACAACGAGGGTGCACGCGTCCTTGTGGTGTGCGCTGAG
ATCACGACCGTGTTCTTCCACGGACTCACTGACACCCACTTGGACATACTGGTGGGCCAGGCTCTTTTTGCT
GACGGAGCATCTGCTGTGATAGTTGGGGCCAATCCAGAGCCTAAAATTGAGAGGCCACTATTTGAAATCGT
GGCATGCAGGCAGACAATCATACCGAACTCAGAGCATGGTGTGGTGGCCAACATTCGTGAAATGGGGTTT
ACTTATTATTTATCAGGAGAAGTCCCCAAATTTGTTGGTGGAAATGTTGTGGATTTTCTGACTAAAACTTTT
GAAAAAGTTGACGGAAAGAATAAGGACTGGAACTCCTTGTTTTTCAGTGTGCACCCTGGTGGACCCGCCAT
TGTAGACCAGGTGGAGGAGCAACTGGGTTTGAAGGAAGGGAAGCTTAGGGCAACAAGGCATGTGTTGAGT
GAGTATGGCAACATGGGAGCTCCATCTGTGCACTTTATTTTGGATGATATGAGAAAGAAGTCGATTGAGGA
AGGCAAATCCACAACTGGCGAAGGTTTGGAATGGGGTGTCGTGATTGGAATCGGACCAGGACTCACTGTT
GAGACAGCCGTACTGCGTAGTGAATCTATTCCATGCTAAATACTTGCATAAAATGATTCATATATTGATTA 
MAPLVKNHGEPQHAKILAIGTANPPNVYYQKDYPDFLFRVTKNEHRTDLREKFDRICEKSRTRKRYLHLTEEILKANPSIY
TYGAPSLDVRQDMLNSEVPKLGQQAALKAIKEWGQPISKITHLIFCTASCVDMPGADFQLVKLLGLNPSVTRTMIYEAGCY
AGATVLRLAKDFAENNEGARVLVVCAEITTVFFHGLTDTHLDILVGQALFADGASAVIVGANPEPKIERPLFEIVACRQTI
IPNSEHGVVANIREMGFTYYLSGEVPKFVGGNVVDFLTKTFEKVDGKNKDWNSLFFSVHPGGPAIVDQVEEQLGLKEGKLR
ATRHVLSEYGNMGAPSVHFILDDMRKKSIEEGKSTTGEGLEWGVVIGIGPGLTVETAVLRSESIPC 
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2. Crystallization kits 
Table 9. The crystallization screens used in this project 
QIAGEN Molecular Dimensions Hampton research Jena bioscience 
JCSG1 
JCSG2 
JCSG3 
JCSG4 
JCSG+ 
PACT 
PGA 
MORPHEUS 
MIDAS+ 
INDEX JBScreen 
ClassicHTS2 
 
3. Synchrotron trips 
Hamburg: Deutsches Elektronen-Synchrotron (DESY) in Helmholtz-Gemeinschaft. 
Switzerland: Swiss Lightsource (SLS) at the Paul Scherrer Institut (PSI). 
Grenoble-France: The High Throughput Crystallization Facility at HTX lab using Crystallization 
Information Management System (CRIMS). 
4. PDB-code of previously mentioned crystallized plant type III PKSs 
Table 10. The PDB numbers of crystallized plant type III PKSs mentioned in this project 
Enzyme PDB-code 
MsCHS 1BI5 
PsSTS and AhSTS 1XES and 1Z1E 
GhPS 1QLV 
CClCUS 3OV2 
OsCUS 3OIT 
RpBAS 3A5Q 
CmACS 3WD7 
CmQNS 3WD8 
AaPCS 2D3M 
AaPCSM207G (function of OKS)  2D51 
HaBPS 5UCO 
MdBIS3 5W8Q 
MdBIS3 complexed with benzoyl-CoA 5WC4 
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5. Expression, purification and crystallization of the mutant HsBPST135K 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig VIII.1a First purification trial of HsBPST135K. SDS-PAGE shows pure protein and a relatively sharp 
peak appeared in gel filtration chromatography. The specific fractions from 16 to 21, which correspond to the 
main sharp peak, were collected, concentrated and subjected to crystallization screens. 
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 S200 16/60              
 7 mg/ml HsBPST135K      
20 mM Tris HCl   pH 8.4 
100 mM MaCl 
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Fig VIII.1b The first crystallization screens of HsBPST135K. The mutant did not develope any crystals, but it 
showed heavy precipitation in 95% of conditions after 12 h.  
 
  
 
 
 
 
 
 
 
 
Fig VIII.2a Second purification trial of HsBPST135K. Large culture volumes were used to increase the 
protein amount more than in the first trial. SDS-PAGE shows highly concentrated pure protein. 
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Fig VIII.2b A relatively sharp peak appeared in gel filtration chromatography of HsBPST135K. The specific 
fractions from 16 to 21, which correspond to the main sharp peak, were collected, concentrated and subjected 
to crystallization screens. 
 
  
 
 
 
 
 
 
 
 
 
Fig VIII.3a Thermofluor assay results to detect the best buffer for HsBPST135K. High amounts of NaCl (100-
500 mM) resulted in low stability of the protein in Tris-HCl buffer pH 8.5. 
  
            Fig IV.32a HsBPS screen                                                                                                                     
  S200 16/60              
15  mg/ml HsBPST135K      
20 mM Tris HCl   pH 8.4 
150 mM NaCl 
10% Glycerol 
 Fractions collected 
for crystallization 
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Fig VIII.3b Thermoflour assay results to detect the best additive for HsBPST135K.  High thermal signals 
were recorded, but they did not show better stability of HsBPST135K in the buffer. 
17 mg/ml protein in 20 mM Tris-HCl buffer was used in crystallization screens, but again heavey 
precipitate formed in almost all conditions.  
 
 
 
 
 
 
 
  
